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This review covers the literature published in 2014 for marine natural products (MNPs), with 1116
citations (753 for the period January to December 2014) referring to compounds isolated from
marine microorganisms and phytoplankton, green, brown and red algae, sponges, cnidarians,
bryozoans, molluscs, tunicates, echinoderms, mangroves and other intertidal plants and
microorganisms. The emphasis is on new compounds (1378 in 456 papers for 2014), together with
the relevant biological activities, source organisms and country of origin. Reviews, biosynthetic
studies, ﬁrst syntheses, and syntheses that lead to the revision of structures or stereochemistries,
have been included.1 Introduction
2 Reviews
3 Marine microorganisms and phytoplankton
3.1 Marine-sourced bacteria (excluding from mangroves)
3.2 Bacteria from mangroves
3.3 Marine-sourced fungi (excluding from mangroves)
















17 Referencesanterbury, Christchurch, New Zealand.
Auckland, Auckland, New Zealand
and Physical Sciences, Victoria University
Waikato, Hamilton, New Zealand
tion (ESI) available. See DOI:
11 Introduction
These annual reviews of marine natural products were initiated
by the late Professor D. John Faulkner in 19841,2 and continued
by the New Zealand group since 2003. A feature of the reviews
has been the inclusion of the structures for all new MNPs, and
any subsequently revised structures. The number of new MNPs
reported each year has steadily grown from 332 in 1984 to 1378
in this present review of the 2014 literature. This has inevitably
resulted in an increased size for each review. With the ever-
increasing size creating diﬃculties for preparation of the
annual review, the NPR Editorial Board suggested changing the
format to focus on a selection of highlighted structures. To
maintain the usual comprehensive coverage of all new and
revised MNPs, we have prepared a ESI‡ document with links
associated with this review, showing all structures, along with
their names, taxonomic origins, locations for collections, and
biological activities. The numbers for all highlighted structures
in this review (169) are shown in non-italicised bold font, while
italicised numbers refer to the remaining structures in the ESI
document.‡ For structures that have their absolute congura-
tions fully described, the compound number in the diagrams is
preceded with †. In addition to the highlighted compounds in
this review, we have retained the inclusion of reference to rst
syntheses of MNPs, and comments on new information on
ecological aspects, bioactivities or other relevant data for
previously reported MNPs, all as non-highlighted material. The
Reviews section (Section 2) has also been reformatted to show
selected highlights, with all other reviews referenced in
a section of the ESI document.‡This journal is © The Royal Society of Chemistry 2016





























































































View Article Online2 Reviews
There continues to be a steady increase in the number of
reviews of various aspects of MNP studies. Some of the moreJohn Blunt obtained his BSc
(Hons) and PhD degrees from the
University of Canterbury, fol-
lowed by postdoctoral appoint-
ments in Biochemistry at the
University of Wisconsin–Madi-
son, and with Sir Ewart Jones at
Oxford University. He took up
a lectureship at the University of
Canterbury in 1970, from where
he retired as an Emeritus
Professor in 2008. His research
interests are with natural prod-
ucts, the application of NMR techniques to structural problems, and
the construction of databases to facilitate natural product investi-
gations.
Brent Copp received his BSc
(Hons) and PhD degrees from the
University of Canterbury, where
he studied the isolation, structure
elucidation and structure–
activity relationships of biologi-
cally active marine natural
products under the guidance of
Professors Blunt and Munro. He
undertook postdoctoral research
with Jon Clardy at Cornell and
Chris Ireland at the University of
Utah. 1992–93 was spent
working in industry as an isolation chemist with Xenova Plc, before
returning to New Zealand to take a lectureship at the University of
Auckland, where he is currently an Associate Professor.
Rob Keyzers carried out his BSc
(Hons) and PhD studies at
Victoria University of Wellington.
His thesis research, carried out
under the guidance of Assoc. Prof.
Peter Northcote, a former
contributor to this review,
focused on spectroscopy-guided
isolation of sponge metabolites.
He then carried out post-doctoral
research with Mike Davies-Cole-
man (Rhodes University, South
Africa) and Raymond Andersen
(University of British Columbia, Canada) before a short role as
a avour and aroma chemist at CSIRO in Adelaide, Australia. He
was appointed to the faculty at his alma mater in 2009 where he is
currently a Senior Lecturer.
This journal is © The Royal Society of Chemistry 2016signicant reviews (16) are given here while a listing of the
remainder (71) is given in the ESI section.‡ A comprehensive
review of MNPs reported in 2012 has appeared.3 ‘Marine-sourced
anticancer and cancer pain control agents in clinical and late
preclinical development’ have been reviewed,4 and ‘New horizons
for old drugs and drug leads’were described.5 The implications of
the Convention on Biological Diversity (1999) and its Nagoya
Protocol (2010) on the collection of marine genetic resources
has been discussed and should be noted by all who collect
marine organisms for MNP studies.6 The putative microbial
origin of sponge metabolites has been the subject of several
reviews and articles.7–11 Developments in chemical ecology for
sh and benthic algae and invertebrates for 2010–2012 have
been reviewed, with comment on the biosynthesis of bioactive
MNPs by symbiotic microorganisms.12 Polyketide biosynthesis
in dinoagellates has been reviewed.13 There have been
comprehensive reviews for marine nucleosides,14 saxitoxin,15
and tetrodotoxin.16 A review of ‘Emerging strategies and inte-
grated systems microbiology technologies for biodiscovery of marine
bioactive compounds’ provides a very useful oversight of
a number of developing techniques.17 ‘AlgaeBase: an on-lineMurray Munro, Emeritus
Professor in Chemistry at the
University of Canterbury, has
worked on natural products right
through his career. This started
with diterpenoids (PhD; Peter
Grant, University of Otago), fol-
lowed by alkaloids during a post-
doctoral spell with Alan
Battersby at Liverpool. A sabbat-
ical with Ken Rinehart at the
University of Illinois in 1973 led
to an interest in marine natural
products with a particular focus on bioactive compounds which has
continued to this day. In recent years his research interests have
widened to include terrestrial/marine fungi and actinomycetes.
Miche`le Prinsep received her BSc
(Hons) and PhD degrees from the
University of Canterbury, where
she studied the isolation and
structural elucidation of biologi-
cally active secondary metabo-
lites from sponges and bryozoans
under the supervision of Profes-
sors Blunt and Munro. She
undertook postdoctoral research
on cyanobacteria with Richard
Moore at the University of
Hawaii before returning to New
Zealand to take up a lectureship at the University of Waikato, where
she is currently an Associate Professor.
Nat. Prod. Rep., 2016, 33, 382–431 | 383





























































































View Article Onlineresource for algae’ is an article describing a very comprehensive
algal database.18 As in previous years, the MarinLit database19
has been updated and used as the literature source for the
preparation of this present review.3 Marine microorganisms and
phytoplankton
Even considering the trend of recent years that many marine
natural products research eﬀorts are directed towards micro-
organisms, there has been a sharp upward swing in the number
of new metabolites reported from marine microorganisms (677
vs. 493 in 2013). Unless otherwise stated, compounds described
in this section were obtained from cultures of the named
microorganisms.3.1 Marine-sourced bacteria (excluding from mangroves)
The number of new compounds reported from marine bacteria
(164) is similar to the 158 reported in 2013. A metagenomic
approach has identied the gene cassette responsible for the
biosynthesis of calyculin A, originally isolated from the sponge
Discodermia calyx,20 as microbial in origin, arising from Candi-
datus Entotheonella sp. Functional analysis of the biosynthetic
pathway has shown that the end product is actually a diphos-
phate protoxin, phosphocalyculin A 1 rather than calyculin A,
suggesting a phosphorylation/dephosphorylation mechanism
for the active chemical defence of the host sponge.21 A further
diphosphate, protoxin phosphocalyculin C 2, has been isolated
from D. calyx but can be assumed to have arisen from the same
microbial source. Phosphocalyculin C, although potent (IC50 ¼
36 nM vs. P388), is 5000 times less toxic than calyculin C itself.22
A Chinese sediment-derived Actinoalloteichus cyanogriseus23
was the source of cyanogramide 3, an unprecedented spirocyclic
alkaloid with multidrug-resistance (MDR) reversing activity.24
An interesting dereplication strategy was utilised in the study of
sponge-associated Actinokineospora sp. Principal Component
Analysis (PCA), hierarchical clustering (HCA) and orthogonal
partial least square-discriminant analysis (OPLS-DA) were
employed to evaluate HRFTMS and NMR data of crude extracts
arising from four diﬀerent fermentation regimes. Statistical
analysis enabled identication of the most suitable one-strain-
many-compounds (OSMAC) culture conditions and extraction384 | Nat. Prod. Rep., 2016, 33, 382–431method resulting in isolation of the O-glycosylated angucyclines
actinosporin A 4 and B 5 of which actinosporin A 4 possessed
moderate activity against the causative agent of sleeping sick-
ness, Trypanosoma brucei (T. brucei).25
A Korean sediment-derived strain of Bacillus subtilis (B.
subtilis) has yielded a variety of linear lipopeptides with
diﬀering biological properties, the gageopeptides A–D 6–9,26
gageostatins A–C 10–1227 and gageotetrins A–C 13–15.28 Most
are non-cytotoxic with good antibacterial activity, but better
antifungal activity especially against the late blight pathogen
Phytophthora capsici in the case of gageotetrins A–C. A trans-
formation-associated recombination (TAR) cloning approach
was used to capture, activate and express a 67-kb non-ribosomal
peptide synthetase (NRPS) biosynthetic gene cluster from Sac-
charomonospora sp., resulting in isolation of the dichlorinated
lipopeptide antibiotic taromycin A 16.29
Solwaraspora sp. (ascidian, Trididemnum orbiculatum, Flor-
ida Keys, U.S.A.) produced the trialkyl-substituted aromatic
acids, solwaric acids A 17 and B 18. Enrichment with 13C-
labelled glucose followed by acquisition of a 13C–13C COSY
enabled unambiguous determination of the position of the
methyl group on the phenyl ring, an approach which could be
very useful for structural determination of molecules with
multiple quaternary carbons.30
Heronapyrroles A–C are nitropyrrole metabolites with
a partially oxidised farnesyl chain appended that were obtained
from a Streptomyces sp.31 Biosynthetic considerations prompted
the hypothesis that a mono-tetrahydrofuran-diol, heronapyrrole
D might be an as yet unidentied metabolite of the bacterium.
Following a putative biomimetic synthesis of heronapyrrole D
19 the metabolite was then detected in cultures of the bacte-
rium, thus validating this approach.32 Total synthesis of her-
onapyrrole C31 has also been reported.33 Mollemycin A 20 is
a rst-in-class glycol-hexadepsipeptide-polyketide from a Strep-
tomyces sp. (sediment, South Molle Is., Queensland, Australia)
and active against certain Gram-positive and Gram negative
bacteria, in addition to extremely potent antimalarial activityThis journal is © The Royal Society of Chemistry 2016
This journal is © The Royal Society of Chemistry 2016 Nat. Prod. Rep., 2016, 33, 382–431 | 385



























































































































































































View Article Onlineagainst drug sensitive and MDR Plasmodium falciparum (P. fal-
ciparum) clones.34
A deep-sea strain of Streptomyces, previously a source of
spiroindimicins A–D,35 lynamycins A and D35 and piericidins36386 | Nat. Prod. Rep., 2016, 33, 382–431has now led to isolation of a number of bisindole alkaloids;
indimicins A–E 21–25, lynamycins F 26 and G 2737 and pier-
icidin E1 2836 using the same modied A1BFe + C medium.
Piericidin E1 28 was shown to be an intermediate in the
biosynthesis of piericidin A138 during identication of the
biosynthetic gene cluster.Growth of the strain in modied ISP3 medium yielded her-
onamides D–F 29–31.39 Violapyrones H 32, I 33, B 34 and C 3540
were obtained from Streptomyces sp. (starsh, Acanthaster
planci, Chuuk, Federated States of Micronesia).41 Violapyrone C
35 has since been synthesised and the absolute conguration
determined.42
A study of the biosynthetic pathway for marineosins43 in
Streptomyces sp. led to isolation of 23-hydrox-
yundecylprodiginine 36, 23-ketoundecylprodiginine 37, pre-
marineosin A 38 and 16-ketopremarineosin A 39.44 Syntheses of
23-hydroxyundecylprodiginine 36 (both enantiomers and theThis journal is © The Royal Society of Chemistry 2016





























































































View Article Onlineperdeuterated version) and of 23-ketoundecylprodiginine 37
were reported, as was the feeding of synthetic prodiginine
analogues which led to the production of novel premarineosins,
although these were not fully characterised.45
The structure of merochlorin A46,47 has been revised to 4048
and a biomimetic synthesis of ()-merochlorin B46 has been
achieved,49while a study of the biosynthesis of themerochlorins
revealed that just four enzymes are involved50 and that a vana-
dium-dependent chloroperoxidase mediated a complex series
of unprecedented transformations in the biosynthesis. Devel-
opment of a chlorination method paralleling the biocatalytic
process led to the identication of previously undiscovered
merochlorins 41–43.51 The known synthetic compound ser-
iniquinone 4452 has now been obtained as a natural product
from Serinicoccus sp. and displayed potent and selective anti-
tumour activity.53
Investigation of the biosynthesis of sulfur-containing rose-
obacticides54,55 produced by Phaeobacter inhibens indicated that
these compounds arise from three subunits – dimethylsulfo-
niopropionate, phenylacetic acid and p-coumaric acid and that
roseobacticides regulate the symbiosis between P. inhibens and
the microalga Emiliana huxleyi.56 Further new metabolites 45–
103 were obtained from the genera Actinoalloteichus, Actino-
madura, Actinokineospora, Amycolatopsis, Bacillus, Dermacoccus,This journal is © The Royal Society of Chemistry 2016Escherichia, Jejua, Micrococcus, Micromonospora, Nocardiopsis,
Pelomonas, Pseudoalteromonas, Rapidithrix, Salinispora and
Shewanella.57–80 As usual, many new metabolites, and some with
revised structures, were also obtained from the genus Strepto-
myces including 104–172.81–103 The genera Verrucosispora and
Vibrio also yielded new metabolites 173 and 174.104,105 Investi-
gation of an octocoral-associated Pseudoalteromonas sp. by
MALDI-imaging mass spectrometry (IMS) and molecular
network analyses indicated that the strain produces higher
levels of the antifungal polyketides, alteramides106,107 in the dark
than in the light and also led to revision of the conguration at
C-6 for 175 and 176.108 In the light, these compounds were
inactivated through a photoinduced intramolecular cyclisation
and production of higher levels of these antifungal metabolites
in the dark was proposed as a strategy to protect the host corals
during night feeding, when they are more exposed.108 Synthesis
of the proposed structure of heronamide C109 has indicated that
the actual structure of the natural product needs to be re-
examined110 and the structure of anthracimycin111 has also been
corrected to 177.112 Total syntheses of indoxamycins113 has led
to stereochemical revision for the indoxamycins B,114 D113 and
E113 to 178–180.115 A number of other total syntheses of bacterial
metabolites have been reported. These include syntheses of the
depsipeptides, solanamides A116 and B116,117 and arenamides B118
and C,118,119 and synthesis120 of the nucleoside antibiotic
A201A.121,122 Total synthesis of dixiamycin B123 was achieved
utilising electrochemical oxidation.124 The alkaloid mansour-
amycin D125,126 was synthesised, as was 5-deoxyte-
trodotoxin.127,128 New biological activities have been reported for
sporolide B129 from Salinispora tropica,130 for some buteno-
lides131,132 and undecylprodigiosin133 from Streptomyces
strains.134,135 Biosynthetic studies have been conducted into
various bacterial metabolites including arachidonic acid (in
Aureispira marina),136,137 macrolactins138 and bacillaene139 (in
Bacillus marinus),140 polybrominated aromatics141 (in Mar-
inomonas mediterranea142 and Pseudoalteromonas spp.143),
lomaiviticins144 (in Salinispora pacica145,146 (formerly Micro-
monospora lomaivitiensis)), tropodithietic acid147 (in Phaeobacter
inhibens),148 sulfur volatiles149 (in the Roseobacter clade)150 and
avaroferrin151 and putrebactin152 (in Shewanella sp.).153 Biosyn-
thetic studies within the genus Streptomyces include those on
thiocoraline154 (in S. albus),155 ikarugamycin,156–158 anti-
mycins159,160 and polyhydroxylated saturated fatty acids,161
marinophenazines162–164 and the isoprenylated phenazines,165,166
JBIR-46, JBIR-47 and JBIR-48.1673.2 Bacteria from mangroves
There has been an increase in the number of new metabolites
reported from bacteria associated with mangroves (23 in 2014
vs. 10 in 2013). Lechevalieria aerocolonigenes yielded the cyclo-
pentadecane metabolites, mangromicins A 181, B 182168 and
D–I 183–188,169 with mangromicin A 181 exhibiting potent
antitrypanosomal and radical scavenging (DPPH) activi-
ties.168,169 New divergolide congeners 189–192 were obtained
from an endophytic Streptomyces strain170 and the biosynthetic
gene cluster for divergolides171 identied and characterised.172Nat. Prod. Rep., 2016, 33, 382–431 | 387





























































































View Article OnlineOther metabolites 193–203 were isolated from the genera Jish-
engella, Micromonospora, Streptomyces and Verrucosispora,173–176
and a bio-inspired total synthesis of the indole sesquiterpenoid
sespenine177 completed.178
3.3 Marine-sourced fungi (excluding from mangroves)
Studies of fungi continue to rise with 318 new compounds re-
ported in 2014 compared to 223 in 2013. Sponge-associated
Aspergillus similanensis yielded two isocoumarin derivatives 204
and 205, and a deacetyl analogue of chevalone C,179 chevalone E
206, in addition to pyripyropene S 207.180 While chevalone E 206
itself did not display signicant antibacterial activity, it did
exhibit synergy with the antibiotics oxacillin and ampicillin
against MRSA.181 Ultrasonication of Aspergillus versicolor spores
led to the isolation of a mutant with neomycin resistance from
which six metabolites not present in the parent strain,
including 208 were obtained. Although several patents exist for
synthesis of the planar structure of this compound,182–184 this is
the rst natural product (NP) isolation and establishment of
stereochemistry.
Cyclo(D-Tyr-D-Pro) was also claimed as a rst NP isolation but
this has previously been obtained from both terrestrial185 and
marine186 sources.187 Lumazine peptides, penilumamide B–D
209–211 and a cyclic pentapeptide, asperpeptide A 212 were
obtained from a gorgonian-derived Aspergillus sp. The presence
of the sulfone penilumamide188 and the derived sulfoxide388 | Nat. Prod. Rep., 2016, 33, 382–431penilumamide C 210 led to speculation that these compounds
were derived from oxidation of a putative metabolite containing
a methionine residue. This led to a feeding experiment with L-
methionine resulting in isolation of the sulde, penilumamide
B 209. Yields of penilumamide B 209 and penilumamide
increased with increasing concentration of L-methionine and
when penilumamide B 209 was exposed to air, penilumamide
was detected aer a few days whilst penilumamide C 210 was
formed several days later.189
Of the two prenylated hydroquinone derivatives 213 and 214
obtained from a gorgonian-derived Aspergillus sp., 214 exhibited
very potent activity against respiratory syncytial virus (RSV).190
These two metabolites diﬀer only in the conguration of
a methyl group on a cyclohexane ring yet given that 214 is an
extremely potent anti-RSV agent whilst its epimer 213 is
completely inactive, indicating the importance of the congu-
ration of this ring for anti RSV-activity.
So-coral associated Chondrostereum sp. has previously been
reported to produce hirsutane-framed sesquiterpenes.191–193
Cultivation of the fungus in a medium with glycerol as the
carbon source led to the isolation of the sesquiterpenes chon-
drosterin I 215 and J 216 of which chondrosterin J 216 displayed
potent activity against HTCLs.194 Chemical epigenetic modi-
cation of Cochliobolus lunatus (sea anemone Palythoa haddoni)
with inhibitors of histone deacetylase (HDAC) resulted in
isolation of two brominated 14-membered resorcylic acid
lactones 217 and 218, but only in the presence of an HDAC
inhibitor.195This journal is © The Royal Society of Chemistry 2016





























































































View Article OnlineThe chromones engyodontiumone A–H 219–226 and the
phenol derivatives 227–229 were derived from deep-sea derived
Engyodontium album. Of these, engyodontiumones E–G 223–225
were obtained as racemates.196 The known polyketide aspergillus
one B197 was also isolated and was a potent inhibitor of settle-
ment of Balanus amphitrite (B. amphitrite) larvae.196 Fermentation
of a lamentous fungus of the Eurotiomycetes class (ascidian,
Lissoclinum patella, Papua New Guinea) produced the pentacyclic
oxazinin A 230, derived from a combination of benzoxazine,
isoquinoline and pyran rings. Oxazinin A 230 occurred as
a racemate and was antimycobacterial.198
Neosartorya pseudoscheri (starsh Acanthaster planci,
Hainan, China) produced diﬀerent suites of metabolites when
cultured in diﬀerent media. When cultured in glycerol–
peptone–yeast extract (GlyPy), the diketopiperazines neosartin A
231 and B 232 were produced along with six known diketopi-
perazines and a precursor alkaloid but when fermented in
glucose–peptone–yeast extract (GluPy), a tetracyclic-fused alka-
loid neosartin C 233 was produced along with a known mer-
oterpenoid and ve known gliotoxin analogues 234–238,
obtained here for the rst time as NPs.199 Endophytic Paecilo-
myces variotii (red alga, Grateloupia turuturu, Qingdao, China)
yielded varioxepine A 239, an alkaloid with an unprecedented
3,6,8-trioxabicyclo[3.2.1]octane unit.200This journal is © The Royal Society of Chemistry 2016Biosynthetic feeding experiments on Penicillium citrinum
using 13C labelled glucose, anthranilic acid and ornithine resul-
ted in isolation of two new citrinalins, 17-hydroxycitrinalin B 240
and citrinalin C 241 and supported the proposition that the cit-
rinalins arise from a bicyclo[2.2.2]diazaoctane precursor. Also in
this investigation, synthesis of the enantiomer of citrinalin B201
led to revision of the structure of citrinalin B to 242.202 Pen-
icillipyrones A 243 and B 244 are meroterpenoids obtained from
a sediment-derived Penicillium strain and represent a new skel-
etal class with a unique linkage between the drimane sesquiter-
pene and pyrone moieties. Penicillipyrone B 244 elicited
signicant induction of quinone reductase in murine hepatoma
cells, indicating a possible cancer preventative role.203
Metabolites 245–254 were also obtained from the genera
Acremonium, Arthrinium, Ascotricha and Astrocystis.204–207 As usual,
a large number of metabolites were obtained from species of the
Aspergillus genus. Two indole diterpenoids 255 and 256, and an
isocoumarin 257 were obtained from A. avus. The known
compounds b-aatrem,208 paspalinine209,210 and leporine B211 wereNat. Prod. Rep., 2016, 33, 382–431 | 389





























































































View Article Onlineisolated and leporine A212 was prepared from the last of these.
Congurations were established for each as 258–261 respectively
and b-aatrem and leporine B were isolated for the rst time as
MNPs.213 Other metabolites isolated from the genus Aspergillus
include 262–327 (the last obtained from co-culture with an
unidentied bacterium).214–237 New metabolites 328–371 were also
obtained from the genera Beauveria, Cladosporium, Cochliobolus,
Curvularia, Dendrodochium, Diaporthaceae, Dichotomomyces,
Emericella and Eurotium.238–250 A pyrrolidinoindoline diketopiper-
azine dimer, cristatumin E, isolated from Eurotium herbariorum,251
appears to be identical to the previously reported eurocristatine.252
The genera Hansfordia, Humicola, Isaria, Neosartorya, Nigrospora,
Paecilomyces and Paraconiothyrium also yielded the new metabo-
lites 372–399.179,253–258 The genus Penicillium was the source of
many other metabolites 400–461.259–278 Other genera to yield new
the metabolites 462–520 were Pseudallescheria, Spicaria, Spi-
romastix, Stachybotrys, Talaromyces, Trichoderma, Xylaria and
Xylariaceae,279–291 while 521 was obtained from a strain of the
order Xylariales and also synthesised.292 A number of syntheses of
fungal metabolites have resulted in structural revisions of the
natural products, including syntheses of ()-protubonine A 522,
()-protubonine B 523 (Aspergillus sp.)293,294 and (+)-cristatumin C
524 (Eurotium cristatum).295,296 Synthesis of the racemate of oxali-
cumone C (Penicillium oxalicum)297 followed by resolution by chiral
HPLC and examination of experimental and calculated ECD data,
resulted in the conguration of the natural product being
assigned as (S)-525.298 Culture of a strain of Aspergillus clavatus
isolated from the hydrothermal vent crab Xenograpsus testudinatus
in the presence of the abiotic stress agent and hydrothermal vent
uid component zinc (as zinc sulfate), elicited production of
a known synthetic cyclic peptide299 that was isolated for the rst
time from a natural source and named as clavatustide C 526. The
fungus did not produce clavatustide C 526 when cultured in the
absence of zinc.300 Pericosine E301 (Periconia byssoides) occurs as an
enantiomeric mixture in nature and synthesis of the preferred
enantiomer ()-pericosine E 527 has been reported.302 First
syntheses of a number of fungal metabolites achieved include
those of secalonic acids A303 (Paecilomyces sp.)304 and D305 (Glio-
cladium sp.)306,307 ()-sorbiterrin A308 (Penicillium terrestre),309
()-auronamide C310 (Penicillium aurantiogriseum),311 calcaripep-
tides A–C312 (Calcarisporium sp.),313 ()-aspergilazine A314 (Asper-
gillus taichungensis),315 aspirin316 (Aspergillus versicolor),317
cochliomycin B318 (Cochliobolus lunatus),319 dendroides320 (Den-
drodochium sp.) A,321 B322 and E,322 paecilocin323 (Paecilomyces
variotii),324 penicimonoterpene325 (Penicillium chrysogenum)326 and
(+)-penostatin E327 (Penicillium sp.).328 The benzaldehyde derivative
isotetrahydro-auroglaucin329,330 has been shown to exhibit anti-
inammatory activity, inhibiting the NF-kB pathway through
suppressing production of both pro-inammatory mediators and
cytokines.331 Oxirapentyns A332,333 and B333 exhibited growth stim-
ulatory eﬀects on seedling roots of barley and wheat334 while iso-
echinulin A335,336 was a strong inhibitor of settlement of larvae of
the barnacle B. amphitrite.337 Methylpenicinoline338 also displayed
anti-inammatory activity, suppressing expression of pro-inam-
matory mediators through the NF-kB and MAPK pathways.339
Heavy metal stress of two strains of hydrothermal vent fungi
(Aspergillus sclerotiorum and A. clavatus) induced biosynthesis of390 | Nat. Prod. Rep., 2016, 33, 382–431metabolites that were not produced under normal culture
conditions: A. sclerotiorum produced aspochracin340,341 when
stressed with copper and produced stephacidin A342 and notoa-
mides B342 and F343 under normal culture conditions whilst A.
clavatus produced the acetophenone derivative clavatol344,345 under
stress conditions and deoxytryptoquivaline346 and tryptoquivaline
A346 in metal-free culture.3473.4 Fungi from mangroves
There has been a considerable increase in the number of new
metabolites reported from mangrove-associated fungi (108 in
2014 vs. 75 in 2013), with the majority coming from endophytic
species. Co-culture of Alternaria and Phomopsis species led to
isolation of three cyclic peptides 528–530, all of which exhibited
signicant activity against a range of plant pathogenic
fungi,348,349 whilst co-culture of two brown alga (Sargassum)-
derived Aspergillus species also produced a cyclic peptide, psy-
chrophilin E 531.350This journal is © The Royal Society of Chemistry 2016





























































































View Article OnlineAspergillus avipes was the source of the aromatic butyr-
olactones, avipesin A 532 and B 533 and the previously syn-
thesised 534351 and 535,352 of which avipesin A 532 exhibited
moderate to good antibacterial activity. Unlike penicillin, it was
able to penetrate the biolm matrix to kill live bacteria inside
mature Staphylococcus aureus biolm.353 An endophytic Dia-
porthe sp. was the source of diaporine 536, an unprecedented
symmetric polyketide which induces conversion of tumour
associated macrophages from the M2 to the M1 phenotype in
both cellular and animal models.354
The polyketides dothiorelone F 537 and I 538 were obtained
from endophytic Dothiorella sp. along with three known
analogues.355 Of these analogues, dothiorelone G356 is actually
the same as the previously reported cytosporone R,357 also ob-
tained from a mangrove associated species (Leucostoma per-
soonii). Peniphenones A–D 539–543 were obtained from
Penicillium dipodomyicola. Of these, peniphenone A 539, 540
occurs as a racemate and was separated into its enantiomers by
chiral HPLC while peniphenones B 541 and C 542 stronglyThis journal is © The Royal Society of Chemistry 2016inhibited Mycobacterium tuberculosis protein tyrosine phos-
phatase B (MptpB).358
The polyketides 544 and 545 were obtained from co-culture
of mangrove soil derived Penicillium sp. with the sediment
derived bacterium Streptomyces fradiae and were not produced
in discrete bacterial and fungal control cultures, suggesting the
activation of silent gene clusters by co-cultivation. These also
occurred as a racemate and were separated by chiral chroma-
tography into 544359 a known terrestrial fungal metabolite
(9R,14S)-epoxy-11-deoxyfunicone, but now isolated as a rst-
time MNP, and the enantiomer (9S,14R)-epoxy-11-deoxy-
funicone 545.360 An endophytic Penicillium sp. was the source of
a phenyl ether derivative 546 and a spiroax-4-ene-12-one deriv-
ative 547 with the spiroax-4-ene-12-one derivative 547 more
potent to the MG-63 cell line with in vivo activity and signicant
inhibition of human osteosarcoma in nude mice upon oral
administration.361 The prenylated phenols vaccinol A–G, 548–
554 and the naphthalene derivative vaccinal A 555 were isolated
from Pestalotiopsis vaccinii. Vaccinal A 555 exhibited potent
COX-2 inhibition.362 Other genera or families of fungi associ-
ated with mangroves to yield the new metabolites 556–635 were
Acremonium, Alternaria, Daldinia, Guignardia, Penicillium, Pes-
talotiopsis, Phoma, Phomopsis, Pseudolagarobasidium, Rhy-
tidhysteron, Stemphylium and Xylariaceae.363–388
3.5 Cyanobacteria
There has been an increase in the number of new metabolites
reported from cyanobacteria since 2013, but the total numbers
are still low overall (20 in 2014 vs. 9 in 2013), seemingly
continuing an overall downward trend. Typical of the phylum,
the vast majority of metabolites reported were peptidic in
nature. Although not peptidic, yoshinone A 636 and the dia-
stereoisomers yoshinone B1 and B2 637 were isolated from
Leptolyngbya sp. Yoshinone A 636 inhibited diﬀerentiation of
3T3-L1 cells into adipocytes without accompanying cytotoxicity
suggesting potential as an anti-obesity lead.389 A cyanobacterial
assemblage, consisting mostly of Lyngbya sp. (now renamed as
Moorea sp.) yielded the dolastatin 13 analogue, kurahamide
638, a strong inhibitor of the proteases elastase and chymo-
trypsin390 and the acetylenic lipopeptide kurahyne 639 an
inhibitor of the HeLa cell line and inducer of apoptosis.391
Mooreamide A 640 is a cannabinomimetic lipid obtained
from Moorea bouillonii and is the most potent marine-derived
inhibitor of the neuroreceptor CB1 reported to date.392 Two new
aplysiatoxin analogues, 3-methoxyaplysiatoxin 641 and 3-
methoxydebromoaplysiatoxin 642 were isolated from Tricho-
desmium erythraeum and 642, along with the co-isolated
known debromo analogues debromoaplysiatoxin393 andNat. Prod. Rep., 2016, 33, 382–431 | 391





























































































View Article Onlineanhydrodebromoaplysiatoxin,394 were inhibitors of the Chi-
kungunya virus.395
Other new metabolites 643–655 were obtained from the
genera Anabaena, Lyngbya, Moorea, Oscillatoria and Sym-
ploca.396–402 The absolute congurations of coibacins A and B403
have been determined as 656 and 657 respectively by total
synthesis.404 Syntheses of biselyngbyolide A405 (Lyngbya (Moorea)
sp.),406 apratoxin C407 (Lyngbya (Moorea) sp.),408 malevamide D409
(Symploca hydnoides),410 micromide411 (Symploca sp.),412 and 12-
epi-hapalindole Q isonitrile413 (Hapalosiphon laingii),414 have
also been achieved. Total syntheses of the proposed structures392 | Nat. Prod. Rep., 2016, 33, 382–431for itralamide B415 and coibamide A416 have indicated that the
structures of these natural products require revision.417,418
Grassypeptolides A–C419 were shown to selectively inhibit the
dipeptidyl peptidase (DPP8) protease and molecular docking
studies indicated that grassypeptolide A binds to the enzyme at
two diﬀerent sites.420 Gallinamide A421 was shown to be a potent
and selective inhibitor of the human cysteine protease
cathepsin L.422 A genome mining approach was utilised to
identify three proteusin rSAM epimerases, enzymes which
install multiple D-amino acids in genetically encoded peptide
chains, from three strains of cyanobacteria including a marine-
derived Pleurocapsa strain.423 A genome mining approach was
also used to show that LanA peptides, linear precursor peptides
of lanthionine-containing peptides (lanthipeptides),424 are
highly diverse among diﬀerent systems and that closely related
lanthipeptide synthetases can be associated with quite diﬀerent
substrate sets.4253.6 Dinoagellates
The number of new metabolites reported from dinoagellates
has remained about the same as for 2013 with 19 compounds
reported in 2014. The linear polyketide, amphirionin-4 658,
from an Amphidinium species displayed very potent and
selective growth promotion activity on murine bone marrow
stromal ST-2 cells. Feeding experiments with 13C single and
double labelled acetate indicated that polyketide 658
comprises a linear C22 chain with two irregular C1 sites
(in the terahydrofuran moiety) and four C1 branches.426
Dinophysis acuminata was the source of the macrolide
acuminolide A 659 which was non-toxic to human tumour cell
lines (HTCLs) but a potent stimulator of actomyosin ATPase
activity.427 Belizentrin 660, a 25-membered macrolactam ob-
tained from Prorocentrum belizeanum is the rst member of its
class of polyunsaturated and polyhydroxylated macrocycles
and displayed potent eﬀects on neuronal network integrity in
cerebellar cells, ultimately resulting in cell death.428
Other genera of dinoagellates from which the new
metabolites 661–675 were isolated include Amphidinium,
Azadinium, Karenia and Vulcanodinium.429–436 Tentative struc-
tures were assigned to ovatoxin-g 676 and an isomer of paly-
toxin, the so-called isobaric palytoxin.437 The absolute
conguration of amphidinin A438 was determined as 677.439
Synthesis of genetically predicted saxitoxin intermediates
with identication and quantication in the dinoagellate
Alexandrium tamarense and the cyanobacterium Anabaena
cicinalis supports the genetically proposed biosynthetic
route440 to saxitoxin.441 Metabolomic and proteomic analyses
indicated that Karenia brevis exhibited allelopathy against two
competitor diatoms Asterionellopsis glacialis and Thalassiosira
pseudonana. The former, which co-occurs with K. brevis,
exhibited somewhat more robust metabolism while in the
latter, energy metabolism was disrupted and cellular protec-
tion mechanisms were impeded.442 Other studies examined
the biosynthesis of brevetoxin,443,444 brevisamide445,446 and the
genetics of toxin production in Alexandrium catenella.447This journal is © The Royal Society of Chemistry 2016





























































































View Article Online4 Green algae
Research into green algal chemistry continues at low ebb with
just 13 relevant articles published and just three new
compounds published for 2014. The new compounds were the
racemosines A–C 678–680,448,449 bisindole alkaloids isolated
from Caulerpa racemosa which are biosynthetically related to
the well-established green algal metabolite caulerpin, also from
a Caulerpa sp.450 Caulerpin featured in studies of anti-
nociception mechanisms451 and the antituberculosis activities
of caulerpin and synthetic analogues.452 Included in the greenThis journal is © The Royal Society of Chemistry 2016algal literature for 2014 was a study on the eﬀect of natural
lycopene (E/Z mixture) on a human prostate cancer cell line,453
while a thought-provoking paper tackled a problem all marine
natural product chemists should be alert to – the misuse of
taxonomic descriptors and the implications that this has.
Misuse of such descriptors appears to be a particular problem
with marine algae.4545 Brown algae
The output of new compounds (17) from brown algae in 2014
was again relatively low and although dominated by terpenoid
chemistry saw the emergence of a new class of brown algal
metabolite. This was the characterisation of a 1-deoxy-
sphingoid, 3-epi-xestoaminol C 681, from a New Zealand
collection of Xiphophora chondrophylla following a M. tubercu-
losis-guided fractionation. A genome-wide screening against
a library of non-essential gene deletion mutants of Saccharo-
myces cerevisiae established the cellular processes that 681
disrupted.455
Some 27 diterpenoids ranging across six classes were iso-
lated from a Chinese collection of Dictyota plectens. These
included seven new diterpenes, belonging to the dolabellanes
682–684, prenylated guaianes 685–687, and a xenicane 688, 19
known analogues and an ethoxylated artifact as well.456 Three
new diterpenoids, a dolabellane 689 a xenicane 690, and a pre-
nylated guaiane 691 with ve previously characterised
compounds were characterised from Mediterranean collections
of several Dictyota spp.457 Three new, 692–694, and three known
dolabellane diterpenoids,458,459 were isolated from a Brazilian D.
pfaﬃ, and a single crystal X-ray analysis established the absolute
conguration of the known 10,18-diacetoxy-8-hydroxy-2,6-dola-
belladiene.458,460 The meroterpenoids sargachromanol Q 695
and R 696 along with the known sargachromanol J461 resulted
from re-examination of the original extract from Sargassum sil-
iquastrum,462 while thunberol, 697, is the only new sterol of ve
isolated from the Chinese Sargassum thunbergii.463 Typical
brown algal phlorotannins such as eckol and dieckol have
stimulated research into a wide range of topics – heme oxy-
genase-1 expression,464 oxidative stress,465 anti-adipogenic
activity,466 anti-HIV-1467 and antibacterial activity.468 Among the
studies on the anti-inammatory properties of phlor-
otannins469,470 was the synthesis of a rhodamine-labelled die-
ckol. Confocal laser microscopy determined that the labeled
dieckol was mainly located in the endoplasmic reticulum and
studies showed that the anti-inammatory activity of the
conjugate was considerably greater than that of dieckol itself.471
The potential therapeutic properties of fucoxanthin and deriv-
atives have been studied,472,473 as have those of polyphenols
such as octaphlorethol,474–476 and mono- and diacylglycerols.477Nat. Prod. Rep., 2016, 33, 382–431 | 393





























































































View Article Online6 Red algae
There continues to be a marked variation in the number of new
compounds obtained from red algae and reported each year,
with 42 for 2014 compared to 9 for 2013. There was the usual
range of structural types with glycolipids 698478 and 699–701,479
halogenated allenes and alkynes 702–704,480 705–709,481 710482
and 711,482 halogenated monoterpenes 712–718,483 sesquiter-
penes 719–725,484 726,485 727,485 and 728–730,486 (including the
unusual seco-laurokamurone 719), diterpenes 731–733,487
brominated aromatics 734488 and 735–737489 and the mahor-
ones 738–739, unusual 2,3-dibrominated 2-cyclopentenones.490
The use of rapid dereplication tools (UHPLC–PDA–HRMS, 2D
HSQC NMR, soware tools and databases) for identication of
the allenes 710 and 711482 and LC-UV-MS-SPE-NMR for the
monoterpenes 712–718483 were notable features.394 | Nat. Prod. Rep., 2016, 33, 382–431A synthesis491 of the brominated sesquiterpene aldingenin
C492 showed that the original structure was incorrect, and it was
suggested that aldingenin C was probably the known
compound caespitol.493 A synthesis494 of the proposed structure
of prevezol B495 has shown that the original structure was
incorrect. Of the 70 polyhalogenated acyclic monoterpenes
isolated from Plocamium spp., surprisingly none had been
synthesised until the use of a broadly applicable approach
generated four of the naturally occurring compounds and
a number of analogues.496 An asymmetric total synthesis of
(+)-bermudenynol497 has been accomplished,498 while a total
synthesis of the snyderane (+)-luzofuran499 has also been
made.500 The anti-inammatory potential of 5b-hydrox-
ypalisadin B501 from Laurencia snackeyi has been demonstrated
in LPS-stimulated RAW 264.7 macrophages502 and LPS-induced
zebrash embryo.5037 Sponges
With 283 new structures reported from the phylum Porifera in
2014, sponges have returned again to be a dominant source of
new bioactive metabolites, although the growing realisation
that microbial symbionts are the real producers of “sponge”
specialised metabolites highlights the need for more detailed
metagenomic and biosynthetic analyses of sponge matrices.This journal is © The Royal Society of Chemistry 2016





























































































View Article OnlineSphingoids 740504 and 741,505 taurinated fatty acids 742–
745506,507 and a large number of polyacetylenes 746–765508–513
have been reported from the genera Callyspongia, Coscinoderma,
Echinoclathria, Petrosia, Placospongia, Siphonochalina and Xes-
tospongia. The synthesis of a series of miyakosyne A (Petrosia
sp.)514 diastereomers followed by RP-HPLC separation at56 C
has revealed that the natural product 766 is actually a mixture of
two stereoisomers in 96 : 4 (14R) : (14S) ratio.515 A compre-
hensive blend of synthesis with NMR, IR and vibrationalcircular dichroism (VCD) spectroscopy has allowed for the
relative congurational assignment of the C-36–C-42 segment
of hemicalide 767 (Hemimycale sp.), as well as securing the
absolute conguration of C-42. This potent (sub-nM) inhibitor
of mitosis was sourced from a deep water sponge collected at
the Torres Islands, Vanuatu, but to date has only been reported
in a patent.516,517 A series of peroxides 768–773,518 halogenated
alkenes 774 and 775,519 and an amide 776520 have been reported
from Plakortis simplex, Dysidea sp. and Anoxycalyx (Scolymastra)
joubini, respectively. Sponges continue to be a prolic source of
peptide natural products. Reisolation of cyclolithistide A from
a deep sea Discodermia japonica (200 m, Sagami Bay, Japan),
originally reported in 1998,521 allowed in-depth LC-MS/MS and
Marfey's analyses that necessitated a revision of the amino acid
sequence and congurations as shown here 777.522 The simple
substitution of a side-chain Asp for hydroxy-Asp in pipecoli-
depsins A 778 and B 779 (Homophymia lamellosa, Saint Marie
Is., Madagascar) resulted in a greater than ten-fold increase in
activity against three HTCLs.523 The synthesis of 778 had already
been reported in 2013.524This journal is © The Royal Society of Chemistry 2016The stellatolides A–G 780–786 are a family of cyclo-
depsipeptides from a Madagascan Ecionemia acervus. The full
stereochemical analyses of several variants were established by
Marfey's analysis, and the solid-phase peptide total synthesis of
780 was also achieved. The unexplained racemisation of L-Thr
during the Marfey's analysis is a salient warning to all experi-
mentalists using this technique. Several of the stellatolides were
cytotoxic in the nM range against three HTCLs.525The genera Asteropus, Discodermia, Pipestela, Reniochalina,
Stylissa, Suberites and Theonella have also yielded a large
number of peptides 787–806.526–532 Callyspongiolide 807 is an
unusual carbamate macrolide with an unprecedented conju-
gated dienyne side chain isolated from Callyspongia sp.
(Ambon, Indonesia). Evaluation of 807 against three HTCLs
indicated potent cytotoxicity (IC50 ¼ 60–320 nM). Notably, the
viability of cell lines treated with callyspongiolide was not
aﬀected by QVD-OPh, a known caspase-inhibitor, suggesting
the test compound induces cellular toxicity in a caspase-inde-
pendent manner.533Nat. Prod. Rep., 2016, 33, 382–431 | 395





























































































View Article OnlineThe total synthesis of halichondrin A has been accomplished.
Halichondrin A is a “phantom” natural product, viz. it is the only
member of the norhalichondrin/halichondrin/homohalichon-
drin family not to have been detected from a natural source,
typically Halichondria okadai,534,535 even though concerted eﬀorts
have been made to try and detect this compound for more than
20 years. Use of the synthetic material to guide studies searching
for the presence of halichondrin A in legacy extracts of H. okadai
were unsuccessful.536 A diketopiperazine 808,537 a 3-alkylpiper-
idine 809,538 seven manzamine-type alkaloids 810–816539,540 and
seven 3-alkylpyridines 817–823541 have been isolated from the
sponge genera Callyspongia, Acanthostrongylophora and Top-
sentia. Axinyssa aculeata (Okinawa) was the source of proto-
aculeine B 824 that is a putative novel N-terminal residue for the
peptidic toxins aculeines A–C. The structure of this polyamine
compound, including identifying its attachment to the peptide
toxins themselves, was determined from detailed synthetic and
mass spectrometric studies.542
Other indole 825–829543,544 and b-carboline 830–837544–546
alkaloids were reported from Hyrtios, and Luﬀariella sponges. A
biomimetic total synthesis of ()-dictazole B, isolated from the
shallow water sponge Smenospongia cerebriformis,547 has been
performed using articial light to facilitate the [2 + 2] photo-
chemical cycloaddition reaction between aplysinopsin mono-
mers, under the presumed high local concentration of the parent
reactant that would be found in the relevant sponge organelle.
This biomimetic route is a viable alternative to the [4 + 2] Diels–
Alder cycloaddition that has been presumed to take place in the
biosynthesis of the cycloaplysinopsins.548 Fieen new aaptamine
alkaloids 838–852549–551 have been reported from Aaptos sponges
while a new polycyclic aromatic alkaloid 853 came from an
Ancorina sp.552 An unbiased screen of a library of 480 sponge
extracts identied the surprisingly simple compound girolline553
from Stylissa carteri (Mont Pass, Pohnpei, Micronesia) as a potent
inhibitor of signalling of MyD88-dependent and -independent
Toll-Like Receptors (TLR) 2, 3, 4, 5 and 7, reducing cytokine
production in peripheral blood mononuclear cells and macro-
phages, therefore imbuing the molecule with potent anti-
inammatory activity. In-depth chemical genetics proling
identied elongation factor 2 as the molecular target of girolline
implying inhibition of protein synthesis as its mode of action.554
Guanidine-derived alkaloids 854–863 were reported from
Monanchora pulchra,555 Acanthella cavernosa556 and Biemna lab-
outei,557 while several brominated hymenialdisine-type 864–867
and oroidin/oroidin dimer-type 868–877 came from Callyspongia
sp.558 and Agelas sp.,559–561 respectively. A highly scalable, multi-
gram synthesis of axinellamines A and B (Axinella sp.)562 and
analogues has been achieved. Evaluation of the antibacterial
properties of racemic synthetic products highlighted their potent396 | Nat. Prod. Rep., 2016, 33, 382–431inhibition of both Gram positive and negative bacteria (MIC 0.5–
8 mg mL1 vs. eight bacterial cell lines), even though the initial
isolation study reported minimal activity. Further detailed
investigation could not determine a specic mode of action but
did suggest secondarymembrane-disruption as the likely route to
activity.563 The comprehensive total synthesis of sceptrin, ageli-
ferin and massadine congeners via single electron cycloaddition
reactions has several wide-ranging consequences. Firstly, it
necessitates the revision of the absolute conguration of sceptrin
and its brominated analogues 878–880564–566 and ageliferin and
congeners 881–883567 as shown here, based upon X-ray crystal
structures. Moreover, the massadines had been thought to be
rearrangement products from the ageliferins,568,569 however the
absolute congurations of the two series of compounds are
antipodal, hence indicating enantiodivergent biosynthetic path-
ways in vivo to these bromopyrrole alkaloids and invalidating the
so-called “Scheuer-hypothesis” for their formation.570,571
Bromotyrosine metabolites 884–893 have been isolated from
Callyspongia,572 Aplysinella573 and Dendrilla574 sponges, while
Haliclona, Petrosia, Phoriospongia and Dragmacidon sponges have
yielded substituted purine/pyrimidine compounds 894–
898.504,575–577 As usual, sponges continue to be a valuable reser-
voir of new terpenoid metabolites. Merosesquiterpenoids 899–
930 came from the sponge genera Aka (Siphonodictyon), Dysidea,
Dactylospongia and Xestosopngia.578–584 In particular, xesto-
lactone A 931 and xestosaprol O 932 were isolated from Xesto-
spongia vansoesti (Palawan Is., Philippines). Xestosaprol O is
twenty times more potent as an inhibitor of indoleamine 2,3-
dioxygenase (IDO; IC50 ¼ 4 mM) than 931 (IC50 ¼ 81 mM),
making it a lead towards inhibitors of tumour immune escape.
The total syntheses of 932 and two analogues were achieved
using the rarely applied silver-catalysed Sato photochemical
coupling, leading to a short and eﬃcient synthesis of the
natural product. Comparative analysis of 932 and its analogues
showed that the 3-OH functional group is highly detrimental for
IDO-inhibitory activity.585This journal is © The Royal Society of Chemistry 2016





























































































View Article OnlineA merotetraterpenoid 933 has been reported from Sarco-
tragus spinosulus.586 Similarly, Axinyssa, Dysidea, Ircinia and
Topsentia sponges were the sources of a number of sesqui-
terpenoids 934–964,587–591 some of which had been cleaved,
while diterpenoids were obtained from Diacarnus mega-
spinorhabdosa 965–970,592 Spongia sp. 971–973593 and Darwinella
oxeata 974–982.594 A large number of sesterterpenoids 983–1011
were reported in 2014 from the sponge genera Clathria, Cosci-
noderma, Hippospongia, Hyrtios, Petrosaspongia, Phorbas and
Scalarispongia.506,595–601 As always, sponges yielded a variety of
steroids 1012–1019,504,505,602,603 steroidal amines 1020 and
1021,604 and degraded steroids 1022–1024605,606 from species of
Echinoclathria, Corticium, Haliclona, Ircinia, Petrosia, Plakortis
and Theonella. T. swinhoei (Xisha Is., S. China Sea) yielded
swinhoeisterols A 1025 and B 1026 with unprecedented 6/6/5/7
tetracyclic frameworks. The absolute congurations of the
compounds were secured by a combination of X-ray diﬀraction,
TDDFT ECD calculations and Mosher's method. Detailed in
silico analysis of both compounds against 211 potential protein
targets of relevance for cancer therapy revealed 1025 should
exhibit activity against the histone acetyltransferase (h)p300.
This was validated in vitro with IC50 ¼ 2.9 mM while 1026 was
almost 100 times less potent (IC50 ¼ 240 mM), indicating the
steric importance of the 9-OH in abrogating activity.607
Cinanthrenol A 1027 is the rst example of a phenanthrene-
containing steroid. It was sourced from Cinachyrella sp.
collected by dredging at 160 m (Oshima-Shinsone, Japan)
where the unique phenanthrene-uorescence signature was
used to select the sponge from amongst detritus. As well as
moderate activity against various HTCLs, 1027 was a potent
estrogen-receptor binder, displacing estradiol in a competitive
manner with IC50 ¼ 10 nM, as well as altering estrogen-
responsive gene expression.608
A series of triterpenoids 1028–1032 have been reported from
Jaspis stellifera609 and Siphonochalina siphonella.610 An articial
“sponge” has been developed for the non-destructiveThis journal is © The Royal Society of Chemistry 2016concentration of marine natural products in sensitive marine
ecosystems. A pump is used to suction sponge-matrix particles
that are ltered into a hollow-bre bioreactor. This is used to
cultivate microbial symbionts that produce secondary metabolites
which are, in turn, trapped on reversed-phase cartridges for
concentration. The articial sponge system was used in three
expeditions across 11 locations, two in the Pacic and one in the
South China Sea, with the deployment at Pulau Lakei (Sarawak,
Malaysia) yielding jasplakinolide, jasplakinolide B and C in
a 18 : 1 : 1 ratio, the same proportions as found from Jaspis
splendens collected near Vanuatu.611,612 Metagenomic analyses
continue to rise in their importance to sponge natural product
biosyntheses. Detailed metagenomic proling of the “High
Microbial Abundance” (38–57%microbial biomass) sponge Pla-
kortis halichondrioides (Little San Salvador Is., Caribbean Sea)
found characteristic gene sequences of poribacteria (a bacterial
phylum found exclusively in sponges) but the known supA and
swfA biosynthetic clusters observed were absent from the por-
ibacteria genomes. Further investigation showed similarity
between these clusters and protist type I polyketide synthetase
(PKS) genes hence protists could be a previously overlooked
reservoir of novel bioactive metabolites.613 A comprehensive
metagenomic survey of the microbial community associated
with the metabolite-rich sponge Theonella swinhoei has uncovered
a new bacterial genus, Entotheonella. This genus is a member of
the new candidate phylum Tectomicrobia and appears to be
a widespread sponge endosymbiont across many diverse sponge
species. Moreover, biosynthetic gene cassettes suitable for
production of many “Theonella swinhoei” NRPS and PKS
compounds, including the onnamide,614 polytheonamide,615 ker-
amamide616 and cyclotheonamide617 classes, have been identied
in the microbial genome.8,9 A metagenomic approach identied
the gene cassette for calyculin A (Discodermia calyx)20 biosynthesis
as being microbial in origin, as described in 3.1 Bacteria, and
resulted in the identication of two diphosphate protoxins (see 1
and 2),21,22 again underscoring the importance of symbiotic
microbial communities in the production of “sponge” metabo-
lites. The microtubule-stabilising mode of action of laulimalide618
and peloruside A619 has been established through the use of high-
resolution crystal structures of the compounds bound to
tubulin,620 while aaptamine621 has been shown to have protective
eﬀects against cisplatin-induced kidney damage,622 and also
prevents photoageing.623 A polybrominated diphenylether624
(Dysidea granulosa) has been shown to inhibit hepatitis C non-
structural protein NS3 helicase, a validated antiviral target.625 The
four bromotyrosine compounds ianthelliformisamine A–C (Sub-
erea ianthelliformis)626 and spermatinamine (Pseudoceratina sp.)627
were selective and potent inhibitors of human carbonic anhydrase
IX (IC50 ¼ 0.20–0.36 mM), with implications for maintaining
cellular pH homeostasis and hence application in a variety of
disease states.628 The sesterterpenoid heteronemin (Hyrtios sp.)629
inhibited trans-activation response DNA-binding protein 43 kDa
(TDP-43), a key factor of several neurodegenerative states. Heter-
onemin binds to TDP-43 (ki ¼ 270 nM) and altered the aggre-
gation state and localisation of this important neurochemical
target.630 The rst total syntheses of an all-(Z) octadeca-pentene-
3-one (Callyspongia sp.),631,632 strongylodiol G (StrongylophoraNat. Prod. Rep., 2016, 33, 382–431 | 397





























































































View Article Onlinesp.),633,634 bitungolide B (Theonella swinhoei),635,636 plakortone L
(Plakortis clathrata),637,638 epiplakinic acid F (Plakinastrella sp.),639
and its methyl ester (Plakortis halichondrioides),640,641 gracilioether
F (Plakinastrella mamilaris),642,643 taumycins A and B (revised 1033
and 1034, Fascaplysinopsis sp.),644,645 polydiscamides B–D (Ircinia
sp.),646,647 callipeltin M (Latrunculia sp.),648,649 topsentolide A2
(revised 1035, Topsentia sp.),650,651 penarolide sulfate A2 (Penares
sp.),652,653 haliclorensin C (Haliclona tulearensis),654,655nakinadine A
(revised 1036, Amphimedon sp.),656,657 thiaplakortone A (Plakortis
lita),658,659 (+)-cylindradine A (Axinella cylindratus),660,661 ianthelli-
formisamines A–C (Suberea ianthelliformis),626,662,663 tokaradine C
(Pseudoceratina purpurea),663,664 (+)-hemistularin 3 (revised 1037,
Verongia sp.),665,666 trachycladines A and B (Trachycladus laevis-
pirulifer),667–669 cyclospongiaquinone-1 (Stelospongia conulata),670,671
deoxyspongiaquinol (revised 1038) and deoxyspongiaquinone
(revised 1039, Euryspongia sp.),672,673 plakinamine B (Plakina
sp.)674,675 and clionamine D (Cliona celata)676,677 have all been
completed. The total syntheses of the putative structures of 15-
oxopuupehenoic acid (Hyrtios sp.)678,679 and astakolactin (Caco-
spongia scalaris)680,681 have also been achieved but the spectro-
scopic data call into question the original identied structures,
with no alternative suggestions provided.8 Cnidarians
The number of new compounds reported from cnidarians in
2014 (201) is similar to the previous decadal average. The
importance of chemical cues in coral reef remediation have been
highlighted in a study that found that coral and sh juveniles
were repelled from reefs that were overshed and seaweed-
dominated.682 A method of recovery of such degraded habitats
was proposed to involve reduction in shing harvest of critical
species of herbivorous shes. The chemistry of both hard and
so corals are dominated by terpenes – alkaloids are only rarely
isolated. In 2014 there were seven examples of alkaloids isolated
from so corals, comprised of an unusual diketopiperazine 1040
from Menella kanisa,683 and six tetraprenylated purines, malon-
ganenone L–Q 1041–1046, from Echinogorgia pseudossapo.684 In
contrast, cnidarians of the order Zoantharia (zoanthids) were the
sources of ve new parazoanthine congeners 1047–1051 (Para-
zoanthus axinellae).685 These structures were established using
a metabolomics model, with LCMS/MS fragment analysis being
used to dene structures and LC-ECD employed to assign abso-
lute conguration (to 1047, 1048 and 1050).Other zoanthamine analogues, 1052–1058, were isolated
from Zoanthus sp.686,687 and Zoanthus kuroshio688 as well as a new398 | Nat. Prod. Rep., 2016, 33, 382–43142-hydroxypalytoxin diastereomer 1059 from Palythoa tuber-
culosa.689 Previous studies of an extract of Palythoa toxica identi-
ed themajor toxin to be a 42-hydroxy analogue of palytoxin 1060
however the conguration at positions C-41 and C-42 remained
unresolved.690 More recent J-based analysis has dened the
conguration at these stereocentres as (41S) and (42S). The same
study also established the absolute conguration of a related
palytoxin analogue isolated from P. tuberculosa as being (42S)-
hydroxy-(50S)-palytoxin 1059. The relative aﬃnity of palytoxin,
1059 and 1060 towards a mouse anti-palytoxin monoclonal
antibody identied palytoxin to have the most potent KD (nM),
while 1059 and 1060 were approximately one and three orders of
magnitude less potent respectively. Similar relative levels of
cytotoxicity towards keratinocytes were also observed, with paly-
toxin being the most potent. Palytoxin is known to be capable of
disrupting mechanisms of cellular ion homeostasis: NMR
studies have dened the C-25–C-33 and C-47–C-53 fragments of
palytoxin as being involved with Ca2+ coordination.691
A series of butenolide and cyclopentenones 1061–1072 were
reported from Subergorgia suberosa and Sinularia sp. so
corals.692–694 A comprehensive investigation of a Bahamian
collection of Pseudopterogorgia rigida identied a chamigrane
1073 and seven bisabolanes 1074–1079 as new sesquiter-
penes.695 The study also reported an extensive number of co-
metabolites 1080–1083 that had been previously reported from
terrestrial plants or as semi-synthetic derivatives 1084–1090.
Other sesquiterpenes 1091–1110 have been reported from
Rumphella antipathies,696–698 Lemnalia philippinensis,699 Menella
kanisa,700 Nephthea erecta,701 an unidentied gorgonian,702 Den-
dronephthya sp.,703 Sinularia kavarattiensis,704 Echinogorgia sas-
sapo reticulata705 and Anthrogorgia ochracea.706 Of these
sesquiterpenes, rumphellaoic acid A 1093697 contains a unique
skeleton, while shagenes A 1102 and B 1103702 and ochracenoid
A 1109706 contain rarely reported skeletons. In the case of the
ochracenoid A, absolute conguration was assigned by use of
TDDFT calculated ECD data.
A South China Sea collection of Anthrogorgia caerulea yiel-
ded, in addition to two known avermectin macrolides, aver-
mectin B2a and 22,23-dihydroavermectin A1a,707 two new
congeners B1c 1111 and B1e 1112.708 All four MNPs exhibited
moderate antifouling activities.
Of the thirty-six cembrane related metabolites 1113–1149 re-
ported from cnidarians in 2014,709–722 secocrassumol 1113
(Lobophytun crassum)709 is notable as it is derived from the cem-
brane skeleton via an unusual C-11–C-12 bond cleavage, sinu-
gyrosanolide A 1114 (Sinularia gyrosa) is an unprecedented C-4
norcembranoid,710 tortuosenes A 1146 and B 1147 (Sarcophyton
tortuosum)721 represent the rst examples of cembranoids con-
taining a C-2–C-20 ring closure, and sinularbols A 1148 and B
1149 (Sinularia arborea) contain a rare C-3–C-9 ring closure.722
Cnidarian chemistry is dominated by metabolites derived
from terpene biosynthesis, with particularly large numbers
falling into the diterpenoid classication. Thirty-eight new
briarane-skeletoned MNPs (1150, gemmacolides AS–AY 1151–
1157, briarenolide J 1158, junceellolides M–P 1159–1162, fra-
gilisinins A–L 1163–1174, dollfusilins A 1175 and B 1176, bria-
violides A–J 1177–1186 and anthrogonoid A 1187) were reportedThis journal is © The Royal Society of Chemistry 2016





























































































View Article Onlinefrom octocoral species Pennatula aculeata, Dichotella gemmacea,
Junceella gemmacea, J. fragilis, Ellisella dollfusi, Briareum viola-
cea, and Anthrogorgia caerulea.723–730 As usually happens each
year, there is duplication of structure/trivial name amongst
a small number of MNPs. In the set of briaranes reported from
Junceella gemmacea (South China Sea) and J. fragilis (also South
China Sea), junceellolide O 1161726 and fragilisinin G 1169727
share the same assigned structure, however spectroscopic and
photometric data reported for the two compounds are quite
diﬀerent clearly indicating that one of the structures is in need
of revision. The structure and absolute conguration of bria-
violide A 1177729 was secured by single crystal X-ray analysis.
The second dominant class of diterpenoid metabolites re-
ported from so corals contain the eunicellin skeleton.This journal is © The Royal Society of Chemistry 2016Examples of eunicellins were reported from Anthrogorgia caer-
ulea (antsimplexin A, 1188),730 Muricella sibogae (sibogins A 1189
and B 1190),731 Cladiella sp. (cladieunicellin J, 1191),732 Klyxum
molle (klymollins T–X, 1192–1196),733 Cladiella sp. (cladieuni-
cellin M–Q, 1197–1201),734 Cladiella kremp (krempelins N–R,Nat. Prod. Rep., 2016, 33, 382–431 | 399





























































































View Article Online1202–1206),735,736 and Cladiella hirsuta (hirsutalin N–R, 1207–
1211).737 Readers should note that cladieunicellin N 1198 is
a structural duplicate of the previously reported Klyxum molle
metabolite klymollin Q,738 exhibiting identical spectroscopic,
spectrometric and chiroptical properties and that the structure
elucidation of cladieunicellin M–Q also led to revision of
conguration at C-7 of the structure of litophynin I diacetate to
that shown in 1212.
Further examples of diterpenoids, 1213 and 1214,739 1215
and 1216,740 cespitulones A 1217 and B 1218,741 dihy-
drosarsolenone 1219, methyldihydrosarsolenoneate 1220, and
sarsolilides B 1221 and C 1222,742 have been isolated from so
corals of the genera Cespitularia, Xenia, and Sarcophyton.
Structure elucidation and determination of absolute congu-
ration of 1219 and 1220742 led the authors to propose a revision
of the relative conguration at C-2 of the previously reported
MNP sarsolenone (to that shown 1223).743 Absolute congura-
tion was assigned to 1219 and 1220 using TDDFT calculations of
ECD data.
Sarcophyton ehrenbergi was the source of a number of pros-
taglandins including sarcoehrendins A–J 1224–1233.744 In
addition, three prostaglandins previously reported as synthetic
compounds 1234–1236 were reported as natural products for
the rst time. Relatively potent activity was observed towards
phosphodiesterase-4, a target for CNS, inammatory and
respiratory diseases. So corals also yielded a variety of steroids
including pregnanes 1237 and 1238,745 seco-sterols 1239–
1244746,747 and hydroxylated/polyhydroxylated sterols 1245–400 | Nat. Prod. Rep., 2016, 33, 382–4311265747–753 from species of Schleronephthya, Subergorgia, Sar-
cophyton, Sinularia, Verrucella, Echinogorgia, and Leptogorgia.
Noteworthy amongst these compounds, was the enhanced
(synergistic) cytotoxicity observed for paclitaxel in the presence
of punicinols A 1257 and B 1258 (Leptogorgia punicea) and that
the two sterols were also able to inhibit A549 tumour cell growth
in a clonogenic assay over a sustained period of ten days.752
In addition to the mildly antiproliferative epoxyergosterols
1266–1271 (Anthopleura midori),754 investigation of MNP chem-
istry of sea anemones and hydrozoa has identied two new
cytolysins (3013 and 3375 Da) from the tentacles of the hydro-
zoan Olindias sambaquiensis755 and PhcrTx1, a 32 amino acid
residue acid-sensing ion channel inhibiting peptide from the
sea anemone Phymanthus crucifer756 that represents the rst
example of a peptide containing an Inhibitor Cysteine Knot
scaﬀold to be isolated from a cnidarian. Further study of the
biological activities of previously reported anemone toxins has
identied Av3 (Anemonia viridis) to show specicity towards
arthropod voltage-gated sodium channels by binding to one of
the transmembrane cles of the channel a-subunit,757 while
AdE-1 (Aiptasia diasphana) prolongs cardiomyocyte action
potential duration while lowering peak amplitude via slowing
inactivation of sodium channels and enhancing the transient K+
current.758 Mutation of the pore-forming toxin sticholysin I
(Stichodactyla helianthus) residue tryptophan 111 to cysteine
reduced the toxins aﬃnity for membranes by an order of
magnitude,759 cysteine mutants of phenylalanine 15 or arginine
52 did not alter pore-forming activity but did protect the toxin
from peroxynitrite oxidative damage,760 while a third study,
using monolayers of phosphatidycholine and sphingomyelin,
determined that the toxin preferentially binds and penetrates
membranes which have moderate enrichment in sphingomye-
lin and membrane uidity.761 The rst total syntheses of
alkaloids N-(3-guanidinopropyl)-2-(4-hydroxyphenyl)-2-oxoace-
tamide (Campanularia sp.)762,763 and ()-tubastrindole B
(Tubastraea sp.),764,765 butenolide (+)-hydroxyancepsenolide
(Pterogorgia anceps),766,767 and diterpenes sandresolide B,768
amphilectolide769 and (+)-ileabethoxazole770 (Pseudopterogorgia
elisabethae)771,772 have been completed. Conversion of bipinna-
tin J (Pseudopterogorgia bipinnata)773 to intricarene (Pseudopter-
ogorgia kallos)774 via a photochemical pathway has been
demonstrated,775 while a photochemical (E/Z) olen isomer-
isation was a critical step in the total synthesis of the natural
product analog 17-deoxyprovidencin.776 Clarication of the
structure of the cladiellin diterpene sclerophytin F (Scle-
rophytum capitalis)777 has been an ongoing issue, with Frie-
drich and Paquette in 2002 proposing the structure should be
revised to be the (3S) diastereomer of sclerophyton A.778
Synthesis of this proposed revised structure gave a product
whose spectroscopic data diﬀered from those reported for the
natural product, suggesting further investigation is needed to
resolve this issue.779 A modular approach to a number of
cladiellin MNPs using a gold-catalysed tandem reaction of
1,7-diynes has been reported.780 Hippuristanol (Isis hippu-
ris)781 analogues have been evaluated as inhibitors of
eukaryotic translation initiation,782 cembranoid and ergosterol
MNPs from Vietnamese cnidarians were found to exhibitThis journal is © The Royal Society of Chemistry 2016





























































































View Article Onlineselective in vitro activity against T. brucei,783 a number of
diterpenes (Sinularia maxima) were found to be modest to
poor inhibitors of NF-kB transcriptional activation,784 struc-
turally simpler analogues of fuscol/eunicol exhibit compa-
rable or better anti-inammatory activity in the mouse ear
edema assay,785 semi-synthetic oxygenated dolabellane diter-
penes exhibit in vitro anti-HIV activity,786 further semi-
synthetic examples of hydoxysterols were found to induce
pregnane X receptor transactivation,787 exibilide788 exhibits
in vivo anti-neuroinammatory activity in rats,789 11-epi-sin-
ulariolide acetate inhibits carcinoma cell migration and
invasion by suppressing a number of phosphorylation-
dependent pathways,790 13-acetoxysarcocrassolide induces
apoptosis in carcinoma cells by activation of p38/JNK and
suppression of PI3K/AKT pathways,791 and cembranoids from
Sarcophyton glaucum exhibit cytotoxicity towards a murine
melanoma cell line.792,7939 Bryozoans
There were only three reports (containing 19 compounds) of
new metabolites isolated from bryozoans in 2014, which is
a large increase on 2013 when only one new metabolite was
reported from this understudied phylum. The bromopyrrole
alkaloids aspidostomides A–H 1272–1279 and aspidazide A
1280 were isolated from the Patagonian bryozoan Aspidostoma
giganteum. Aspidostomide E 1276 exhibited moderate inhibi-
tion of the 786-O renal carcinoma cell line. Aspidazide A 1280 is
a rare asymmetrical diacylazide and NOE NMR correlations and
chemical transformations were utilised in determination of the
structure.794 A series of ceramides neritinaceramide A–E 1281–
1285 were obtained from Bugula neritina and exhibited selective
but weak activity against two HTCLs.795 The same sample yiel-
ded several sterols 1286–1290.796 Convolutamydine A797 dis-
played signicant anti-inammatory activity both in vitro and in
vivo.798
10 Molluscs
The 23 new metabolites reported from molluscs is the average
number reported per year over the past decade. 37-epi-This journal is © The Royal Society of Chemistry 2016Azaspiracid-1 1291 was isolated from contaminated raw shell-
sh – the epimer forms spontaneously via an equilibrium and
formation, as expected, is accelerated by heating.799 Implication
of the latter in relationship to the cooking of shellsh is
important as 37-epi-AZA1 was 5-fold more toxic towards Jurkat T
lymphocyte cells in vitro than AZA1. Corresponding epimers of
the related toxins AZA2 and AZA3 were also detected.
Specimens of the Mediterranean sacoglossan mollusc Thur-
idilla hopei aﬀorded new nor-diterpene aldehydes 1292–1294800
in addition to known congeners thuridillin A, B and C.801 The
mollusc feeds on the green alga Derbesia tenuissima, extracts of
which only contain a known epoxylactone,802 supporting the
assumption that 1292–1294 are mollusc transformation prod-
ucts. Acetylenic alcohols 1295–1299 were isolated from both the
Mediterranean dorid nudibranch Peltodoris atromaculata and
one of the nudibranch's common dietary prey, the sponge
Haliclona fulva.803 In a similar manner, renieramycin-related
alkaloids fennebricin A 1300 and B 1301 were isolated from
both the nudibranch Jorunna funebris and the sponge Xesto-
spongia sp.804 The substructurally-related isoquinoline 1302 was
only identied in the sponge extract. New diketopiperazines
1303–1306 were reported from Pleurobranchus areolatus –
related metabolites have been reported from the ascidian
Didemnum sp., a suspected prey of P. areolatus.805 Further
investigation into the origin of tetrodotoxin in Pleurobranchaea
maculata demonstrated that the mollusc can accumulate the
toxin through its diet however there was no identiable tetro-
dotoxin source in the molluscs local environment.806 Two
studies of sea hares identied two moderately cytotoxic
sesquiterpenes oculiferane 1307 and epi-obtusane 1308 (Aplysia
oculifera)807 and an anti-neuroinammatory diterpene dactylo-
diterpenol acetate 1309 (A. dactylomela).808 6-Bromoisatin, typi-
cally isolated from muricid molluscs, is weakly antiproliferative
towards HT29 cells, and enhances apoptosis in an in vivo colon
cancer model.809 Further structure–activity relationship studies
of the cyclic peptide sanguinamide B (Hexabranchus sangui-
neaus)810 have found that antiproliferative activity is dependent
upon both the location of specic amino acids in the macro-
cycle and their conguration.811,812 New synthetic auristatin
analogues, being related to the original MNP dolastatin 10
(Dolabella auricularia),813 bearing changes at the N-terminus
showed pronounced antitumour activity.814 The binding of
three examples to tubulin was investigated by co-crystal X-ray
studies, identifying an interesting structural feature whereby in
the solid state the valine-dolaisoleucine fragment exists inNat. Prod. Rep., 2016, 33, 382–431 | 401





























































































View Article Onlinethe cis-conguration, whereas in solution it exists solely in the
trans-conguration. In further studies, cholesterol and other
simple sterols puried from mussels showed anti-aging
and neuroprotective properties,815 synthetic tambjamine
analogues show enhanced tumour cell antiproliferative and
chloride transport properties,816 and lamellarin D (Lamellaria
sp.)817 induces senescence in cancer cells, in a process that
includes the generation of intracellular ROS and requires the
presence of topoisomerase I.818 Biosynthesis of long chain
polyunsaturated fatty acids in the scallop Chlamys nobilis was
investigated, revealing the presence of a new elongase, that
can elongate 20:4n-6 and 20:5n-3 to C22 and C24 acids, and
a D8-desaturase.819 A new example of an a4/7-conotoxin, a-
BnIA 1310 was isolated from crude venom of the molluscivo-
rous cone snail Conus bandanus.820 Peptides with the same
sequence, Mr1.1 and Bn1.1, were previously identied by PCR
amplication of venom duct cDNA from molluscs C. marmor-
eus821 and C. bandanus.822 The peptide reversibly inhibited the
human a7 nicotinic acetylcholine receptor (nAChR) and
blocked nerve-evoked skeletal muscle contractions. Conus
bandanus (Vietnam) was also the source of BnIIID 1311, a 15
residue M–1 family peptide containing six cysteines (disulde
connectivity not determined) and three post-translational
modications comprised of a bromotryptophan, g-carboxy
glutamate and amidated aspartic acid residues.823 An unusual
a5/5 conotoxin AusIA 1312 was puried from the venom of C.
australis – both synthetic globular (natural) and ribbon
(diﬀerent disulde linkages) congurations inhibited the a7
nAChR.824 A short cyclic hexapeptide Vi804 1313 was isolated
from crude venom of C. virgo and the solution structure of it
and the DW3 synthetic analogue explored by NMR spectros-
copy.825 The high hydrophobicity of g-conotoxins make them
diﬃcult to synthesise by standard peptide synthesis tech-
niques. A recent report describes the use of a Lys4 solubilising
C-terminus tag to enable the synthesis and NaV subtype
selectivity of three previously reported C. consors g-conotoxins,
g-CnVIB, g-CnVIC and g-CnVID.826 Further studies have re-
ported on the structure and activity of dicarba analogues of a-
RgIA,827 the inuence of disulde connectivity on structure and
bioactivity of a-TxIA,828 the inuence of acetylcholine to
aﬀect the binding of a-MII at nAChRs,829 the neuronal target
selectivity of the Conus textile T-superfamily peptide TxVC,830
and the Ca2+-activated K+ (BK) channel selectivity of the
unusual M superfamily conotoxin Vt3.1.831
11 Tunicates (ascidians)
The 22 new tunicate-derived natural products presented in this
review is the second lowest number reported in one year
over the last decade. A structurally-diverse range of metabo-
lites were reported, with examples of glycerides 1314 and
1315,832 amino alcohols 1316–1322,833 new didemnaketal
congeners 1323, 1324834 and 1325, 1326,835 halogenated alka-
loids 1327 and 1328,836 a new rubrolide (R) 1329837 (that
unfortunately shares the same letter designation as a related
metabolite reported from Aspergillus terreus217), pyr-
idoacridine cnemidine A 1330552 and sulfated sterols 1331 and402 | Nat. Prod. Rep., 2016, 33, 382–4311332.838 Noteworthy was the isolation, structure elucidation
and synthesis of a rare example of a modied nucleoside
bearing a 50-thiomethyl substituent 1333.839 The same study
also led to the reassignment of structure of a known sponge
metabolite hamiguanosinol840 from the enol tautomer to the
guanosine keto tautomer 1334. The tanjungides A 1335 and B
1336,841 novel dibromoindole enamide alkaloids isolated
from Diazona cf. formosa exhibit potent cytotoxicity (<1–2 mM)
towards a panel of HTCLs. An eleven-step linear synthesis
utilising Buchwald vinyliodide amidation and peptide
synthesis established the absolute conguration of the
alkaloids.
Over the years a number of cyclic ribosomal peptides, now
known as the cyanobactins, have been reported from ascid-
ians, typically of the genus Lissoclinum. The true producers of
these natural products are photosynthetic symbiotic cyano-
bacteria of the genus Prochloron. The apparent random
distribution of cyanobactins isolated from ascidians has now
been credited to host phylogeny, with genetic analysis
revealing that ‘Lissoclinum patella’ falls into three phyloge-
netic groups that in turn may contain further cryptic
species.842 The implications that local extinctions of such
cryptic species may reduce marine natural product diversity is
indeed food-for-thought in the context of climate change. A
very interesting demonstration of the use of the biosynthetic
machinery of cyanobactin production was recently reported,
whereby engineered enzymes of the patellamide pathway, in
combination with enzymes from other cyanobactin-related
pathways, were used for the in vitro production of a small
library of cyclic peptides.843 This proof of principle allowed for
the preparation of 1–2 mg of each peptide. Total synthesis has
led to revision of the original structure proposed for didem-
naketal B (Didemnum sp.)844 to 1337, requiring stereochemical
inversion of the C-10–C-20 spiroacetal domain of the MNP.845
Such a revision may be of relevance to the ongoing revision of
the (stereo)structure of didemnaketal A.846 Syntheses of the
reported structures of polycitorols A and B (unidentied
ascidian)847,848 and (+)-didemniserinolipid C (Didemnum
sp.)849,850 suggest that the structures of all three MNPs require
revision. Total synthesis has also led to revision of the struc-
ture of mandelalide A (Lissoclinum sp.)851 to 1338852 and
conrmation of the revised structure of haouamine B
(Aplidium haouarianum),853–855 while the structures of
distomadines A and B (Pseudodistoma aureum)856,857 and
synoxazolidinones A and B (Synoicum pulmonaria)858,859 have
been conrmed by synthesis. Synoxazolidinones A and C and
S. pulmonaria co-metabolites pulmonarins A and B exhibitedThis journal is © The Royal Society of Chemistry 2016





























































































View Article Onlinevariable levels of anti-biofouling activity against a panel of test
organisms, with synoxazolidinone C being particularly potent
as both a growth and adhesion inhibitor.860 The eﬀects of
ascidian extracts on the estrogen receptor-negative breast
cancer cell line MDA-MB-231 were investigated by content-rich
screening, leading to the identication of eusynstyelamide B
(Didemnum candidum, originally isolated from Eusynstyela
latericus861) as a moderate cytotoxin (IC50 5 mM) causing cell
cycle arrest in G2/M and inducing apoptosis.862 The potently
cytotoxic macrolide iejimalide C (Eudistoma cf. rigida)863 joins
congeners iejimalides A and B as being identied as an
inhibitor of the vacuolar-type ATP-driven proton pump (H+-
ATPase).864 Aer 24 h treatment, cells also exhibited actin
aggregates, but as the MNP does not inhibit actin polymeri-
sation in vitro, it was concluded that actin activity was
a consequence of disruption of pH homeostasis. Preliminary
data suggesting that trabectedin (Et 743) exhibits anti-angio-
genic activity towards breast cancer cell lines has been
reported.86512 Echinoderms
The 35 new metabolites reported from echinoderms in this
review is 25% lower than the average number reported per
annum over the last decade. Beyond the simple sulfonic acid
derivative 1339 isolated from the sea urchin Brisaster latifrons866
and the highly substituted unsymmetrical binaphthoquinone
mirabiquinone 1340 (sea urchin Scaphechinus mirabilis),867 the
natural product chemistry of echinoderms is dominated by
steroidal tri- (1341868 and 1342869), tetra- (1343–1352870–873),
penta- and hexaoses (1353–1371).873–875 The aglycone 1372 was
also isolated.874 In many cases these MNPs exhibited biological
activity including anti-inammatory,866 cytotoxic,870,872,874
hemolytic870 and antifungal873,875 properties.
A number of new saponins were identied in extracts of the
Australian sea cucumber Holothuria lessoni using solely LC-MS/
MS metabolomic techniques.876 In a conceptually similar
manner, the chemical diversity of saponins present in diﬀerent
organs of the starsh Asterias rubens was investigated by
combinations of MALDI-TOF and LC-MS(/MS) techniques.877
The latter study concluded that diﬀerent organs are charac-
terised by diﬀerent saponin mixtures and inter-specimen vari-
ability exists suggesting inuence of sex and/or collecting
season on saponin prole. A short octapeptide echinometrin
1373 (sea urchin Echinometra lucunter) was found to exhibit
ability to degranulate mast cells leading to an inammatory
reaction.878 The sequence of the peptide is an internal fragmentThis journal is © The Royal Society of Chemistry 2016of vitellogenin, a nutrient protein present in sea urchin game-
togenic cells, suggesting the possibility that echinometrin is
a cryptide.879
The rst synthesis of a pyranonaphthazarin pigment isolated
from the sea urchin Echinothrix diadema880 has been reported.881
Further studies using puried pentahydroxynaphthoquinone
echinochrome A882,883 have identied it to enhance mitochon-
drial biogenesis,884 to protect cardiomyocyte mitochondria from
the eﬀects of cardiotoxic drugs885 and to inhibit acetylcholin-
esterase in an irreversible and uncompetitive mode.886 The
mechanisms of antioxidant reactivity of the structurally related
echinamines A and B887 has been investigated using DFT
methods.888 The benzochromenone comaparvin (Comanthus
bennetti)889 exhibits anti-inammatory activity in the carra-
geenan-induced rat model.890 A simple synthesis of ovothiol A891
from L-hisidine has been reported,892 the role of a non-heme
iron oxidase enzyme in the biosynthesis of ovothiol A investi-
gated,893 NMR-pH titrations used to investigate the micro-
speciation of the amino acid,894 and the antiproliferative activity
towards Hep-G2 cell line via an autophagy mechanism identi-
ed.895 Sterols and fatty acids from the spiny sea-star Marthas-
terias glacialis exhibit both anti-inammatory896 and cell cycle
arrest properties,897 while sterols from an urchin and a starsh
exhibit selective antiparasitic activity towards T. brucei.783
Investigation of the structure and bioactivity of chimeric
analogues of the starsh cardiac-stomach relaxing SALMFa-
mide neuropeptides S1 and S2 has highlighted the importance
of the C-terminus for bioactivity and that the N-terminus
confers structural stability.898 Treatment of pancreatic cancer in
vivo in athymic mice using a combination of frondoside A
(Cucumaria frondosa)899 and the nucleoside anticancer agent
gemcitabine was signicantly more eﬀective than with either
drug alone.900 The cytotoxic and apoptotic-inducing abilities of
steroids from the cold water starsh Ctenodiscus crispatus901 and
the triterpene glycosides, including echinoside A, from Hol-
othuria scabra and Cucumaria frondosa have been reported.902
Echinoside A and related saponin holothurin A inhibit dietary
fat absorption and decrease the adipose tissue accumulation in
mice,903 and typicosides (Actinocucumis typica)904 exhibit a strong
immunostimulatory eﬀect onmouse macrophages with marked
increase in lysosomal activity and ROS formation.905 Complete
NMR assignments have been reported for four pentaoside
asterosaponins: thornasteroside A, versicoside A, anasteroside
B and asteronylpentaglycoside sulfate (Asterias amurensis).90613 Mangroves
In addition to a series of mildly antioxidant glycosides, mar-
inoids F–M 1374–1381, reported from the whole fruits of the
mangrove Avicennia marina,907,908 seco-diterpene 1382 (Ceriops
decandra),909 cinnamides 1383–1387 (Micromelum falcatum,
mangrove associate),910 protolimonoids 1388–1394 (Xylocarpus
granatum),911 and limonoids 1395–1401,912 1402–1404,913 1405–Nat. Prod. Rep., 2016, 33, 382–431 | 403





























































































View Article Online1408,914 1409–1418,915 1419–1422916 and 1423917 (X. rumphii and
X. granatum) were also isolated from mangroves or their asso-
ciates. The absolute conguration of the unusual spiro-seco-
abietane decandrinin 1382 was secured via analysis of experi-
mental and calculated ECD and ORD chiroptical data909while of
the limonoids reported, the structures of xylorumphiin G
1398,912 xylogranatopyridine A 1402,913 granatumin L 1409915
and granatumin Y 1422916 were established by single crystal X-
ray diﬀraction studies.
Further investigation of previously reported mangrove
MNPs has identied avicequinone C (Avicennia marina)918 as
a 5a-reductase-type 1 inhibitor,919 catunaregin (Micromelum
falcatum)920 as an angiogenesis inhibitor,921 the cardiac
glycoside neriifolin (Cerbera manghas)922 as the acaricidal
component of Panonychus citri,923 and that leaf extracts and
puried components of Avicennia marina exhibit antibacterial
activity with relevance to urinary tract infections.924 Finally,
a new biomimetic synthesis925 and a structure–activity rela-
tionship study of the protein tyrosine phosphatase 1B inhib-
iting properties926 of the unusual dimeric alkylbutenolide
paracaseolide A (Sonneratia paracaseolaris)927 have been
reported.14 Miscellaneous
Two studies of sea grass from the Egyptian Red Sea led to the
identication of avone xyloside 1424 (Thalassia hemprichii)928
and dihydrochalcone diglycoside 1425 (Thalassodendron cil-
iatum)929 as antimicrobial and anti-inuenza A virus MNPs
respectively. Thelepamide 1426 is an unusual ketide-amino acid
isolated from the annelid worm Thelepus crispus.930 The404 | Nat. Prod. Rep., 2016, 33, 382–431relative conguration of the alkaloid was determined by
a combination of heteronuclear J-based congurational analysis
and GIAO calculated chemical shis and DP4 probability
analysis. Mild cytotoxicity towards a leukemia cell line was also
observed. The arenicins, antimicrobial peptides produced by
the polychaete worm Arenicola marina,931 are constitutively
expressed in a range of tissues in the organism suggestive that
the peptides play a front-line role in defense against infec-
tions.932 Cypridina luciferyl sulfate 1427 appears to be a more
stable storage form of cypridina luciferin, the luminescence
precursor of the ostracod Cypridina (Vargula) hilgendori.933 The
luciferin could be converted to luciferyl sulfate by action of
crude extract of the organism, presumably containing a sulfo-
transferase, in the presence of 30-phosphoadenosine 50-phos-
phosulfate (PAPS, a sulfate donor), while the reverse reaction
took place in the presence of adenosine 30,50-diphosphate,
a sulfate acceptor.
Extracts of ovary tissue from Takifugu pardalis yielded a new
tetrodotoxin analogue, 6-deoxyTTX 1428.934 The potent voltage-
gated sodium channel blocker was also detected by LC-MSMS in
other marine animals including snail and octopus. Alanine
scanning of the hagsh (Myxine glutinosa)935 12-amino acid
residue antimicrobial peptide myxinidin has identied
a number of critical residues for the observed biological activ-
ities and that judicious substitution with arginine led to the
identication of more potent analogues.936 The 33-amino-acid
residue peptide pardaxin (atsh Pardachirus marmoratus)
exhibited in vivo activity towards MRSA dermal infection and
enhanced wound healing.937 A range of arsenic-containing
lipids have been synthesised, providing valuable reference
standards for future studies directed towards understanding
the uptake, biotransformation and toxicity of these unusual
MNPs.93815 Conclusion
In a recent review the number of new MNPs reported from
a range of countries was analysed based on the location of the
principal author for each publication.3 What is not apparent
from this analysis is the location of the collecting sites for the
organisms. This can be problematical as shown in an extreme
example: one prominent MNP chemist based in the Mid-West of
the USA, thousands of km from any coastal resource, collected
widely (see Fig. 1).
With the biogeographic aspect of the MarinLit database19
now widely available an alternative perspective is available for
viewing the collection data. It is now possible to search by
region showing who is collecting where and hence theThis journal is © The Royal Society of Chemistry 2016
Fig. 1 Collection sites (red stars) for a US MNP chemist.
Table 1 The 22 oceanic regions or countries used in the survey giving
numbers of publications and new compounds discovered in each
region/country over the period 1965–2014
Country or Oceanic region #Compounds #Papers
Pacic Russia, sea of Japan 377 167
China 2915 942
South China sea and Yellow sea 525 203
Taiwan 1350 376
Japan, including Okinawa 3877 1570
South Korea 848 239
North Pacic islands and atolls 1539 576
South Pacic islands and atolls 1548 522
Maritime SE Asia, Papua-New Guinea 1340 502
Australia 1854 677
Mainland SE Asia (including East Malaysia) 457 173
South Asia 714 333
Indian ocean and islands 326 155
Mediterranean, Arabian Peninsula, Black sea 2358 876
Other African countries 456 154
Atlantic Europe and the Baltic sea 476 210
Atlantic ocean and islands 361 140
South American countries 538 210
Central America 245 86
Gulf of Mexico, Caribbean sea and islands 1524 571
North America 1382 520
Arctic and Antarctica 330 105





























































































View Article Onlineinterests that MNP chemists have in the various regions of the
globe. The 50 years of collecting eﬀort globally is depicted in
Fig. 2. The red stars in Fig. 2 represent the collecting sites,
described in 9000 papers, from which 25 700 new
compounds have been obtained. The actual number of unique
collection sites is less than the number of papers as multiple
collections have oen been made at the same sites. Fig. 2
displays those areas that have had high collecting pressures
and those where there has been, for whatever reason, lower
collecting pressures. An analysis has been made of the col-
lecting eﬀort globally by semi-decade since 1965. For conve-
nience the globe was divided up into 22 regions or countries
(see Table 1) and the published papers for each region
compiled. Totals for papers (citing collection sites) describing
new compounds from 1965 are also listed in Table 1 while
Fig. 3 shows the incidence of discovery of new compounds in
each region or country by semi-decade since 1965. It is worth
noting that since 1965–280 papers contained no biogeo-
graphic data, not even a country or an ocean, to describe the
origin of new compounds being reported. Fortunately, recent
years have seen the increasing use of exact coordinates. The
Japanese region, including Okinawa, has been the most
productive region with 3877 compounds described. This wasFig. 2 All collection sites for MNP discovery, 1965–2014.
This journal is © The Royal Society of Chemistry 2016followed closely by China with 2915 compounds from the
mainland with a further 525 compounds to be included if the
regions of the South China Sea and Yellow Sea are also
considered. But what is remarkable here is the rapid emergence
of MNP chemistry using Chinese-based collections as seen in
Fig. 3. Other regions where there have been extensive collec-
tions are in the Mediterranean (2358) (which includes the
Mediterranean coasts of Spain and France, Italy, the islands of
the Mediterranean, Greece, Turkey, Israel, Egypt, the Arabian
Peninsula, Black Sea and the Mediterranean African coastlines),
Australia (1854), the North (1539) and South (1548) Pacic
islands and atolls, and the Gulf of Mexico, Caribbean Sea and
islands (1524). Other regions that have been well explored
include Taiwan (1350) and Maritime SE-Asia and Papua-New
Guinea (1340).
The graph shows very clearly those countries that were most
closely studied in the early years. Compounds of Japanese origin
were prominent from the 1960s, but the search for MNPs was
quickly taken up with compounds from the Mediterranean,
North Pacic and North American regions appearing in the
early 1970s, followed by Australian and Maritime SE-Asian
compounds later in that decade. Prospecting activity in other
parts of Asia was relatively slow to start and it was not really
until the 1990s that compounds of Mainland SE-Asian, South
Korean, Taiwan and Chinese origin started to appear. The
output from these regions has rapidly accelerated since,
particularly so in the case of compounds of Chinese origin.
Fig. 2 and 3, taken in combination, provide a snapshot of the
past eﬀorts in marine natural products as well as current
endeavours and highlights those areas of the globe that are
currently under-explored.Nat. Prod. Rep., 2016, 33, 382–431 | 405
Fig. 3 The count of new compounds by region/country over the period 1965–2014, by semi-decade.





























































































View Article Online16 Acknowledgements
We thank Dr Serin Dabb and Dr Helen Potter (Royal Society of
Chemistry) for the provision of data used in this review, from
the MarinLit database.1917 References
1 D. J. Faulkner, Nat. Prod. Rep., 1984, 1, 251–280, DOI:
10.1039/np9840100251.
2 D. J. Faulkner, Nat. Prod. Rep., 1984, 1, 551–598, DOI:
10.1039/np9840100551.
3 J. W. Blunt, B. R. Copp, R. A. Keyzers, M. H. G. Munro and
M. R. Prinsep, Nat. Prod. Rep., 2014, 31, 160–258, DOI:
10.1039/c3np70117d.
4 D. J. Newman and G. M. Cragg, Mar. Drugs, 2014, 12, 255–
278, DOI: 10.3390/md12010255.
5 G. M. Cragg, P. G. Grothaus and D. J. Newman, J. Nat. Prod.,
2014, 77, 703–723, DOI: 10.1021/np5000796.406 | Nat. Prod. Rep., 2016, 33, 382–4316 L. E. Lallier, O. McMeel, T. Greiber, T. Vanagt,
A. D. W. Dobson and M. Jaspars, Nat. Prod. Rep., 2014, 31,
612–616, DOI: 10.1039/c3np70123a.
7 C. Hardoim and R. Costa, Mar. Drugs, 2014, 12, 5089–5122,
DOI: 10.3390/md12105089.
8 M. C. Wilson, T. Mori, C. Ru¨ckert, A. R. Uria, M. J. Helf,
K. Takada, C. Gernert, U. A. E. Steﬀens, N. Heycke,
S. Schmitt, C. Rinke, E. J. N. Helfrich, A. O. Brachmann,
C. Gurgui, T. Wakimoto, M. Kracht, M. Cru¨semann,
U. Hentschel, I. Abe, S. Matsunaga, J. Kalinowski,
H. Takeyama and J. Piel, Nature, 2014, 506, 58–62, DOI:
10.1038/nature12959.
9 M. Jaspars and G. Challis, Nature, 2014, 506, 38–39, DOI:
10.1038/nature13049.
10 U. R. Abdelmohsen, K. Bayer and U. Hentschel, Nat. Prod.
Rep., 2014, 31, 381–399, DOI: 10.1039/c3np70111e.
11 P. C. Still, T. A. Johnson, C. M. Theodore, S. T. Loveridge
and P. Crews, J. Nat. Prod., 2014, 77, 690–702, DOI:
10.1021/np500041x.This journal is © The Royal Society of Chemistry 2016





























































































View Article Online12 M. P. Puglisi, J. M. Sneed, K. H. Sharp, R. Ritson-Williams
and V. J. Paul, Nat. Prod. Rep., 2014, 31, 1510–1553, DOI:
10.1039/c4np00017j.
13 R. M. VanWagoner, M. Satake and J. L. C. Wright, Nat. Prod.
Rep., 2014, 31, 1101–1137, DOI: 10.1039/c4np00016a.
14 R.-M. Huang, Y.-N. Chen, Z. Zeng, C.-H. Gao, X. Su and
Y. Peng, Mar. Drugs, 2014, 12, 5817–5838, DOI: 10.3390/
md12125817.
15 A. P. Thottumkara, W. H. Parsons and J. Du Bois, Angew.
Chem., Int. Ed., 2014, 53, 5760–5784, DOI: 10.1002/
anie.201308235.
16 V. Bane, M. Lehane, M. Dikshit, A. O'Riordan and A. Furey,
Toxins, 2014, 6, 693–755, DOI: 10.3390/toxins6020693.
17 J. Rocha-Martin, C. Harrington, A. Dobson and F. O'Gara,
Mar. Drugs, 2014, 12, 3516–3559, DOI: 10.3390/
md12063516.
18 M. D. Guiry, G. M. Guiry, L. Morrison, F. Rindi,
S. V. Miranda, A. C. Mathieson, B. C. Parker,
A. Langangen, D. M. John, I. Ba´rbara, C. F. Carter,
P. Kuipers and D. J. Garbary, Cryptogam.: Algol., 2014, 35,
105–115, DOI: 10.7872/crya.v35.iss2.2014.105.
19 http://pubs.rsc.org/marinlit, accessed 4 December 2015.
20 Y. Kato, N. Fusetani, S. Matsunaga, K. Hashimoto, S. Fujita
and T. Furuya, J. Am. Chem. Soc., 1986, 108, 2780–2781, DOI:
10.1021/ja00270a061.
21 T. Wakimoto, Y. Egami, Y. Nakashima, Y. Wakimoto,
T. Mori, T. Awakawa, T. Ito, H. Kenmoku, Y. Asakawa,
J. Piel and I. Abe, Nat. Chem. Biol., 2014, 10, 648–655,
DOI: 10.1038/nchembio.1573.
22 Y. Egami, T. Wakimoto and I. Abe, Bioorg. Med. Chem. Lett.,
2014, 24, 5150–5153, DOI: 10.1016/j.bmcl.2014.10.002.
23 P. Fu, S. X. Wang, K. Hong, X. Li, P. P. Liu, Y. Wang and
W. M. Zhu, J. Nat. Prod., 2011, 74, 1751–1756, DOI:
10.1021/np200258h.
24 P. Fu, F. Kong, X. Li, Y. Wang and W. Zhu, Org. Lett., 2014,
16, 3708–3711, DOI: 10.1021/ol501523d.
25 U. R. Abdelmohsen, C. Cheng, C. Viegelmann, T. Zhang,
T. Grkovic, S. Ahmed, R. J. Quinn, U. Hentschel and
R. Edrada-Ebel, Mar. Drugs, 2014, 12, 1220–1244, DOI:
10.3390/md12031220.
26 F. S. Tareq, M. A. Lee, H.-S. Lee, Y.-J. Lee, J. S. Lee,
C. M. Hasan, M. T. Islam and H. J. Shin, J. Agric. Food
Chem., 2014, 62, 5565–5572, DOI: 10.1021/jf502436r.
27 F. S. Tareq, M. A. Lee, H.-S. Lee, J.-S. Lee, Y.-J. Lee and
H. J. Shin, Mar. Drugs, 2014, 12(2), 871–885, DOI: 10.3390/
md12020871.
28 F. S. Tareq, M. A. Lee, H.-S. Lee, Y.-J. Lee, J. S. Lee,
C. M. Hasan, M. T. Islam and H. J. Shin, Org. Lett., 2014,
16, 928–931, DOI: 10.1021/ol403657r.
29 K. Yamanaka, K. A. Reynolds, R. D. Kersten, K. S. Ryan,
D. J. Gonzalez, V. Nizet, P. C. Dorrestein and B. S. Moore,
Proc. Natl. Acad. Sci. U. S. A., 2014, 111, 1957–1962, DOI:
10.1073/pnas.1319584111.
30 G. A. Ellis, T. P. Wyche, C. G. Fry, D. R. Braun and
T. S. Bugni, Mar. Drugs, 2014, 12, 1013–1022, DOI:
10.3390/md12021013.This journal is © The Royal Society of Chemistry 201631 R. Raju, A. M. Piggott, L. X. B. Diaz, Z. Khalil and
R. J. Capon, Org. Lett., 2010, 12, 5158–5161, DOI: 10.1021/
ol102162d.
32 J. Schmidt, Z. Khalil, R. J. Capon and C. W. B. Stark,
Beilstein J. Org. Chem., 2014, 10, 1228–1232, DOI: 10.3762/
bjoc.10.121.
33 X.-B. Ding, D. P. Furkert, R. J. Capon andM. A. Brimble, Org.
Lett., 2014, 16, 378–381, DOI: 10.1021/ol403246j.
34 R. Raju, Z. G. Khalil, A. M. Piggott, A. Blumenthal,
D. L. Gardiner, T. S. Skinner-Adams and R. J. Capon, Org.
Lett., 2014, 16, 1716–1719, DOI: 10.1021/ol5003913.
35 W. J. Zhang, Z. Liu, S. M. Li, T. T. Yang, Q. B. Zhang, L. Ma,
X. P. Tian, H. B. Zhang, C. G. Huang, S. Zhang, J. H. Ju,
Y. M. Shen and C. S. Zhang, Org. Lett., 2012, 14, 3364–
3367, DOI: 10.1021/ol301343n.
36 Y. Chen, W. Zhang, Y. Zhu, Q. Zhang, X. Tian, S. Zhang and
C. Zhang, Org. Lett., 2014, 16, 736–739, DOI: 10.1021/
ol4034176.
37 W. Zhang, L. Ma, S. Li, Z. Liu, Y. Chen, H. Zhang, G. Zhang,
Q. Zhang, X. Tian, C. Yuan, S. Zhang, W. Zhang and
C. Zhang, J. Nat. Prod., 2014, 77, 1887–1892, DOI: 10.1021/
np500362p.
38 S. Tamura, N. Takahashi, S. Miyamoto, R. Mori, S. Suzuki
and J. Nagatsu, Agric. Biol. Chem., 1963, 27, 576–582, DOI:
10.1271/bbb1961.27.576.
39 W. Zhang, S. Li, Y. Zhu, Y. Chen, Y. Chen, H. Zhang,
G. Zhang, X. Tian, Y. Pan, S. Zhang, W. Zhang and
C. Zhang, J. Nat. Prod., 2014, 77, 388–391, DOI: 10.1021/
np400665a.
40 J. Zhang, Y. Jiang, Y. Cao, J. Liu, D. Zheng, X. Chen, L. Han,
C. Jiang and X. Huang, J. Nat. Prod., 2013, 76, 2126–2130,
DOI: 10.1021/np4003417.
41 H. J. Shin, H.-S. Lee, J. S. Lee, J. Shin, M. A. Lee, H.-S. Lee,
Y.-J. Lee, J. Yun and J. S. Kang, Mar. Drugs, 2014, 12,
3283–3291, DOI: 10.3390/md12063283.
42 J. S. Lee, J. Shin, H. J. Shin, H.-S. Lee, Y.-J. Lee, H.-S. Lee and
H. Won, Eur. J. Org. Chem., 2014, 2014, 4472–4476, DOI:
10.1002/ejoc.201402524.
43 C. Boonlarppradab, C. A. Kauﬀman, P. R. Jensen and
W. Fenical, Org. Lett., 2008, 10, 5505–5508, DOI: 10.1021/
ol8020644.
44 S. M. Salem, P. Kancharla, G. Florova, S. Gupta, W. Lu and
K. A. Reynolds, J. Am. Chem. Soc., 2014, 136, 4565–4574,
DOI: 10.1021/ja411544w.
45 P. Kancharla, W. Lu, S. M. Salem, J. Xu Kelly and
K. A. Reynolds, J. Org. Chem., 2014, 79, 11674–11689, DOI:
10.1021/jo5023553.
46 L. Kaysser, P. Bernhardt, S. J. Nam, S. Loesgen, J. G. Ruby,
P. Skewes-Cox, P. R. Jensen, W. Fenical and B. S. Moore, J.
Am. Chem. Soc., 2012, 134, 11988–11991, DOI: 10.1021/
ja305665f.
47 G. Sakoulas, S.-J. Nam, S. Loesgen, W. Fenical, P. R. Jensen,
V. Nizet and M. Hensler, PLoS One, 2012, 7, e29439, DOI:
10.1371/journal.pone.0029439.
48 L. Kaysser, P. Bernhardt, S.-J. Nam, S. Loesgen, J. G. Ruby,
P. Skewes-Cox, P. R. Jensen, W. Fenical and B. S. Moore, J.
Am. Chem. Soc., 2014, 136, 14626, DOI: 10.1021/ja509209d.Nat. Prod. Rep., 2016, 33, 382–431 | 407





























































































View Article Online49 R. Meier, S. Strych and D. Trauner, Org. Lett., 2014, 16,
2634–2637, DOI: 10.1021/ol500800z.
50 R. Teufel, L. Kaysser, M. T. Villaume, S. Diethelm,
M. K. Carbullido, P. S. Baran and B. S. Moore, Angew.
Chem., Int. Ed., 2014, 53, 11019–11022, DOI: 10.1002/
anie.201405694.
51 S. Diethelm, R. Teufel, L. Kaysser and B. S. Moore, Angew.
Chem., Int. Ed., 2014, 53, 11023–11026, DOI: 10.1002/
anie.201405696.
52 R. Wilputte and R. H. Martin, Bull. Soc. Chim. Belg., 1956,
65, 874–898, DOI: 10.1002/bscb.19560650908.
53 L. Trzoss, T. Fukuda, L. V. Costa-Lotufo, P. Jimenez, J. J. La
Clair andW. Fenical, Proc. Natl. Acad. Sci. U. S. A., 2014, 111,
14687–14692, DOI: 10.1073/pnas.1410932111.
54 M. R. Seyedsayamdost, G. Carr, R. Kolter and J. Clardy, J.
Am. Chem. Soc., 2011, 133, 18343–18349, DOI: 10.1021/
ja207172s.
55 M. R. Seyedsayamdost, R. J. Case, R. Kolter and J. Clardy,
Nat. Chem., 2011, 3, 331–335, DOI: 10.1038/nchem.1002.
56 M. R. Seyedsayamdost, R. Wang, R. Kolter and J. Clardy, J.
Am. Chem. Soc., 2014, 136, 15150–15153, DOI: 10.1021/
ja508782y.
57 P. Fu, Y. Zhu, X. Mei, Y. Wang, H. Jia, C. Zhang and W. Zhu,
Org. Lett., 2014, 16, 4264–4267, DOI: 10.1021/ol5019757.
58 T. P. Wyche, J. S. Piotrowski, Y. Hou, D. Braun,
R. Deshpande, S. McIlwain, I. M. Ong, C. L. Myers,
I. A. Guzei, W. M. Westler, D. R. Andes and T. S. Bugni,
Angew. Chem., Int. Ed., 2014, 53, 11583–11586, DOI:
10.1002/anie.201405990.
59 T. Grkovic, U. R. Abdelmohsen, E. M. Othman, H. Stopper,
R. Edrada-Ebel, U. Hentschel and R. J. Quinn, Bioorg. Med.
Chem. Lett., 2014, 24, 5089–5092, DOI: 10.1016/
j.bmcl.2014.08.068.
60 Y. Dashti, T. Grkovic, U. R. Abdelmohsen, U. Hentschel and
R. J. Quinn,Mar. Drugs, 2014, 12, 3046–3059, DOI: 10.3390/
md12053046.
61 Y. Kwon, S.-H. Kim, Y. Shin, M. Bae, B.-Y. Kim, S. K. Lee,
K.-B. Oh, J. Shin and D.-C. Oh, Mar. Drugs, 2014, 12,
2326–2340, DOI: 10.3390/md12042326.
62 Z. Ma, J. Hu, X. Wang and S. Wang, J. Antibiot., 2014, 67,
175–178, DOI: 10.1038/ja.2013.89.
63 C.-H. Gao, Y.-N. Chen, L.-X. Pan, F. Lei, B. Long, L.-Q. Hu,
R.-C. Zhang, K. Ke and R.-M. Huang, J. Antibiot., 2014, 67,
541–543, DOI: 10.1038/ja.2014.27.
64 Z. Ma and J. Hu, Appl. Biochem. Biotechnol., 2014, 173, 705–
715, DOI: 10.1007/s12010-014-0879-1.
65 K. Chakraborty, B. Thilakan and V. K. Raola, J. Agric. Food
Chem., 2014, 62, 12194–12208, DOI: 10.1021/jf504845m.
66 M. A. M. Mondol and H. J. Shin,Mar. Drugs, 2014, 12, 2913–
2921, DOI: 10.3390/md12052913.
67 J. Bai, D. Liu, S. Yu, P. Proksch and W. Lin, Tetrahedron
Lett., 2014, 55, 6286–6291, DOI: 10.1016/
j.tetlet.2014.09.100.
68 M. Wagner, W. M. Abdel-Mageed, R. Ebel, A. T. Bull,
M. Goodfellow, H.-P. Fiedler and M. Jaspars, J. Nat. Prod.,
2014, 77, 416–420, DOI: 10.1021/np400952d.408 | Nat. Prod. Rep., 2016, 33, 382–43169 X. Yan, X.-X. Tang, L. Chen, Z.-W. Yi, M.-J. Fang, Z. Wu and
Y.-K. Qiu, Mar. Drugs, 2014, 12, 2156–2163, DOI: 10.3390/
md12042156.
70 N. Takatani, K. Nishida, T. Sawabe, T. Maoka, K. Miyashita
and M. Hosokawa, Appl. Microbiol. Biotechnol., 2014, 98,
6633–6640, DOI: 10.1007/s00253-014-5702-y.
71 E. E. Eltamany, U. R. Abdelmohsen, A. K. Ibrahim,
H. A. Hassanean, U. Hentschel and S. A. Ahmed, Bioorg.
Med. Chem. Lett., 2014, 24, 4939–4942, DOI: 10.1016/
j.bmcl.2014.09.040.
72 T. Kawahara, M. Itoh, M. Izumikawa, I. Kozone, N. Sakata,
T. Tsuchida and K. Shin-ya, J. Antibiot., 2014, 67, 261–263,
DOI: 10.1038/ja.2013.124.
73 S. Sato, F. Iwata, T. Fukae and M. Katayama, J. Antibiot.,
2014, 67, 479–482, DOI: 10.1038/ja.2014.17.
74 M. C. Kim, E. Hwang, T. Kim, J. Ham, S. Y. Kim and
H. Cheol Kwon, J. Nat. Prod., 2014, 77, 2326–2330, DOI:
10.1021/np400888e.
75 Y. Kim, H. Ogura, K. Akasaka, T. Oikawa, N. Matsuura,
C. Imada, H. Yasuda and Y. Igarashi, Mar. Drugs, 2014,
12, 4110–4125, DOI: 10.3390/md12074110.
76 X.-X. He, X.-J. Chen, G.-T. Peng, S.-Y. Guan, L.-F. Lei,
J.-H. Yao, B.-X. Liu and C.-X. Zhang, Nat. Prod. Res., 2014,
28, 680–682, DOI: 10.1080/14786419.2014.891591.
77 J. Tebben, C. Motti, D. Tapiolas, P. Thomas-Hall and
T. Harder, Mar. Drugs, 2014, 12, 2802–2815, DOI: 10.3390/
md12052802.
78 Y. Sangnoi, A. Plubrukarn, V. Arunpairojana and
A. Kanjana-Opas, World J. Microbiol. Biotechnol., 2014, 30,
1135–1139, DOI: 10.1007/s11274-013-1531-x.
79 M. Xu, M. L. Hillwig, A. L. Lane, M. S. Tiernan, B. S. Moore
and R. J. Peters, J. Nat. Prod., 2014, 77, 2144–2147, DOI:
10.1021/np500422d.
80 Y. Wang, X. Tang, Z. Shao, J. Ren, D. Liu, P. Proksch and
W. Lin, J. Antibiot., 2014, 67, 395–399, DOI: 10.1038/
ja.2014.3.
81 A. L. Kunz, A. Labes, J. Wiese, T. Bruhn, G. Bringmann and
J. F. Imhoﬀ,Mar. Drugs, 2014, 12, 1699–1714, DOI: 10.3390/
md12041699.
82 D. Sun, W. Sun, Y. Yu, Z. Li, Z. Deng and S. Lin, Nat. Prod.
Res., 2014, 28, 1602–1606, DOI: 10.1080/
14786419.2014.928877.
83 W. Ai, X.-P. Lin, Z. Tu, X.-P. Tian, X. Lu, F. Mangaladoss,
Z.-L. Zhong and Y. Liu, Nat. Prod. Res., 2014, 28, 1219–
1224, DOI: 10.1080/14786419.2014.891204.
84 X. Zhou, H. Huang, J. Li, Y. Song, R. Jiang, J. Liu, S. Zhang,
Y. Hua and J. Ju, Tetrahedron, 2014, 70, 7795–7801, DOI:
10.1016/j.tet.2014.02.007.
85 D. Liu, A. Yang, C. Wu, P. Guo, P. Proksch and W. Lin,
Bioorg. Med. Chem. Lett., 2014, 24, 5288–5293, DOI:
10.1016/j.bmcl.2014.09.049.
86 Y. Song, Q. Li, X. Liu, Y. Chen, Y. Zhang, A. Sun, W. Zhang,
J. Zhang and J. Ju, J. Nat. Prod., 2014, 77, 1937–1941, DOI:
10.1021/np500399v.
87 A. Tripathi, M. M. Schoeld, G. E. Chlipala, P. J. Schultz,
I. Yim, S. A. Newmister, T. D. Nusca, J. B. Scaglione,
P. C. Hanna, G. Tamayo-Castillo and D. H. Sherman, J.This journal is © The Royal Society of Chemistry 2016





























































































View Article OnlineAm. Chem. Soc., 2014, 136, 1579–1586, DOI: 10.1021/
ja4115924.
88 H. Huang, Y. Cao, L. Tian, W. Lin and K. Zhang, Chem. Nat.
Compd., 2014, 50, 402–404, DOI: 10.1007/s10600-014-0970-
4.
89 S. Huang, L. Ma, M. H. Tong, Y. Yu, D. O'Hagan and
H. Deng, Org. Biomol. Chem., 2014, 12, 4828–4831, DOI:
10.1039/c4ob00970c.
90 J. Deng, C. Lu, S. Lia, H. Hao, Z. Li, J. Zhu, Y. Li and Y. Shen,
Bioorg. Med. Chem. Lett., 2014, 24, 1362–1365, DOI: 10.1016/
j.bmcl.2014.01.037.
91 Z. Lin, M. Koch, C. D. Pond, G. Mabeza, R. A. Seronay,
G. P. Concepcion, L. R. Barrows, B. M. Olivera and
E. W. Schmidt, J. Antibiot., 2014, 67, 121–126, DOI:
10.1038/ja.2013.115.
92 R. Sugiyama, S. Nishimura, N. Matsumori, Y. Tsunematsu,
A. Hattori and H. Kakeya, J. Am. Chem. Soc., 2014, 136,
5209–5212, DOI: 10.1021/ja500128u.
93 L. Farnaes, N. G. Coufal, C. A. Kauﬀman, A. L. Rheingold,
A. G. DiPasquale, P. R. Jensen and W. Fenical, J. Nat.
Prod., 2014, 77, 15–21, DOI: 10.1021/np400466j.
94 E. Harunari, C. Imada, Y. Igarashi, T. Fukuda, T. Terahara
and T. Kobayashi, Mar. Drugs, 2014, 12, 491–507, DOI:
10.3390/md12010491.
95 Y. Sun, K. Takada, Y. Nogi, S. Okada and S. Matsunaga, J.
Nat. Prod., 2014, 77, 1749–1752, DOI: 10.1021/np500337m.
96 P. Fu, M. Johnson, H. Chen, B. A. Posner and
J. B. MacMillan, J. Nat. Prod., 2014, 77, 1245–1248, DOI:
10.1021/np500207p.
97 J. Lee, H. Kim, T. G. Lee, I. Yang, D. H. Won, H. Choi,
S.-J. Nam and H. Kang, J. Nat. Prod., 2014, 77, 1528–1531,
DOI: 10.1021/np500285a.
98 K. Moon, C.-H. Ahn, Y. Shin, T. H. Won, K. Ko, S. K. Lee,
K.-B. Oh, J. Shin, S.-I. Nam and D.-C. Oh, Mar. Drugs,
2014, 12, 2526–2538, DOI: 10.3390/md12052526.
99 M. W. Mullowney, E. O´. hAinmhire, A. Shaikh, X. Wei,
U. Tanouye, B. D. Santarsiero, J. E. Burdette and
B. T. Murphy, Mar. Drugs, 2014, 12, 3574–3586, DOI:
10.3390/md12063574.
100 K. Ko, S.-H. Lee, S.-H. Kim, E.-H. Kim, K.-B. Oh, J. Shin and
D.-C. Oh, J. Nat. Prod., 2014, 77, 2099–2104, DOI: 10.1021/
np500500t.
101 H. Kim, I. Yang, R. S. Patil, S. Kang, J. Lee, H. Choi,
M.-S. Kim, S.-J. Nam and H. Kang, J. Nat. Prod., 2014, 77,
2716–2719, DOI: 10.1021/np500558b.
102 Y.-Y. Bu, H. Yamazaki, K. Ukai and M. Namikoshi, Mar.
Drugs, 2014, 12, 6102–6112, DOI: 10.3390/md12126102.
103 M. C. Duncan, W. R. Wong, A. J. Dupzyk, W. M. Bray,
R. G. Linington and V. Auerbuch, Antimicrob. Agents
Chemother., 2014, 58, 1118–1126, DOI: 10.1128/
AAC.02025-13.
104 N. Yi-Lei, W. Yun-Dan, W. Chuan-Xi, L. Ru, X. Yang,
F. Dong-Sheng, J. Hong and L. Yun-Yang, Nat. Prod. Res.,
2014, 28, 2134–2139, DOI: 10.1080/14786419.2014.926350.
105 H. K. Zane, H. Naka, F. Rosconi, M. Sandy, M. G. Haygood
and A. Butler, J. Am. Chem. Soc., 2014, 136, 5615–5618, DOI:
10.1021/ja5019942.This journal is © The Royal Society of Chemistry 2016106 H. Shigemori, M. A. Bae, K. Yazawa, T. Sasaki and
J. Kobayashi, J. Org. Chem., 1992, 57, 4317–4320, DOI:
10.1021/jo00041a053.
107 C. Olano, I. Garcia, A. Gonzalez, M. Rodriguez, D. Rozas,
J. Rubio, M. Sanchez-Hidalgo, A. F. Brana, C. Mendez and
J. A. Salas, Microb. Biotechnol., 2014, 7, 242–256, DOI:
10.1111/1751-7915.12116.
108 W. J. Moree, O. J. McConnell, D. D. Nguyen, L. M. Sanchez,
Y.-L. Yang, X. Zhao, W.-T. Liu, P. D. Boudreau, J. Srinivasan,
L. Atencio, J. Ballesteros, R. G. Gavila´n, D. Torres-Mendoza,
H. M. Guzma´n, W. H. Gerwick, M. Gutie´rrez and
P. C. Dorrestein, ACS Chem. Biol., 2014, 9, 2300–2308,
DOI: 10.1021/cb500432j.
109 R. Raju, A. M. Piggott, M. M. Conte and R. J. Capon, Org.
Biomol. Chem., 2010, 8, 4682–4689, DOI: 10.1039/
c0ob00267d.
110 K. Sakanishi, S. Itoh, R. Sugiyama, S. Nishimura, H. Kakeya,
Y. Iwabuchi and N. Kanoh, Eur. J. Org. Chem., 2014, 2014,
1376–1380, DOI: 10.1002/ejoc.201301487.
111 K. H. Jang, S. J. Nam, J. B. Locke, C. A. Kauﬀman,
D. S. Beatty, L. A. Paul and W. Fenical, Angew. Chem., Int.
Ed., 2013, 52, 7822–7824, DOI: 10.1002/anie.201302749.
112 K. H. Jang, S.-J. Nam, J. B. Locke, C. A. Kauﬀman,
D. S. Beatty, L. A. Paul and W. Fenical, Angew. Chem., Int.
Ed., 2014, 53, 621, DOI: 10.1002/anie.201310144.
113 S. Sato, F. Iwata, T. Mukai, S. Yamada, J. Takeo, A. Abe and
H. Kawahara, J. Org. Chem., 2009, 74, 5502–5509, DOI:
10.1021/jo900667j.
114 O. F. Jeker and E. M. Carreira, Angew. Chem., Int. Ed., 2012,
51, 3474–3477, DOI: 10.1002/anie.201109175.
115 C. He, C. Zhu, B. Wang and H. Ding, Chem.–Eur. J., 2014, 20,
15053–15060, DOI: 10.1002/chem.201403986.
116 M. Mansson, A. Nielsen, L. Kjaerulﬀ, C. H. Gotfredsen,
M. Wietz, H. Ingmer, L. Gram and T. O. Larsen, Mar.
Drugs, 2011, 9, 2537–2552, DOI: 10.3390/md9122537.
117 B. Kitir, M. Baldry, H. Ingme and C. A. Olsen, Tetrahedron,
2014, 70, 7721–7732, DOI: 10.1016/j.tet.2014.05.107.
118 R. N. Asolkar, K. C. Freel, P. R. Jensen, W. Fenical,
T. P. Kondratyuk, E.-J. Park and J. M. Pezzuto, J. Nat.
Prod., 2009, 72, 396–402, DOI: 10.1021/np800617a.
119 S. Chandrasekhar, K. Sathish, G. P. K. Reddy and
P. S. Mainkar, Tetrahedron: Asymmetry, 2014, 25, 348–355,
DOI: 10.1016/j.tetasy.2014.01.004.
120 S. Nie, W. Li and B. Yu, J. Am. Chem. Soc., 2014, 136, 4157–
4160, DOI: 10.1021/ja501460j.
121 H. A. Kirst, D. E. Dorman, J. L. Occolowitz, N. D. Jones,
J. W. Paschal, R. L. Hamill and E. F. Szymanski, J.
Antibiot., 1985, 38, 575–586, DOI: 10.7164/
antibiotics.38.575.
122 Q. H. Zhu, J. Li, J. Y. Ma, M. H. Luo, B. Wang, H. B. Huang,
X. P. Tian, W. J. Li, S. Zhang, C. S. Zhang and J. H. Ju,
Antimicrob. Agents Chemother., 2012, 56, 110–114, DOI:
10.1128/aac.05278-11.
123 Q. B. Zhang, A. Mandi, S. M. Li, Y. C. Chen, W. J. Zhang,
X. P. Tian, H. B. Zhang, H. X. Li, W. M. Zhang, S. Zhang,
J. H. Ju, T. Kurtan and C. S. Zhang, Eur. J. Org. Chem.,
2012, 5256–5262, DOI: 10.1002/ejoc.201200599.Nat. Prod. Rep., 2016, 33, 382–431 | 409





























































































View Article Online124 B. R. Rosen, E. W. Werner, A. G. O'Brien and P. S. Baran, J.
Am. Chem. Soc., 2014, 136, 5571–5574, DOI: 10.1021/
ja5013323.
125 U. W. Hawas, M. Shaaban, K. A. Shaaban, M. Speitling,
A. Maier, G. Kelter, H. H. Fiebig, M. Meiners, E. Helmke
and H. Laatsch, J. Nat. Prod., 2009, 72, 2120–2124, DOI:
10.1021/np900160g.
126 K. S. Prakash and R. Nagarajan, Org. Lett., 2014, 16, 244–
246, DOI: 10.1021/ol4032396.
127 M. Yotsu-Yamashita, B. Schimmele and T. Yasumoto,
Biosci., Biotechnol., Biochem., 1999, 63, 961–963, DOI:
10.1271/bbb.63.961.
128 Y. Satake, M. Adachi, S. Tokoro, M. Yotsu-Yamashita,
M. Isobe and T. Nishikawa, Chem.–Asian J., 2014, 9, 1922–
1932, DOI: 10.1002/asia.201402202.
129 G. O. Buchanan, P. G. Williams, R. H. Feling,
C. A. Kauﬀman, P. R. Jensen and W. Fenical, Org. Lett.,
2005, 7, 2731–2734, DOI: 10.1021/ol050901i.
130 K. Dineshkumar, V. Aparna, K. Z. Madhuri and W. Hopper,
Chem. Biol. Drug Des., 2014, 83, 350–361, DOI: 10.1111/
cbdd.12252.
131 V. J. R. V. Mukku, M. Speitling, H. Laatsch and E. Helmke, J.
Nat. Prod., 2000, 63, 1570–1572, DOI: 10.1021/np0001676.
132 J. S. Dickschat, T. Martens, T. Brinkhoﬀ, M. Simon and
S. Schulz, Chem. Biodiversity, 2005, 2, 837–865, DOI:
10.1002/cbdv.200590062.
133 D. Kim, J. S. Lee, Y. K. Park, J. F. Kim, H. Jeong, T. Oh,
B. S. Kim and C. H. Lee, J. Appl. Microbiol., 2007, 102,
937–944, DOI: 10.1111/j.1365-2672.2006.03172.x.
134 M. Strand, M. Carlsson, H. Uvell, K. Islam, K. Edlund,
I. Cullman, B. Altermark, Y.-F. Mei, M. Elofsson,
N.-P. Willassen, G. Wadell and F. Almqvist, Mar. Drugs,
2014, 12, 799–821, DOI: 10.3390/md12020799.
135 M. Leiro´s, E. Alonso, J. A. Sanchez, M. E. Rateb, R. Ebel,
W. E. Houssen, M. Jaspars, A. Alfonso and L. M. Botana,
ACS Chem. Neurosci., 2014, 5, 71–80, DOI: 10.1021/
cn4001878.
136 S. Hosoya, V. Arunpairojana, C. Suwannachart, A. Kanjana-
Opas and A. Yokota, Int. J. Syst. Evol. Microbiol., 2006, 56,
2931–2935, DOI: 10.1099/ijs.0.64504-0.
137 T. Ujihara, M. Nagano, H. Wada and S. Mitsuhashi, FEBS
Lett., 2014, 588, 4032–4036, DOI: 10.1016/
j.febslet.2014.09.023.
138 K. Gustafson, M. Roman and W. Fenical, J. Am. Chem. Soc.,
1989, 111, 7519–7524, DOI: 10.1021/ja00201a036.
139 J. Moldenhauer, D. C. G. Go¨tz, C. R. Albert, S. K. Bischof,
K. Schneider, R. D. Su¨ssmuth, M. Engeser, H. Gross,
G. Bringmann and J. Piel, Angew. Chem., Int. Ed., 2010,
49, 1465–1467, DOI: 10.1002/anie.200905468.
140 W. Qin, Y. Liu, P. Ren, J. Zhang, H. Li, L. Tian and W. Li,
ChemBioChem, 2014, 15, 2747–2753, DOI: 10.1002/
cbic.201402384.
141 E. L. Teuten, L. Xu and C. M. Reddy, Science, 2005, 307, 917–
920, DOI: 10.1126/science.1106882.
142 V. Agarwal and B. S. Moore, ACS Chem. Biol., 2014, 9, 1980–
1984, DOI: 10.1021/cb5004338.410 | Nat. Prod. Rep., 2016, 33, 382–431143 V. Agarwal, A. A. El Gamal, K. Yamanaka, D. Poth,
R. D. Kersten, M. Schor, E. E. Allen and B. S. Moore, Nat.
Chem. Biol., 2014, 10, 640–647, DOI: 10.1038/
nchembio.1564.
144 H. He, J. Am. Chem. Soc., 2001, 123, 5362–5363, DOI:
10.1021/ja010129o.
145 A. J. Waldman and E. P. Balskus, Org. Lett., 2014, 16, 640–
643, DOI: 10.1021/ol403714g.
146 J. E. Janso, B. A. Haltli, A. S. Eusta´quio, K. Kulowski,
A. J. Waldman, L. Zha, H. Nakamura, V. S. Bernan, H. He,
G. T. Carter, F. E. Koehn and E. P. Balskus, Tetrahedron,
2014, 70, 4156–4164, DOI: 10.1016/j.tet.2014.03.009.
147 A. Penesyan, J. Tebben, M. Lee, T. Thomas, S. Kjelleberg,
T. Harder and S. Egan, Mar. Drugs, 2011, 9, 1391–1402,
DOI: 10.3390/md9081391.
148 N. L. Brock, A. Nikolay and J. S. Dickschat, Chem. Commun.,
2014, 50, 5487–5489, DOI: 10.1039/c4cc01924e.
149 A. R. J. Curson, J. D. Todd, M. J. Sullivan and
A. W. B. Johnston, Nat. Rev. Microbiol., 2011, 9, 849–859,
DOI: 10.1038/nrmicro2653.
150 N. L. Brock, M. Menke, T. A. Klapschinski and
J. S. Dickschat, Org. Biomol. Chem., 2014, 12, 4318–4323,
DOI: 10.1039/c4ob00719k.
151 T. Boettcher and J. Clardy, Angew. Chem., Int. Ed., 2014, 53,
3510–3513, DOI: 10.1002/anie.201310729.
152 C. Z. Soe and R. Codd, ACS Chem. Biol., 2014, 9, 945–956,
DOI: 10.1021/cb400901j.
153 M. Fujita and R. Sakai, Mar. Drugs, 2014, 12, 4799–4809,
DOI: 10.3390/md12094799.
154 F. Romero and F. Espliego, J. Antibiot., 1997, 50, 734–737,
DOI: 10.7164/antibiotics.50.734.
155 A. H. Al-Mestarihi, G. Villamizar, J. Ferna´ndez, O. E. Zolova,
F. Lombo´ and S. Garneau-Tsodikova, J. Am. Chem. Soc.,
2014, 136, 17350–17354, DOI: 10.1021/ja510489j.
156 K. Jomon, Y. Kuroda, M. Ajisaka and H. Sakai, J. Antibiot.,
1972, 25, 271–280, DOI: 10.7164/antibiotics.25.271.
157 J. Antosch, F. Schaefers and T. A. M. Gulder, Angew. Chem.,
Int. Ed., 2014, 53, 3011–3014, DOI: 10.1002/anie.201310641.
158 G. Zhang, W. Zhang, Q. Zhang, T. Shi, L. Ma, Y. Zhu, S. Li,
H. Zhang, Y.-L. Zhao, R. Shi and C. Zhang, Angew. Chem.,
Int. Ed., 2014, 53, 4840–4844, DOI: 10.1002/anie.201402078.
159 L. L. Yan, N. N. Han, Y. Q. Zhang, L. Y. Yu, J. Chen,
Y. Z. Wei, Q. P. Li, L. Tao, G. H. Zheng, S. E. Yang,
C. X. Jiang and X. D. Zhang, J. Antibiot., 2010, 63, 259–
261, DOI: 10.1038/ja.2010.21.
160 Z. Han, Y. Xu, O. McConnell, L. L. Liu, Y. X. Li, S. H. Qi,
X. Z. Huang and P. Y. Qian, Mar. Drugs, 2012, 10, 668–
676, DOI: 10.3390/md10030668.
161 C. Viegelmann, L. Margassery, J. Kennedy, T. Zhang,
C. O'Brien, F. O'Gara, J. Morrissey, A. Dobson and
R. Edrada-Ebel, Mar. Drugs, 2014, 12, 3323–3351, DOI:
10.3390/md12063323.
162 A. P. D. d. M. Espindola, Ph.D. Thesis, University of
California, San Diego, USA, 2008.
163 Y. Song, H. Huang, Y. Chen, J. Ding, Y. Zhang, A. Sun,
W. Zhang and J. Ju, J. Nat. Prod., 2013, 76, 2263–2268,
DOI: 10.1021/np4006025.This journal is © The Royal Society of Chemistry 2016





























































































View Article Online164 P. Zeyhle, J. S. Bauer, M. Steimle, F. Leipoldt, M. Ro¨sch,
J. Kalinowski, H. Gross and L. Heide, ChemBioChem,
2014, 15, 2385–2392, DOI: 10.1002/cbic.201402394.
165 M. Izumikawa, S. T. Khan, M. Takagi and K. Shin-ya, J. Nat.
Prod., 2010, 73, 208–212, DOI: 10.1021/np900747t.
166 S. T. Khan, M. Izumikawa, K. Motohashi, A. Mukai,
M. Takagi and K. Shin-ya, FEMS Microbiol. Lett., 2010,
304, 89–96, DOI: 10.1111/j.1574-6968.2009.01886.x.
167 P. Zeyhle, J. S. Bauer, J. Kalinowski, K. Shin-ya, H. Gross and
L. Heide, PLoS One, 2014, 9, 99–122, DOI: 10.1371/
journal.pone.0099122.
168 T. Nakashima, M. Iwatsuki, J. Ochiai, Y. Kamiya, K. Nagai,
A. Matsumoto, A. Ishiyama, K. Otoguro, K. Shiomi,
Y. Takahashi and S. O¯mura, J. Antibiot., 2014, 67, 253–
260, DOI: 10.1038/ja.2013.129.
169 T. Nakashima, Y. Kamiya, M. Iwatsuki, Y. Takahashi and
S. O¯mura, J. Antibiot., 2014, 67, 533–539, DOI: 10.1038/
ja.2014.34.
170 Z. Xu, M. Baunach, L. Ding, H. Peng, J. Franke and
C. Hertweck, ChemBioChem, 2014, 15, 1274–1279, DOI:
10.1002/cbic.201402071.
171 L. Ding, A. Maier, H. H. Fiebig, H. Gorls, W. H. Lin,
G. Peschel and C. Hertweck, Angew. Chem., Int. Ed., 2011,
50, 1630–1634, DOI: 10.1002/anie.201006165.
172 S.-R. Li, G.-S. Zhao, M.-W. Sun, H.-G. He, H.-X. Wang,
Y.-Y. Li, C.-H. Lu and Y.-M. Shen, Gene, 2014, 544, 93–99,
DOI: 10.1016/j.gene.2014.04.052.
173 P. Wang, F. Kong, J. Wei, Y. Wang, W. Wang, K. Hong and
W. Zhu, Mar. Drugs, 2014, 12, 477–490, DOI: 10.3390/
md12010477.
174 K. Kyeremeh, K. S. Acquah, A. Sazak, W. Houssen,
J. Tabudravu, H. Deng and M. Jaspars, Mar. Drugs, 2014,
12, 999–1012, DOI: 10.3390/md12020999.
175 J. Zhang, Z. Qian, X. Wu, Y. Ding, J. Li, C. Lu and Y. Shen,
Org. Lett., 2014, 16, 2752–2755, DOI: 10.1021/ol501072t.
176 K. Kyeremeh, K. Acquah, M. Camas, J. Tabudravu,
W. Houssen, H. Deng and M. Jaspars, Mar. Drugs, 2014,
12, 5197–5208, DOI: 10.3390/md12105197.
177 L. Ding, A. Maier, H. H. Fiebig, W. H. Lin and C. Hertweck,
Org. Biomol. Chem., 2011, 9, 4029–4031, DOI: 10.1039/
c1ob05283g.
178 Y. Sun, P. Chen, D. Zhang, M. Baunach, C. Hertweck and
A. Li, Angew. Chem., Int. Ed., 2014, 53, 9012–9016, DOI:
10.1002/anie.201404191.
179 N. M. Gomes, L. J. Bessa, S. Buttachon, P. M. Costa,
J. Buaruang, T. Dethoup, A. M. S. Silva and A. Kijjoa, Mar.
Drugs, 2014, 12, 822–839, DOI: 10.3390/md12020822.
180 R. Obata, T. Sunazuka, Z. Li, Z. Tian, Y. Harigaya, N. Tabata,
H. Tomoda and S. Omura, J. Antibiot., 1996, 49, 1133–1148,
DOI: 10.7164/antibiotics.49.1133.
181 C. Prompanya, T. Dethoup, L. Bessa, M. Pinto, L. Gales,
P. Costa, A. Silva and A. Kijjoa, Mar. Drugs, 2014, 12,
5160–5173, DOI: 10.3390/md12105160.
182 M. Hoﬀmann and M. Molenda, Eur. Pat. Appl., EP 2090291
A1 20090819, 2009.This journal is © The Royal Society of Chemistry 2016183 A. Furukawa, T. Yoshimoto, O. Tsuru, K. Ajisawa and
Y. Kinoshita, Jpn. Kokai Tokkyo Koho, JP 03056462 A
19910312, 1991.
184 H. Eberhardt, Ger. Oﬀen., DE 2456634 A1 19760812, 1976.
185 A. Gusterova, V. Ivanova, K. Aleksieva, M. Kolarova,
B. Schlegel and U. Graefe, Biotechnol. Biotechnol. Equip.,
2004, 18, 72–76, DOI: 10.1080/13102818.2004.10819233.
186 B. Solomon and E. Rosenberg, PCT Int. Appl., WO
2003104441 A2 20031218, 2003.
187 Y. Dong, C.-B. Cui, C.-W. Li, W. Hua, C.-J. Wu, T.-J. Zhu and
Q.-Q. Gu, Mar. Drugs, 2014, 12, 4326–4352, DOI: 10.3390/
md12084326.
188 S. W. Meyer, T. F. Mordhorst, C. Lee, P. R. Jensen,
W. Fenical and M. Kock, Org. Biomol. Chem., 2010, 8,
2158–2163, DOI: 10.1039/b910629d.
189 M. Chen, C.-L. Shao, X.-M. Fu, C.-J. Kong, Z.-G. She and
C.-Y. Wang, J. Nat. Prod., 2014, 77, 1601–1606, DOI:
10.1021/np5001686.
190 M. Chen, C.-L. Shao, H. Meng, Z.-G. She and C.-Y. Wang, J.
Nat. Prod., 2014, 77, 2720–2724, DOI: 10.1021/np500650t.
191 H. J. Li, Y. L. Xie, Z. L. Xie, Y. Chen, C. K. Lam andW. J. Lan,
Mar. Drugs, 2012, 10, 627–638, DOI: 10.3390/md10030627.
192 H. J. Li, T. Chen, Y. L. Xie, W. D. Chen, X. F. Zhu and
W. J. Lan, Mar. Drugs, 2013, 11, 551–558, DOI: 10.3390/
md11020551.
193 H. J. Li, W. J. Lan, C. K. Lam, F. Yang and X. F. Zhu, Chem.
Biodiversity, 2011, 8, 317–324, DOI: 10.1002/
cbdv.201000036.
194 H.-J. Li, W.-H. Jiang, W.-L. Liang, J.-X. Huang, Y.-F. Mo,
Y.-Q. Ding, C.-K. Lam, X.-J. Qian, X.-F. Zhu and W.-J. Lan,
Mar. Drugs, 2014, 12, 167–175, DOI: 10.3390/md12010167.
195 W. Zhang, C.-L. Shao, M. Chen, Q.-A. Liu and C.-Y. Wang,
Tetrahedron Lett., 2014, 55, 4888–4891, DOI: 10.1016/
j.tetlet.2014.06.096.
196 Q. Yao, J. Wang, X. Zhang, X. Nong, X. Xu and S. Qi, Mar.
Drugs, 2014, 12, 5902–5915, DOI: 10.3390/md12125902.
197 K. Trisuwan, V. Rukachaisirikul, M. Kaewpet,
S. Phongpaichit, N. Hutadilok-Towatana, S. Preedanon
and J. Sakayaroj, J. Nat. Prod., 2011, 74, 1663–1667, DOI:
10.1021/np200374j.
198 Z. Lin, M. Koch, M. H. A. Aziz, R. Galindo-Murillo,
M. D. Tianero, T. E. Cheatham, L. R. Barrows, C. A. Reilly
and E. W. Schmidt, Org. Lett., 2014, 16, 4774–4777, DOI:
10.1021/ol502227x.
199 W.-L. Liang, X. Le, H.-J. Li, X.-L. Yang, J.-X. Chen, J. Xu,
H.-L. Liu, L.-Y. Wang, K.-T. Wang, K.-C. Hu, D.-P. Yang
and W.-J. Lan, Mar. Drugs, 2014, 12, 5657–5676, DOI:
10.3390/md12115657.
200 P. Zhang, A. Ma´ndi, X.-M. Li, F.-Y. Du, J.-N. Wang, X. Li,
T. Kurta´n and B.-G. Wang, Org. Lett., 2014, 16, 4834–4837,
DOI: 10.1021/ol502329k.
201 E. F. Pimenta, A. M. Vita-Marques, A. Tininis,
M. H. R. Seleghim, L. D. Sette, K. Veloso, A. G. Ferreira,
D. E. Williams, B. O. Patrick, D. S. Dalisay, R. J. Andersen
and R. G. S. Berlinck, J. Nat. Prod., 2010, 73, 1821–1832,
DOI: 10.1021/np100470h.Nat. Prod. Rep., 2016, 33, 382–431 | 411





























































































View Article Online202 E. V. Mercado-Marin, P. Garcia-Reynaga, S. Romminger,
E. F. Pimenta, D. K. Romney, M. W. Lodewyk,
D. E. Williams, R. J. Andersen, S. J. Miller, D. J. Tantillo,
R. G. S. Berlinck and R. Sarpong, Nature, 2014, 509, 318–
324, DOI: 10.1038/nature13273.
203 L. Liao, J.-H. Lee, M. You, T. J. Choi, W. Park, S. K. Lee,
D.-C. Oh, K.-B. Oh and J. Shin, J. Nat. Prod., 2014, 77,
406–410, DOI: 10.1021/np400826p.
204 N. Khamthong, V. Rukachaisirikul, C. Pakawatchai,
S. Saithong, S. Phongpaichit, S. Preedanon and
J. Sakayaroj, Phytochem. Lett., 2014, 10, 50–54, DOI:
10.1016/j.phytol.2014.08.002.
205 J.-F. Wang, F.-Q. Xu, Z. Wang, X. Lu, J.-T. Wan, B. Yang,
X.-F. Zhou, T.-Y. Zhang, Z.-C. Tu and Y. Liu, Nat. Prod.
Res., 2014, 28, 1070–1074, DOI: 10.1080/
14786419.2014.905935.
206 W.-J. Wang, D.-Y. Li, Y.-C. Li, H.-M. Hua, E.-L. Ma and
Z.-L. Li, J. Nat. Prod., 2014, 77, 1367–1371, DOI: 10.1021/
np500110z.
207 J. Kornsakulkarn, S. Saepua, S. Komwijit, P. Rachtawee and
C. Thongpanchang, Tetrahedron, 2014, 70, 2129–2133, DOI:
10.1016/j.tet.2014.02.004.
208 M. R. TePaske, J. B. Gloer, D. T. Wicklow and P. F. Dowd, J.
Nat. Prod., 1992, 55, 1080–1086, DOI: 10.1021/
np50086a008.
209 R. J. Cole, J. W. Dorner, J. A. Lansden, R. H. Cox, C. Pape,
B. Cunfer, S. S. Nicholson and D. M. Bedell, J. Agric. Food
Chem., 1977, 25, 1197–1201, DOI: 10.1021/jf60213a061.
210 H. Sun, S. Gao, X. Li, C. Li and B. Wang, Chin. J. Oceanol.
Limnol., 2013, 31, 464–470, DOI: 10.1007/s00343-013-2106-
2.
211 C. Zhang, L. Jin, B. Mondie, S. S. Mitchell, A. L. Castelhano,
W. Cai and N. Bergenhem, Bioorg. Med. Chem. Lett., 2003,
13, 1433–1435, DOI: 10.1016/s0960-894x(03)00153-7.
212 M. R. TePaske, J. B. Gloer, D. T. Wicklow and P. F. Dowd,
Tetrahedron Lett., 1991, 32, 5687–5690, DOI: 10.1016/
s0040-4039(00)96814-x.
213 K. Sun, Y. Li, L. Guo, Y. Wang, P. Liu and W. Zhu, Mar.
Drugs, 2014, 12, 3970–3981, DOI: 10.3390/md12073970.
214 J. Xu, S. Zhao and X. Yang, Nat. Prod. Res., 2014, 28, 994–
997, DOI: 10.1080/14786419.2014.902945.
215 W. Fang, X. Lin, X. Zhou, J. Wan, X. Lu, B. Yang, W. Ai,
J. Lin, T. Zhang, Z. Tu and Y. Liu, Med. Chem. Commun.,
2014, 5, 701–705, DOI: 10.1039/c3md00371j.
216 X. Hu, Q.-W. Xia, Y.-Y. Zhao, Q.-H. Zheng, Q.-Y. Liu, L. Chen
and Q.-Q. Zhang, Heterocycles, 2014, 89, 1662–1669, DOI:
10.3987/COM-14-13004.
217 T. Zhu, Z. Chen, P. Liu, Y. Wang, Z. Xin and W. Zhu, J.
Antibiot., 2014, 67, 315–318, DOI: 10.1038/ja.2013.135.
218 X. Hu, Q.-W. Xia, Y.-Y. Zhao, Q.-H. Zheng, Q.-Y. Liu, L. Chen
and Q.-Q. Zhang, Chem. Pharm. Bull., 2014, 62, 942–946,
DOI: 10.1248/cpb.c14-00312.
219 J.-F. Wang, X.-P. Lin, C. Qin, S.-R. Liao, J.-T. Wan,
T.-Y. Zhang, J. Liu, M. Fredimoses, H. Chen, B. Yang,
X.-F. Zhou, X.-W. Yang, Z.-C. Tu and Y.-H. Liu, J. Antibiot.,
2014, 67, 581–583, DOI: 10.1038/ja.2014.39.412 | Nat. Prod. Rep., 2016, 33, 382–431220 X. Ma, T. Zhu, Q. Gu, R. Xi, W. Wang and D. Li, J. Ocean
Univ. China, 2014, 13, 1067–1070, DOI: 10.1055/s-0033-
1338558.
221 X.-H. Nong, Y.-F. Wang, X.-Y. Zhang, M.-P. Zhou, X.-Y. Xu
and S.-H. Qi, Mar. Drugs, 2014, 12, 6113–6124, DOI:
10.3390/md12126113.
222 L. Koch, A. Lodin, I. Herold, M. Ilan, S. Carmeli and
O. Yarden, Mar. Drugs, 2014, 12, 4713–4731, DOI: 10.3390/
md12094713.
223 X.-H. Liu, F.-P. Miao, X.-R. Liang and N.-Y. Ji, Nat. Prod.
Res., 2014, 28, 1182–1186, DOI: 10.1080/
14786419.2014.923996.
224 F. Song, B. Ren, C. Chen, K. Yu, X. Liu, Y. Zhang, N. Yang,
H. He, X. Liu, H. Dai and L. Zhang, Appl. Microbiol.
Biotechnol., 2014, 98, 3753–3758, DOI: 10.1007/s00253-
013-5409-5.
225 X. Wang, Y. Mou, J. Hu, N. Wang, L. Zhao, L. Liu, S. Wang
and D. Meng, Chem. Biodiversity, 2014, 11, 133–139, DOI:
10.1002/cbdv.201300115.
226 J. Peng, H. Gao, X. Zhang, S. Wang, C. Wu, Q. Gu, P. Guo,
T. Zhu and D. Li, J. Nat. Prod., 2014, 77, 2218–2223, DOI:
10.1021/np500469b.
227 J. Peng, H. Gao, J. Li, J. Ai, M. Geng, G. Zhang, T. Zhu, Q. Gu
and D. Li, J. Org. Chem., 2014, 79, 7895–7904, DOI: 10.1021/
jo5010179.
228 M. Chen, X.-M. Fu, C.-J. Kong and C.-Y. Wang, Nat. Prod.
Res., 2014, 28, 895–900, DOI: 10.1080/
14786419.2014.891114.
229 F.-P. Miao, X.-R. Liang, X.-H. Liu and N.-Y. Ji, J. Nat. Prod.,
2014, 77, 429–432, DOI: 10.1021/np401047w.
230 Y. Zhou, A. Debbab, V. Wray, W. Lin, B. Schulz, R. Trepos,
C. Pile, C. Hellio, P. Proksch and A. H. Aly, Tetrahedron Lett.,
2014, 55, 2789–2792, DOI: 10.1016/j.tetlet.2014.02.062.
231 M. Chen, C.-L. Shao, C.-J. Kong, Z.-G. She and C.-Y. Wang,
Chem. Nat. Compd., 2014, 50, 617–620, DOI: 10.1007/
s10600-014-1037-2.
232 T. Fukuda, Y. Kurihara, A. Kanamoto and H. Tomoda, J.
Antibiot., 2014, 67, 593–595, DOI: 10.1038/ja.2014.46.
233 Z. G. Khalil, X. Huang, R. Raju, A. M. Piggott and
R. J. Capon, J. Org. Chem., 2014, 79, 8700–8705, DOI:
10.1021/jo501501z.
234 Y. Liu, S. Zhao, W. Ding, P. Wang, X. Yang and J. Xu, Mar.
Drugs, 2014, 12, 5124–5131, DOI: 10.3390/md12105124.
235 Q. Tang, K. Guo, X.-Y. Li, X.-Y. Zheng, X.-J. Kong,
Z.-H. Zheng, Q.-Y. Xu and X. Deng, Mar. Drugs, 2014, 12,
5993–6002, DOI: 10.3390/md12125993.
236 X.-W. Chen, C.-W. Li, C.-B. Cui, W. Hua, T.-J. Zhu and
Q.-Q. Gu, Mar. Drugs, 2014, 12, 3116–3137, DOI: 10.3390/
md12063116.
237 S. S. Ebada, T. Fischer, S. Klaßen, A. Hamacher, Y. O. Roth,
M. U. Kassack and E. H. Roth, Nat. Prod. Res., 2014, 28,
1241–1245, DOI: 10.1080/14786419.2014.895730.
238 F.-Y. Du, P. Zhang, X.-M. Li, C.-S. Li, C.-M. Cui and
B.-G. Wang, J. Nat. Prod., 2014, 77, 1164–1169, DOI:
10.1021/np4011037.
239 F.-Y. Du, X.-M. Li, P. Zhang, C.-S. Li and B.-G. Wang, Mar.
Drugs, 2014, 12, 2816–2826, DOI: 10.3390/md12052816.This journal is © The Royal Society of Chemistry 2016





























































































View Article Online240 G. Wu, X. Sun, G. Yu, W. Wang, T. Zhu, Q. Gu and D. Li, J.
Nat. Prod., 2014, 77, 270–275, DOI: 10.1021/np400833x.
241 Q.-A. Liu, C.-L. Shao, Y.-C. Gu, M. Blum, L.-S. Gan,
K.-L. Wang, M. Chen and C.-Y. Wang, J. Agric. Food
Chem., 2014, 62, 3183–3191, DOI: 10.1021/jf500248z.
242 W. B. Han, Y. H. Lu, A. H. Zhang, G. F. Zhang, Y. N. Mei,
N. Jiang, X. Lei, Y. C. Song, S. W. Ng and R. X. Tan, Org.
Lett., 2014, 16, 5366–5369, DOI: 10.1021/ol502572g.
243 D.-X. Xu, P. Sun, T. Kurta´n, A. Ma´ndi, H. Tang, B. Liu,
W. H. Gerwick, Z.-W. Wang and W. Zhang, J. Nat. Prod.,
2014, 77, 1179–1184, DOI: 10.1021/np500024r.
244 N. Khamthong, V. Rukachaisirikul, S. Phongpaichit,
S. Preedanon and J. Sakayaroj, Phytochem. Lett., 2014, 10,
59, DOI: 10.1016/j.phytol.2014.06.014.
245 H. Harms, V. Rempel, S. Kehraus, M. Kaiser, P. Hufendiek,
C. E. Mu¨ller and G. M. Ko¨nig, J. Nat. Prod., 2014, 77, 673–
677, DOI: 10.1021/np400850.
246 M. Fredimoses, X. Zhou, X. Lin, X. Tian, W. Ai, J. Wang,
S. Liao, J. Liu, B. Yang, X. Yang and Y. Liu, Mar. Drugs,
2014, 12, 3190–3202, DOI: 10.3390/md1206319.
247 X. Yang, M.-C. Kang, Y. Li, E.-A. Kim, S.-M. Kang and
Y.-J. Jeon, J. Microbiol. Biotechnol., 2014, 24, 1346–1353,
DOI: 10.4014/jmb.1405.05035.
248 F.-Y. Du, X.-M. Li, J.-Y. Song, C.-S. Li and B.-G. Wang, Helv.
Chim. Acta, 2014, 97, 973–978, DOI: 10.1002/
hlca.201300358.
249 Z. Liu, G. Xia, S. Chen, Y. Liu, H. Li and Z. She, Mar. Drugs,
2014, 12, 3669–3680, DOI: 10.3390/md12063669.
250 M. Chen, C.-L. Shao, K.-L. Wang, Y. Xu, Z.-G. She and
C.-Y. Wang, Tetrahedron, 2014, 70, 9132–9138, DOI:
10.1016/j.tet.2014.08.055.
251 Y. Li, K.-L. Sun, Y. Wang, P. Fu, P.-P. Liu, C. Wang and
W.-M. Zhu, Chin. Chem. Lett., 2014, 24, 1049–1052, DOI:
10.1016/j.cclet.2013.07.028.
252 N. M. Gomes, T. Dethoup, N. Singburaudom, L. Gales,
A. M. S. Silva and A. Kijjoa, Phytochem. Lett., 2012, 5, 717–
720, DOI: 10.1016/j.phytol.2012.07.010.
253 Z. Wu, D. Liu, P. Proksch, P. Guo and W. Lin, Mar. Drugs,
2014, 12, 3904–3916, DOI: 10.3390/md12073904.
254 E. J. Mejia, S. T. Loveridge, G. Stepan, A. Tsai, G. S. Jones,
T. Barnes, K. N. White, M. Drasˇkovic´, K. Tenney,
M. Tsiang, R. Geleziunas, T. Cihlar, N. Pagratis, Y. Tian,
H. Yu and P. Crews, J. Nat. Prod., 2014, 77, 618–624, DOI:
10.1021/np400889x.
255 A. N. Yurchenko, O. F. Smetanina, A. I. Kalinovsky,
M. A. Pushilin, V. P. Glazunov, Y. V. Khudyakova,
N. N. Kirichuk, S. P. Ermakova, S. A. Dyshlovoy,
E. A. Yurchenko and S. S. Ayatullov, J. Nat. Prod., 2014,
77, 1321–1328, DOI: 10.1021/np500014m.
256 J.-J. Dong, J. Bao, X.-Y. Zhang, X.-Y. Xu, X.-H. Nong and
S.-H. Qi, Tetrahedron Lett., 2014, 55, 2749–2753, DOI:
10.1016/j.tetlet.2014.03.060.
257 Y. Mizushina, H. Suzuki-Fukudome, T. Takeuchi,
K. Takemoto, I. Kuriyama, H. Yoshida, S. Kamisuki and
F. Sugawara, Bioorg. Med. Chem., 2014, 22, 1070–1076,
DOI: 10.1016/j.bmc.2013.12.038.This journal is © The Royal Society of Chemistry 2016258 M. Garc´ıa-Caballero, L. Can˜edo, A. Ferna´ndez-Medarde,
M. A´. Medina and A. R. Quesada, Mar. Drugs, 2014, 12,
279–299, DOI: 10.3390/md12010279.
259 Y. Liu, X.-M. Li, L.-H. Meng and B.-G. Wang, Phytochem.
Lett., 2014, 10, 145–148, DOI: 10.1016/j.phytol.2014.08.018.
260 C.-Y. An, X.-M. Li, C.-S. Li, G.-M. Xuand and B.-G. Wang,
Mar. Drugs, 2014, 12, 746–756, DOI: 10.3390/md12020746.
261 J. Wang, Y. Zhao, L. Men, Y. Zhang, Z. Liu, T. Sun, Y. Geng
and Z. Yu, Chem. Nat. Compd., 2014, 50, 405–407, DOI:
10.1007/s10600-014-0971-3.
262 J. Peng, X. Zhang, L. Du, W. Wang, T. Zhu, Q. Gu and D. Li,
J. Nat. Prod., 2014, 77, 424–428, DOI: 10.1021/np400977e.
263 X. Wang, H. Wang, T. Liu and Z. Xin, Appl. Microbiol.
Biotechnol., 2014, 98, 4875–4885, DOI: 10.1007/s00253-
014-5572-3.
264 Y.-L. Sun, X.-Y. Zhang, Z.-H. Zheng, X.-Y. Xu and S.-H. Qi,
Nat. Prod. Res., 2014, 28, 239–244, DOI: 10.1080/
14786419.2013.843177.
265 J.-B. He, Y.-N. Ji, D.-B. Hu, S. Zhang, H. Yan, X.-C. Liu,
H.-R. Luo and H.-J. Zhu, Tetrahedron Lett., 2014, 55, 2684–
2686, DOI: 10.1016/j.tetlet.2014.03.031.
266 X.-D. Li, F.-P. Miao, X.-R. Liang and N.-Y. Ji, Magn. Reson.
Chem., 2014, 52, 247–250, DOI: 10.1002/mrc.4049.
267 O. I. Zhuravleva, M. P. Sobolevskaya, E. V. Leshchenko,
N. N. Kirichuk, V. A. Denisenko, P. S. Dmitrenok,
S. A. Dyshlovoy, A. M. Zakharenko, N. Y. Kim and
S. S. Ayatullov, J. Nat. Prod., 2014, 77, 1390–1395, DOI:
10.1021/np500151b.
268 O. Zhuravleva, M. Sobolevskaya, S. Ayatullov, N. Kirichuk,
V. Denisenko, P. Dmitrenok, E. Yurchenko and
S. Dyshlovoy, Mar. Drugs, 2014, 12, 5930–5943, DOI:
10.3390/md12125930.
269 J. Bao, J.-F. Luo, X.-C. Qin, X.-Y. Xu, X.-Y. Zhang, Z.-C. Tu
and S.-H. Qi, Bioorg. Med. Chem. Lett., 2014, 24, 2433–
2436, DOI: 10.1016/j.bmcl.2014.04.028.
270 P.-L. Wang, D.-Y. Li, L.-R. Xie, X. Wu, H.-M. Hua and
Z.-L. Li, Nat. Prod. Res., 2014, 28, 290–293, DOI: 10.1080/
14786419.2013.856906.
271 J. Bao, X.-Y. Zhang, J. Dong, X. Xu, X.-H. Nong and S.-H. Qi,
Chem. Lett., 2014, 43, 837–839, DOI: 10.1246/cl.140138.
272 C.-S. Li, X.-M. Li, C.-Y. An and B.-G. Wang, Helv. Chim. Acta,
2014, 97, 1440–1444, DOI: 10.1002/hlca.201400035.
273 M.-W. Xia, C.-B. Cui, C.-W. Li and C.-J. Wu, Mar. Drugs,
2014, 12, 1545–1568, DOI: 10.3390/md12031545.
274 S.-M. Fang, C.-J. Wu, C.-W. Li and C.-B. Cui, Mar. Drugs,
2014, 12, 1788–1814, DOI: 10.3390/md12041788.
275 C.-J. Wu, C.-W. Li and C.-B. Cui,Mar. Drugs, 2014, 12, 1815–
1838, DOI: 10.3390/md12041815.
276 F. J. T. Marante, I. H. B. de Laguna, N. V. Torres and
R. Mioso, Appl. Biochem. Biotechnol., 2014, 174, 2426–
2434, DOI: 10.1007/s12010-014-1180-z.
277 M. P. Sobolevskaya, O. I. Zhuravleva, E. V. Leshchenko,
S. S. Ayatullov, Y. V. Khudyakova, N. Y. Kim,
N. N. Kirichuk and S. A. Dyshlovoy, Chem. Nat. Compd.,
2014, 50, 1122–1124, DOI: 10.1007/s10600-014-1179-2.
278 T. H. Quang, N. T. T. Ngan, W. Ko, D.-C. Kim, C.-S. Yoon,
J. H. Sohn, J. H. Yim, Y.-C. Kim and H. Oh, Bioorg. Med.Nat. Prod. Rep., 2016, 33, 382–431 | 413





























































































View Article OnlineChem. Lett., 2014, 24, 5787–5791, DOI: 10.1016/
j.bmcl.2014.10.035.
279 W.-J. Lan, W. Liu, W.-L. Liang, Z. Xu, X. Le, J. Xu, C.-K. Lam,
D.-P. Yang, H.-J. Li and L.-Y. Wang, Mar. Drugs, 2014, 12,
4188–4199, DOI: 10.3390/md12074188.
280 Y. Luan, H. Wei, Z. Zhang, Q. Che, Y. Liu, T. Zhu, A. Ma´ndi,
T. Kurta´n, Q. Gu and D. Li, J. Nat. Prod., 2014, 77, 1718–
1723, DOI: 10.1021/np500458a.
281 S. Niu, D. Liu, X. Hu, P. Proksch, Z. Shao and W. Lin, J. Nat.
Prod., 2014, 77, 1021–1030, DOI: 10.1021/np5000457.
282 Y. Li, C. Wu, D. Liu, P. Proksch, P. Guo and W. Lin, J. Nat.
Prod., 2014, 77, 138–147, DOI: 10.1021/np400824u.
283 Y. Li, D. Liu, S. Cen, P. Proksch and W. Lin, Tetrahedron,
2014, 70, 7010–7015, DOI: 10.1016/j.tet.2014.07.047.
284 B. Wu, V. Oesker, J. Wiese, S. Malien, R. Schmaljohann and
J. F. Imhoﬀ,Mar. Drugs, 2014, 12, 1924–1938, DOI: 10.3390/
md12041924.
285 D. Kuml, T. Dethoup, S. Buttachon, N. Singburaudom,
A. M. S. Silva and A. Kijjoa, Nat. Prod. Commun., 2014, 9,
1147–1197.
286 L. Chen, Q.-Q. Zhang, X. Hu, M.-W. Gong, W.-W. Zhang,
Q.-H. Zheng and Q.-Y. Liu, Heterocycles, 2014, 89, 189–
196, DOI: 10.3987/com-13-12874.
287 T. Yamada, Y. Mizutani, Y. Umebayashi, N. Inno,
M. Kawashima, T. Kikuchi and R. Tanaka, Tetrahedron
Lett., 2014, 55, 662–664, DOI: 10.1016/j.tetlet.2013.11.107.
288 B. Wu, V. Oesker, J. Wiese, R. Schmaljohann and
J. F. Imhoﬀ, Mar. Drugs, 2014, 12, 1208–1219, DOI:
10.3390/md12031208.
289 S. El-saedi, J. S. Mezogi and A. A. Akasha, PharmaTutor
Mag., 2014, 2, 131–144, URL: http://www.pharmatutor.org/
articles/phytochemical-studies-verticillium-teneru-
acremonium.
290 X. Huang, X. Sun, S. Lin, Z. Xiao, H. Li, D. Bo and Z. She,
Nat. Prod. Res., 2014, 28, 111–114, DOI: 10.1080/
14786419.2013.850687.
291 X.-H. Nong, X.-Y. Zhang, X.-Y. Xu, Y.-L. Sun and S.-H. Qi,
Nat. Prod. Commun., 2014, 9, 467–475.
292 N. Kotoku, K. Higashimoto, M. Kurioka, M. Arai, A. Fukuda,
Y. Sumii, Y. Sowa, T. Sakai and M. Kobayashi, Bioorg. Med.
Chem. Lett., 2014, 24, 3389–3391, DOI: 10.1016/
j.bmcl.2014.05.083.
293 S. U. Lee, Y. Asami, D. Lee, J. H. Jang, J. S. Ahn and H. Oh, J.
Nat. Prod., 2011, 74, 1284–1287, DOI: 10.1021/np100880b.
294 P. Lorenzo, R. A´lvarez and A´. R. de Lera, Eur. J. Org. Chem.,
2014, 2014, 2557–2564, DOI: 10.1002/ejoc.201400029.
295 F. Y. Du, X. M. Li, C. S. Li, Z. Shang and B. G. Wang, Bioorg.
Med. Chem. Lett., 2012, 22, 4650–4653, DOI: 10.1016/
j.bmcl.2012.05.088.
296 P. Lorenzo, R. A´lvarez and A´. R. de Lera, J. Nat. Prod., 2014,
77, 421–423, DOI: 10.1021/np400969u.
297 Y.-L. Sun, J. e. Bao, K.-S. Liu, X.-Y. Zhang, F. He, Y.-F. Wang,
X.-H. Nong and S.-H. Qi, Planta Med., 2013, 79, 1474–1479,
DOI: 10.1055/s-0033-1350805.
298 C. Wink, L. Andernach, T. Opatz and S. R. Waldvogel, Eur. J.
Org. Chem., 2014, 2014, 7788–7792, DOI: 10.1055/s-0033-
1350805.414 | Nat. Prod. Rep., 2016, 33, 382–431299 A. Sakurai and Y. Okumura, Bull. Chem. Soc. Jpn., 1979, 52,
540–543, DOI: 10.1246/bcsj.52.540.
300 P. Ye, L. Shen, W. Jiang, Y. Ye, C.-T. A. Chen, X. Wu,
K. Wang and B. Wu, Mar. Drugs, 2014, 12, 3203–3217,
DOI: 10.3390/md12063203.
301 T. Yamada, M. Iritani, H. Ohishi, K. Tanaka, K. Minoura,
M. Doi and A. Numata, Org. Biomol. Chem., 2007, 5, 3979–
3986, DOI: 10.1039/b713060k.
302 K. Mizuki, K. Iwahashi, N. Murata, M. Ikeda, Y. Nakai,
H. Yoneyama, S. Harusawa and Y. Usami, Org. Lett., 2014,
16, 3760–3763, DOI: 10.1021/ol501631r.
303 B. Franck, E. M. Gottschalk, V. Ohnsorge and G. Baumann,
Angew. Chem., Int. Ed., 1964, 76, 441–442, DOI: 10.1002/
anie.196404412.
304 L. Wen, Z. Guo, F. Liu, Q. Wan, Z. Yu, Y. Lin and L. Fu,
Huaxue Yanjiu Yu Yingyong, 2009, 21, 198–202.
305 P. S. Steyn, Tetrahedron, 1970, 26, 51–57, DOI: 10.1016/
0040-4020(70)85006-2.
306 H. Ren, L. Tian, Q. Q. Gu and W. M. Zhu, Arch. Pharmacal
Res., 2006, 29, 59–63, DOI: 10.1007/BF02977469.
307 T. Qin and J. A. Porco, Angew. Chem., Int. Ed., 2014, 53,
3107–3110, DOI: 10.1002/anie.201311260.
308 L. Chen, T. J. Zhu, Y. Q. Ding, I. A. Khan, Q. Q. Gu and
D. H. Li, Tetrahedron Lett., 2012, 53, 325–328, DOI:
10.1016/j.tetlet.2011.11.038.
309 C. Qi, T. Qin, D. Suzuki and J. A. Porco Jr, J. Am. Chem. Soc.,
2014, 136, 3374–3377, DOI: 10.1021/ja500854q.
310 F. H. Song, B. A. Ren, K. Yu, C. X. Chen, H. Guo, N. Yang,
H. Gao, X. T. Liu, M. Liu, Y. J. Tong, H. Q. Dai, H. Bai,
J. D. Wang and L. X. Zhang, Mar. Drugs, 2012, 10, 1297–
1306, DOI: 10.3390/md10061297.
311 K. Sorra, K. Mukkanti and S. Pusuluri, Synthesis, 2014, 46,
189–194, DOI: 10.1055/s-0033-1338558.
312 J. Silber, B. Ohlendorf, A. Labes, C. Naether and J. F. Imhoﬀ,
J. Nat. Prod., 2013, 76, 1461–1467, DOI: 10.1021/np400262t.
313 S. Das and R. K. Goswami, J. Org. Chem., 2014, 79, 9778–
9791, DOI: 10.1021/jo5019798.
314 S. Cai, X. Kong, W. Wang, H. Zhou, T. Zhu, D. Li and Q. Gu,
Tetrahedron Lett., 2012, 53, 2615–2617, DOI: 10.1016/
j.tetlet.2012.03.043.
315 E. M. Boyd and J. Sperry, Org. Lett., 2014, 16, 5056–5059,
DOI: 10.1021/ol5024097.
316 N. Y. Ji, X. H. Liu, F. P. Miao andM. F. Qiao, Org. Lett., 2013,
15, 2327–2329, DOI: 10.1021/ol4009624.
317 A. M. Levinson, Org. Lett., 2014, 16, 4904–4907, DOI:
10.1021/ol5024163.
318 C. L. Shao, H. X. Wu, C. Y. Wang, Q. A. Liu, Y. Xu, M. Y. Wei,
P. Y. Qian, Y. C. Gu, C. J. Zheng, Z. G. She and Y. C. Lin, J.
Nat. Prod., 2011, 74, 629–633, DOI: 10.1021/np100641b.
319 Y. Gao, J. Liu, L. Wang, M. Xiao and Y. Du, Eur. J. Org.
Chem., 2014, 2014, 2092–2098, DOI: 10.1002/
ejoc.201301613.
320 P. Sun, D. X. Xu, A. Mandl, T. Kurtan, T. J. Li, B. Schulz and
W. Zhang, J. Org. Chem., 2013, 78, 7030–7047, DOI: 10.1021/
jo400861j.This journal is © The Royal Society of Chemistry 2016





























































































View Article Online321 A. Venkanna, B. Siva, B. Poornima, K. S. Babu and J. M. Rao,
Tetrahedron Lett., 2014, 55, 403–406, DOI: 10.1016/
j.tetlet.2013.11.044.
322 D. K. Mohapatra, K. Pulluri, E. Bhimireddy, D. P. Reddy and
J. S. Yadav, Asian J. Org. Chem., 2014, 3, 1210–1216, DOI:
10.1002/ajoc.201402126.
323 J. Liu, F. Li, E. L. Kim, J. L. Li, J. Hong, K. S. Bae,
H. Y. Chung, H. S. Kim and J. H. Jung, J. Nat. Prod., 2011,
74, 1826–1829, DOI: 10.1021/np200350b.
324 C. Sreelakshmi, A. B. Rao, M. L. Narasu, P. J. Reddy and
B. V. S. Reddy, Tetrahedron Lett., 2014, 55, 1303–1305,
DOI: 10.1016/j.tetlet.2013.12.089.
325 S. S. Gao, X. M. Li, F. Y. Du, C. S. Li, P. Proksch and
B. G. Wang, Mar. Drugs, 2011, 9, 59–70, DOI: 10.3390/
md9010059.
326 J.-C. Zhao, X.-M. Li, J. Gloer and B.-G. Wang, Mar. Drugs,
2014, 12, 3352–3370, DOI: 10.3390/md12063352.
327 C. Iwamoto, K. Minoura, T. Oka, T. Ohta, S. Hagishita and
A. Numata, Tetrahedron, 1999, 55, 14353–14368, DOI:
10.1016/S0040-4020(99)00884-4.
328 K. Fujioka, H. Yokoe, A. Inoue, K. Soga, M. Tsubuki and
K. Shishido, J. Org. Chem., 2014, 79, 7512–7519, DOI:
10.1021/jo501225y.
329 T. Hamasaki, M. Fukunaga, Y. Kimura and Y. Hatsuda,
Agric. Biol. Chem., 1980, 44, 1685–1687, DOI: 10.1271/
bbb1961.44.1685.
330 S. Wang, X. M. Li, F. Teuscher, D. L. Li, A. Diesel, R. Ebel,
P. Proksch and B. G. Wang, J. Nat. Prod., 2006, 69, 1622–
1625, DOI: 10.1021/np060248n.
331 K.-S. Kim, X. Cui, D.-S. Lee, W. Ko, J. Sohn, J. Yim, R.-B. An,
Y.-C. Kim andH. Oh, Int. J. Mol. Sci., 2014, 15, 23749–23765,
DOI: 10.3390/ijms151223749.
332 S. Takahashi, Y. Itoh, M. Takeuchi, K. Furuya, K. Kodama,
A. Naito, T. Haneishi, S. Sato and C. Tamura, J. Antibiot.,
1983, 36, 1418–1420, DOI: 10.7164/antibiotics.36.1418.
333 O. F. Smetanina, A. N. Yurchenko, S. S. Ayatullov,
A. I. Kalinovsky, M. A. Pushilin, Y. V. Khudyakova,
N. N. Slinkina, S. P. Ermakova and E. A. Yurchenko,
Phytochem. Lett., 2012, 5, 165–169, DOI: 10.1016/
j.phytol.2011.12.002.
334 M. M. Anisimov, E. L. Chaikina, O. F. Smetanina and
S. S. Ayatullov, Nat. Prod. Commun., 2014, 9, 835–836.
335 H. Nagasawa, A. Isogai, A. Suzuki and S. Tamura,
Tetrahedron Lett., 1976, 1601–1604, DOI: 10.1016/s0040-
4039(01)91627-2.
336 D. L. Li, X. M. Li, T. G. Li, H. Y. Dang and B. G. Wang, Helv.
Chim. Acta, 2008, 91, 1888–1893, DOI: 10.1002/
hlca.200890202.
337 X.-P. Sun, Y. Xu, F. Cao, R.-F. Xu, X.-L. Zhang and
C.-Y. Wang, Chem. Nat. Compd., 2014, 50, 1153–1155,
DOI: 10.1007/s10600-014-1189-0.
338 M. F. Elsebai, V. Rempel, G. Schnakenburg, S. Kehraus,
C. E. Mu¨ller and G. M. Ko¨nig, ACS Med. Chem. Lett., 2011,
2, 866–869, DOI: 10.1021/ml200183z.
339 D.-C. Kim, H.-S. Lee, W. Ko, D.-S. Lee, J. Sohn, J. Yim,
Y.-C. Kim and H. Oh, Molecules, 2014, 19, 18073–18089,
DOI: 10.3390/molecules191118073.This journal is © The Royal Society of Chemistry 2016340 R. Myokei, A. Sakurai, C.-F. Chang, Y. Kodaira,
N. Takahashi and S. Tamura, Agric. Biol. Chem., 1969, 33,
1491–1500, DOI: 10.1271/bbb1961.33.1491.
341 K. Motohashi and S. Inaba, Biosci., Biotechnol., Biochem.,
2009, 73, 1898–1900, DOI: 10.1271/bbb.90228.
342 H. Kato, T. Yoshida, T. Tokue, Y. Nojiri, H. Hirota, T. Ohta,
R. M. Williams and S. Tsukamoto, Angew. Chem., Int. Ed.,
2007, 46, 2254–2256, DOI: 10.1002/anie.200604381.
343 K. Kito, R. Ookura, T. Kusumi, M. Namikoshi and T. Ooi,
Heterocycles, 2009, 78, 2101–2106, DOI: 10.3987/com-09-
11702.
344 D. Weber, S. Gorzalczany, V. Martino, C. Acevedo,
O. Sterner and T. Anke, Z. Naturforsch., C: J. Biosci., 2005,
60, 467–477, URL: http://lup.lub.lu.se/record/152371.
345 K. Trisuwan, V. Rukachaisirikul, Y. Sukpondma,
S. Preedanon, S. Phongpaichit, N. Rungjindamai and
J. Sakayaroj, J. Nat. Prod., 2008, 71, 1323–1326, DOI:
10.1021/np8002595.
346 J. X. Peng, T. Lin, W. Wang, Z. H. Xin, T. J. Zhu, Q. Q. Gu
and D. H. Li, J. Nat. Prod., 2013, 76, 1133–1140, DOI:
10.1021/np400200k.
347 W. Jiang, Y. Zhong, L. Shen, X. Wu, Y. Ye, C.-T. A. Chen and
B. Wu, Curr. Org. Chem., 2014, 18, 925–934, DOI: 10.2174/
138527281807140515155705.
348 C. Li, J. Wang, C. Luo, W. Ding and D. G. Cox, Nat. Prod.
Res., 2014, 28, 616–621, DOI: 10.1080/
14786419.2014.887074.
349 C. Li, D. G. Cox, S. Huang and W. Ding, Pharmacogn. Mag.,
2014, 10, 410–414, DOI: 10.4103/0973-1296.141781.
350 S. S. Ebada, T. Fischer, A. Hamacher, F.-Y. Du, Y. O. Roth,
M. U. Kassack, B.-G. Wang and E. H. Roth, Nat. Prod.
Res., 2014, 28, 776–781, DOI: 10.1080/
14786419.2014.880911.
351 F. Salmon-Legagneur and M. Le Gall, Bull. Soc. Chim. Fr.,
1966, 553–555.
352 L. Andernach, L. P. Sandjo, J. C. Liermann, I. Buckel,
E. Thines and T. Opatz, Eur. J. Org. Chem., 2013, 5946–
5951, DOI: 10.1002/ejoc.201300530.
353 Z.-Q. Bai, X. Lin, Y. Wang, J. Wang, X. Zhou, B. Yang, J. Liu,
X. Yang, Y. Wang and Y. Liu, Fitoterapia, 2014, 95, 194–202,
DOI: 10.1016/j.tote.2014.03.021.
354 H. C. Wu, H. M. Ge, L. Y. Zang, Y. C. Bei, Z. Y. Niu, W. Wei,
X. J. Feng, S. Ding, S. W. Ng, P. P. Shenv and R. X. Tan, Org.
Biomol. Chem., 2014, 12, 6545–6548, DOI: 10.1039/
c4ob01123f.
355 X.-P. Du and W.-J. Su, Chem. Nat. Compd., 2014, 50, 214–
216, DOI: 10.1007/s10600-014-0915-y.
356 S. Komai, T. Hosoe, T. Itabashi, K. Nozawa, K. Okada,
T. G. M. de Campos, M. Chikamori, T. Yaguchi,
K. Fukushima, M. Miyaji and K. Kawai, Mycotoxins, 2004,
54, 15–19, DOI: 10.2520/myco.54.15.
357 J. Beau, N. Mahid, W. N. Burda, L. Harrington, L. N. Shaw,
T. Mutka, D. E. Kyle and B. Barisic, Mar. Drugs, 2012, 10,
762–774, DOI: 10.3390/md10040762.
358 H. Li, J. Jiang, Z. Liu, S. Lin, G. Xia, X. Xia, B. Ding, L. He,
Y. Lu and Z. She, J. Nat. Prod., 2014, 77, 800–806, DOI:
10.1021/np400880w.Nat. Prod. Rep., 2016, 33, 382–431 | 415





























































































View Article Online359 Y. Shen, X. Du, Z. Zheng, Y. Huang, S. Song and W. Su,
Faming Zhuanli Shenqing Gongkai Shuomingshu, CN
1733693 A 20060215, 2006.
360 Y. Wang, L. Wang, Y. Zhuang, F. Kong, C. Zhang and
W. Zhu, Mar. Drugs, 2014, 12, 2079–2088, DOI: 10.3390/
md12042079.
361 C. Zheng, Y. Chen, L.-L. Jiang and X.-M. Shi, Phytochem.
Lett., 2014, 10, 272–275, DOI: 10.1016/j.phytol.2014.10.011.
362 J. Wang, X.Wei, X. Lu, F. Xu, J. Wan, X. Lin, X. Zhou, S. Liao,
B. Yang, Z. Tu and Y. Liu, Tetrahedron, 2014, 70, 9695–9701,
DOI: 10.1016/j.tet.2014.10.056.
363 L. Hammerschmidt, A. Debbab, T. D. Ngoc, V. Wray,
C. P. Hemphil, W. Lin, H. Broetz-Oesterhelt,
M. U. Kassack, P. Proksch and A. H. Aly, Tetrahedron Lett.,
2014, 55, 3463–3468, DOI: 10.1016/j.tetlet.2014.04.063.
364 J. Wang, D. G. Cox, W. Ding, G. Huang, Y. Lin and C. Li,
Mar. Drugs, 2014, 12, 2840–2850, DOI: 10.3390/
md12052840.
365 G. Xia, J. Li, H. Li, Y. Long, S. Lin, Y. Lu, L. He, Y. Lin, L. Liu
and Z. She, Mar. Drugs, 2014, 12, 2953–2969, DOI: 10.3390/
md12052953.
366 Z.-X. Hu, Y.-B. Xue, X.-B. Bi, J.-W. Zhang, Z.-W. Luo, X.-N. Li,
G.-M. Yao, J.-P. Wang and Y.-H. Zhang, Mar. Drugs, 2014,
12, 5563–5575, DOI: 10.3390/md12115563.
367 W. Ai, X. Wei, X. Lin, L. Sheng, Z. Wang, Z. Tu, X. Yang,
X. Zhou, J. Li and Y. Liu, Tetrahedron, 2014, 70, 5806–
5814, DOI: 10.1016/j.tet.2014.06.041.
368 L.-H. Meng, X.-M. Li, Y. Liu and B.-G. Wang,Org. Lett., 2014,
16, 6052–6055, DOI: 10.1021/ol503046u.
369 P. Zhang, L.-H. Meng, A. Ma´ndi, T. Kurta´n, X.-M. Li, Y. Liu,
X. Li, C.-S. Li and B.-G. Wang, Eur. J. Org. Chem., 2014, 2014,
4029–4036, DOI: 10.1002/ejoc.201400067.
370 L.-H. Meng, X.-M. Li, C.-T. Lv, C.-G. Huang and B.-G. Wang,
J. Nat. Prod., 2014, 77, 1921–1927, DOI: 10.1021/np500382k.
371 J. Li, J. Wang, C.-S. Jiang, G. Li and Y.-W. Guo, J. Asian Nat.
Prod. Res., 2014, 16, 542–548, DOI: 10.1080/
10286020.2014.911290.
372 X.-S. Huang, B. Yang, X.-F. Sun, G.-P. Xia, Y.-Y. Liu, L. Ma
and Z.-G. She, Helv. Chim. Acta, 2014, 97, 664–668, DOI:
10.1002/hlca.201300248.
373 Z.-F. Zhou, T. Kurta´n, X.-H. Yang, A. Ma´ndi, M.-Y. Geng,
B.-P. Ye, O. Taglialatela-Scafati and Y.-W. Guo, Org. Lett.,
2014, 16, 1390–1393, DOI: 10.1021/ol5001523.
374 B. Yang, J. Dong, X. Lin, X. Zhou, Y. Zhang and Y. Liu,
Tetrahedron, 2014, 70, 3859–3863, DOI: 10.1016/
j.tet.2014.04.043.
375 J. Li, X. Yang, Y. Lin, J. Yuan, Y. Lu, X. Zhu, J. Li, M. Li,
Y. Lin, J. He and L. Liu, Fitoterapia, 2014, 97, 241–246,
DOI: 10.1016/j.bmc.2013.12.038.
376 Z.-F. Zhou, X.-H. Yang, H.-L. Liu, Y.-C. Gu, B.-P. Ye and
Y.-W. Guo, Helv. Chim. Acta, 2014, 97, 1564–1570, DOI:
10.1002/hlca.201400062.
377 H. Luo, X.-M. Li, C.-S. Li and B.-G. Wang, Phytochem. Lett.,
2014, 9, 22–25, DOI: 10.1016/j.phytol.2014.03.012.
378 C. Zheng, G. Huang, X. Tang, D. Wang, X. Gong, Q. Zhang,
X. Song and G. Chen, Chin. J. Org. Chem., 2014, 34, 1172–
1176, DOI: 10.6023/cjoc201401014.416 | Nat. Prod. Rep., 2016, 33, 382–431379 J.-F. Sun, X. Lin, X.-F. Zhou, J. Wan, T. Zhang, B. Yang,
X.-W. Yang, Z. Tu and Y. Liu, J. Antibiot., 2014, 67, 451–
457, DOI: 10.1038/ja.2014.24.
380 F. Kong, Y. Wang, P. Liu, T. Dong and W. Zhu, J. Nat. Prod.,
2014, 77, 132–137, DOI: 10.1021/np400802d.
381 J. X. Yang, S. X. Qiu, Z. She and Y. Lin, Chem. Nat. Compd.,
2014, 50, 424–426, DOI: 10.1007/s10600-014-0976-y.
382 W. Zhang, L. Xu, L. Yang, Y. Huang, S. Li and Y. Shen,
Fitoterapia, 2014, 96, 146–151, DOI: 10.1016/
j.tote.2014.05.001.
383 M. Wibowo, V. Prachyawarakorn, T. Aree, S. Wiyakrutta,
C. Mahidol, S. Ruchirawat and P. Kittakoop, Eur. J. Org.
Chem., 2014, 2014, 3976–3980, DOI: 10.1002/
ejoc.201402262.
384 K. Pudhom, T. Teerawatananond and S. Chookpaiboon,
Mar. Drugs, 2014, 12, 1271–1280, DOI: 10.3390/
md12031271.
385 K. Pudhom and T. Teerawatananond, J. Nat. Prod., 2014, 77,
1962–1966, DOI: 10.1021/np500068y.
386 X.-M. Zhou, C.-J. Zheng, X.-P. Song, C.-R. Han, W.-H. Chen
and G.-Y. Chen, J. Antibiot., 2014, 67, 401–403, DOI:
10.1038/ja.2014.6.
387 X.-M. Zhou, C.-J. Zheng, G.-Y. Chen, X.-P. Song, C.-R. Han,
G.-N. Li, Y.-H. Fu, W.-H. Chen and Z.-G. Niu, J. Nat. Prod.,
2014, 77, 2021–2028, DOI: 10.1021/np500340y.
388 B. Yang, J. Dong, X. Lin, H. Tao, X. Zhou and Y. Liu, Nat.
Prod. Res., 2014, 28, 967–970, DOI: 10.1080/
14786419.2014.901318.
389 T. Inuzuka, K. Yamamoto, A. Iwasaki, O. Ohno, K. Suenaga,
Y. Kawazoe and D. Uemura, Tetrahedron Lett., 2014, 55,
6711–6714, DOI: 10.1016/j.tetlet.2014.10.032.
390 A. Iwasaki, S. Sumimoto, O. Ohno, S. Suda and K. Suenaga,
Bull. Chem. Soc. Jpn., 2014, 87, 609–613, DOI: 10.1246/
bcsj.20140008.
391 A. Iwasaki, O. Ohno, S. Sumimoto, S. Suda and K. Suenaga,
RSC Adv., 2014, 4, 12840–12843, DOI: 10.1039/c4ra00132j.
392 E. Mevers, T. Matainaho, M. A. V. Di Marzo and
W. H. Gerwick, Lipids, 2014, 49, 1127–1132, DOI: 10.1007/
s11745-014-3949-9.
393 Y. Kato and P. J. Scheuer, J. Am. Chem. Soc., 1974, 96, 2245–
2246, DOI: 10.1021/ja00814a041.
394 G. R. Pettit, J.-P. Xu, D. L. Doubek, J.-C. Chapuis and
J. M. Schmidt, J. Nat. Prod., 2004, 67, 1252–1255, DOI:
10.1021/np030198b.
395 D. K. Gupta, P. Kaur, S. T. Leong, L. T. Tan, M. R. Prinsep
and J. J. H. Chu, Mar. Drugs, 2014, 12, 115–127, DOI:
10.3390/md12010115.
396 T.-H. Bui, V. Wray, M. Nimtz, T. Fossen, M. Preisitsch,
G. Schro¨der, K. Wende, S. E. Heiden and S. Mundt, J. Nat.
Prod., 2014, 77, 1287–1296, DOI: 10.1021/np401020a.
397 O. Ohno, A. Watanabe, M. Morita and K. Suenaga, Chem.
Lett., 2014, 43, 287–289, DOI: 10.1246/cl.130960.
398 A. Iwasaki, O. Ohno, S. Sumimoto, S. Suda and K. Suenaga,
Tetrahedron Lett., 2014, 55, 4126–4128, DOI: 10.1016/
j.tetlet.2014.05.099.
399 W. Jiang, W. Zhou, H. Uchida, M. Kikumori, K. Irie,
R. Watanabe, T. Suzuki, B. Sakamoto, M. Kamio andThis journal is © The Royal Society of Chemistry 2016





























































































View Article OnlineH. Nagai, Mar. Drugs, 2014, 12, 2748–2759, DOI: 10.3390/
md12052748.
400 W. Jiang, S. Tan, Y. Hanaki, K. Irie, H. Uchida, R. Watanabe,
T. Suzuki, B. Sakamoto, M. Kamio and H. Nagai, Mar.
Drugs, 2014, 12, 5788–5800, DOI: 10.3390/md12125788.
401 J. Quintana, L. M. Bayona, L. Castellanos, M. Puyana,
P. Camargo, F. Aristiza´bal, C. Edwards, J. N. Tabudravu,
M. Jaspars and F. A. Ramos, Bioorg. Med. Chem., 2014, 22,
6789–6795, DOI: 10.1016/j.bmc.2014.10.039.
402 E. Mevers, F. P. J. Haeckl, P. D. Boudreau, T. Byrum,
P. C. Dorrestein, F. A. Valeriote and W. H. Gerwick, J. Nat.
Prod., 2014, 77, 969–975, DOI: 10.1021/np401051z.
403 M. J. Balunas, M. F. Grosso, F. A. Villa, N. Engene,
K. L. McPhail, K. Tidgewell, L. M. Pineda, L. Gerwick,
C. Spadafora, D. E. Kyle and W. H. Gerwick, Org. Lett.,
2012, 14, 3878–3881, DOI: 10.1021/ol301607q.
404 V. M. T. Carneiro, C. M. Avila, M. J. Balunas, W. H. Gerwick
and R. A. Pilli, J. Org. Chem., 2014, 79, 630–642, DOI:
10.1021/jo402339y.
405 M. Morita, O. Ohno and K. Suenaga, Chem. Lett., 2012, 41,
165–167, DOI: 10.1246/cl.2012.165.
406 Y. Tanabe, E. Sato, N. Nakajima, A. Ohkubo, O. Ohno and
K. Suenaga, Org. Lett., 2014, 16, 2858–2861, DOI: 10.1021/
ol500996n.
407 H. Luesch, W. Y. Yoshida, R. E. Moore and V. J. Paul, Bioorg.
Med. Chem., 2002, 10, 1973–1978, DOI: 10.1016/S0968-
0896(02)00014-7.
408 Y. Masuda, J. Suzuki, Y. Onda, Y. Fujino, M. Yoshida and
T. Doi, J. Org. Chem., 2014, 79, 8000–8009, DOI: 10.1021/
jo501130b.
409 F. D. Horgen, E. B. Kazmierski, H. E. Westenburg,
W. Y. Yoshida and P. J. Scheuer, J. Nat. Prod., 2002, 65,
487–491, DOI: 10.1021/np010560r.
410 W. Telle, G. Kelter, H.-H. Fiebig, P. G. Jones and T. Lindel,
Beilstein J. Org. Chem., 2014, 10, 316–322, DOI: 10.3762/
bjoc.10.29.
411 P. G. Williams, W. Y. Yoshida, R. E. Moore and V. J. Paul, J.
Nat. Prod., 2004, 67, 49–53, DOI: 10.1021/np030215x.
412 J. Han, J. Lian, X. Tian, S. Zhou, X. Zhen and S. Liu, Eur. J.
Org. Chem., 2014, 2014, 7232–7238, DOI: 10.1002/
ejoc.201402977.
413 D. Klein, D. Daloze, J. C. Braekman, L. Hoﬀmann and
V. Demoulin, J. Nat. Prod., 1995, 58, 1781–1785, DOI:
10.1021/np50125a025.
414 Z. Lu, M. Yang, P. Chen, X. Xiong and A. Li, Angew. Chem.,
Int. Ed., 2014, 53, 13840–13844, DOI: 10.1002/
anie.201406626.
415 J. I. Jimenez, T. Vansach, W. Y. Yoshida, B. Sakamoto,
P. Poerzgen and F. D. Horgen, J. Nat. Prod., 2009, 72,
1573–1578, DOI: 10.1021/np900173d.
416 R. A. Medina, D. E. Goeger, P. Hills, S. L. Mooberry,
N. Huang, L. I. Romero, E. Ortega-Barria, W. H. Gerwick
and K. L. McPhail, J. Am. Chem. Soc., 2008, 130, 6324,
DOI: 10.1021/ja801383f.
417 X. Wang, C. Lv, J. Liu, L. Tang, J. Feng, S. Tang, Z. Wang,
Y. Liu, Y. Meng, T. Ye and Z. Xu, Synlett, 2014, 25, 1014–
1018, DOI: 10.1055/s-0033-1340872.This journal is © The Royal Society of Chemistry 2016418 W. He, H.-B. Qiu, Y.-J. Chen, J. Xi and Z.-J. Yao, Tetrahedron
Lett., 2014, 55, 6109–6112, DOI: 10.1016/
j.tetlet.2014.09.047.
419 J. C. Kwan, R. Ratnayake, K. A. Abboud, V. J. Paul and
H. Luesch, J. Org. Chem., 2010, 75, 8012–8023, DOI:
10.1021/jo1013564.
420 J. C. Kwan, Y. Liu, R. Ratnayake, R. Hatano, A. Kuribara,
C. Morimoto, K. Ohnuma, V. J. Paul, T. Ye and H. Luesch,
ChemBioChem, 2014, 15, 799–804, DOI: 10.1002/
cbic.201300762.
421 R. G. Linington, B. R. Clark, E. E. Trimble, A. Almanza,
L. D. Urena, D. E. Kyle and W. H. Gerwick, J. Nat. Prod.,
2009, 72, 14–17, DOI: 10.1021/np8003529.
422 B. Miller, A. J. Friedman, H. Choi, J. Hogan,
J. A. McCammon, V. Hook and W. H. Gerwick, J. Nat.
Prod., 2014, 77, 92–99, DOI: 10.1021/np400727r.
423 B. I. Morinaka, A. L. Vagstad, M. J. Helf, M. Gugger,
C. Kegler, M. F. Freeman, H. B. Bode and J. Piel, Angew.
Chem., Int. Ed., 2014, 53, 85038507, DOI: 10.1002/
anie.201400478.
424 Q. Zhang, Y. Yu, J. E. Velasquez and W. A. van der Donk,
Proc. Natl. Acad. Sci. U. S. A., 2012, 109, 18361–18366,
DOI: 10.1073/pnas.1210393109.
425 Q. Zhang, X. Yang, H. Wang and W. A. van der Donk, ACS
Chem. Biol., 2014, 9, 2686–2694, DOI: 10.1021/cb500622c.
426 M. Minamida, K. Kumagai, D. Ulanova, M. Akakabe,
Y. Konishi, A. Tominaga, H. Tanaka, M. Tsuda,
E. Fukushi, J. Kawabata, A. Masuda and M. Tsuda, Org.
Lett., 2014, 16, 4858–4861, DOI: 10.1021/ol5023504.
427 B. S. Hwang, H. S. Kim, W. Yih, E. J. Jeong and J.-R. Rho,
Org. Lett., 2014, 16, 5362–5365, DOI: 10.1021/ol502567g.
428 H. J. Domı´nguez, J. G. Napolitano, M. T. Ferna´ndez-
Sa´nchez, D. Cabrera-Garc´ıa, A. Novelli, M. Norte,
J. J. Ferna´ndez and A. H. Daranas, Org. Lett., 2014, 16,
4546–4549, DOI: 10.1021/ol502102f.
429 G. Nuzzo, A. Cutignano, A. Sardo and A. Fontana, J. Nat.
Prod., 2014, 77, 1524–1527, DOI: 10.1021/np500275x.
430 M. Akakabe, K. Kumagai, M. Tsuda, Y. Konishi,
A. Tominaga, M. Tsuda, E. Fukushi and J. Kawabata,
Tetrahedron Lett., 2014, 55, 3491–3494, DOI: 10.1016/
j.tetlet.2014.04.086.
431 M. Akakabe, K. Kumagai, M. Tsuda, Y. Konishi,
A. Tominaga, M. Tsuda, E. Fukushi and J. Kawabata,
Tetrahedron, 2014, 70, 2962–2965, DOI: 10.1016/
j.tet.2014.03.025.
432 T. Inuzuka, K. Yamada and D. Uemura, Tetrahedron Lett.,
2014, 55, 6319–6323, DOI: 10.1016/j.tetlet.2014.09.094.
433 T. Kubota, T. Iwai, K. Sakai, T. Gonoi and J. Kobayashi, Org.
Lett., 2014, 16, 5624–5627, DOI: 10.1021/ol502685z.
434 J. Kilcoyne, C. Nulty, T. Jauﬀrais, P. McCarron, F. Herve,
B. Foley, F. Rise, S. Crain, A. L. Wilkins, M. J. Twiner,
P. Hess and C. O. Miles, J. Nat. Prod., 2014, 77, 2465–
2474, DOI: 10.1021/np500555k.
435 R. Suzuki, R. Irie, Y. Harntaweesup, K. Tachibana,
P. T. Holland, D. T. Harwood, F. Shi, V. Beuzenberg,
Y. Itoh, S. Pascal, P. J. B. Edwards and M. Satake, Org.
Lett., 2014, 16, 5850–5853, DOI: 10.1021/ol502700h.Nat. Prod. Rep., 2016, 33, 382–431 | 417





























































































View Article Online436 A. I. Selwood, A. L. Wilkins, R. Munday, H. Gu, K. F. Smith,
L. L. Rhodes and F. Rise, Tetrahedron Lett., 2014, 55, 5508–
5510, DOI: 10.1016/j.tetlet.2014.08.056.
437 M. Garc´ıa-Altares, L. Tartaglione, C. Dell'Aversano,
O. Carnicer, P. de la Iglesia, M. Forino, J. Dioge`ne and
P. Ciminiello, Anal. Bioanal. Chem., 2014, 407, 1191–1204,
DOI: 10.1007/s00216-014-8338-y.
438 J. Kobayashi, N. Yamaguchi and M. Ishibashi, Tetrahedron
Lett., 1994, 35, 7049–7050, DOI: 10.1016/0040-4039(94)
88222-3.
439 T. Iwai, T. Kubota and J. Kobayashi, J. Nat. Prod., 2014, 77,
1541–1544, DOI: 10.1021/np5003065.
440 R. Kellmann, T. K. Mihali, Y. J. Jeon, R. Pickford, F. Pomati
and B. A. Neilan, Appl. Environ. Microbiol., 2008, 74, 4044–
4053, DOI: 10.1128/aem.00353-08.
441 S. Tsuchiya, Y. Cho, K. Konoki, K. Nagasawa, Y. Oshima and
M. Yotsu-Yamashita, Org. Biomol. Chem., 2014, 12, 3016–
3020, DOI: 10.1039/c4ob00071d.
442 K. L. Poulson-Ellestad, C. M. Jones, J. Roy, M. R. Viant,
F. M. Fernandez, J. Kubanek and B. L. Nunn, Proc. Natl.
Acad. Sci. U. S. A., 2014, 111, 9009–9014, DOI: 10.1073/
pnas.1402130111.
443 M. Satake and A. J. Bourdelais, Org. Lett., 2008, 10, 3465–
3468, DOI: 10.1016/0041-0101(86)90134-0.
444 K. Calabro, J.-M. Guigonis, J.-L. Teyssie´, F. Oberha¨nsli,
J.-P. Goudour, M. Warnau, M.-Y. D. Bottein and
O. P. Thomas, Toxins, 2014, 6, 1785–1798, DOI: 10.3390/
toxins6061785.
445 M. Satake and A. J. Bourdelais, Org. Lett., 2008, 10, 3465–
3468, DOI: 10.1016/0041-0101(86)90134-0.
446 M. Satake, T. Shirai, Y. Takimoto, T. Kuranaga,
K. Tachibana, D. G. Baden and J. L. C. Wright,
Heterocycles, 2014, 89, 127–142, DOI: 10.3987/COM-13-
12880.
447 Y. Zhang, S.-F. Zhang, L. Lin and D.-Z. Wang, Mar. Drugs,
2014, 12, 5698–5718, DOI: 10.3390/md12115698.
448 D.-Q. Liu, S.-C. Mao, H.-Y. Zhang, X.-Q. Yu, M.-T. Feng,
B. Wang, L.-H. Feng and Y.-W. Guo, Fitoterapia, 2013, 91,
15–20, DOI: 10.1016/j.tote.2013.08.014.
449 H. Yang, D.-Q. Liu, T.-J. Liang, J. Li, A.-H. Liu, P. Yang,
K. Lin, X.-Q. Yu, Y.-W. Guo, S.-C. Mao and B. Wang, J.
Asian Nat. Prod. Res., 2014, 16, 1158–1165, DOI: 10.1080/
10286020.2014.965162.
450 B. C. Maiti, R. H. Thomson and M. Mahendran, J. Chem.
Res., Synop., 1978, 126–127.
451 L. Cavalcante-Silva, M. Falca˜o, A. Vieira, M. Viana, J. de
Arau´jo-Ju´nior, J. Sousa, T. Silva, J. Barbosa-Filho, F. Noe¨l,
G. de Miranda, B. Santos and M. Alexandre-Moreira,
Molecules, 2014, 19, 14699–14709, DOI: 10.3390/
molecules190914699.
452 I. C. Canche´ Chay, R. G. Cansino, C. I. E. Pinzo´n,
R. O. Torres-Ochoa and R. Mart´ınez, Mar. Drugs, 2014, 12,
1757–1772, DOI: 10.3390/md12041757.
453 G. L. Renju, G. M. Kurup and V. R. Bandugula, Tumor Biol.,
2014, 35, 10747–10758, DOI: 10.1007/s13277-014-2339-5.
454 Z.-M. Hu, L.-B. Juan and D.-L. Duan, Chin. Sci. Bull., 2014,
59, 1479–1481, DOI: 10.1007/s11434-014-0143-7.418 | Nat. Prod. Rep., 2016, 33, 382–431455 N. Dasyam, A. B. Munkacsi, N. H. Fadzilah,
D. S. Senanayake, R. F. O'Toole and R. A. Keyzers, J. Nat.
Prod., 2014, 77, 1519–1523, DOI: 10.1021/np500171z.
456 S. Cheng, M. Zhao, Z. Sun, W. Yuan, S. Zhang, Z. Xiang,
Y. Cai, J. Dong, K. Huang and P. Yan, J. Nat. Prod., 2014,
77, 2685–2693, DOI: 10.1021/np5006955.
457 A. Othmani, N. Bouzidi, Y. Viano, Z. Alliche, H. Seridi,
Y. Blache, M. El Hattab, J.-F. Briand and G. Culioli, J.
Appl. Phycol., 2014, 26, 1573–1584, DOI: 10.1007/s10811-
013-0185-2.
458 C. Ireland and D. J. Faulkner, J. Org. Chem., 1977, 42, 3157–
3162, DOI: 10.1021/jo00439a010.
459 J. P. Barbosa, R. C. Pereira and J. L. Abrantes, Planta Med.,
2004, 70, 856–860, DOI: 10.1055/s-2004-827235.
460 A. Pardo-Vargas, I. de Barcelos Oliveira, P. R. S. Stephens,
C. C. Cirne-Santos, I. C. N. de P. Paixa˜o, F. A. Ramos,
C. Jime´nez, J. Rodr´ıguez, J. A. L. C. Resende, V. L. Teixeira
and L. Castellanos, Mar. Drugs, 2014, 12, 4247–4259, DOI:
10.3390/md12074247.
461 K. H. Jang, B. H. Lee, B. W. Choi, H. S. Lee and J. Shin, J.
Nat. Prod., 2005, 68, 716–723, DOI: 10.1021/np058003i.
462 J.-I. Lee, B. J. Park, H. Kim and Y. Seo, Bull. Korean Chem.
Soc., 2014, 35, 2867–2869, DOI: 10.5012/
bkcs.2014.35.9.2867.
463 W.-F. He, L.-G. Yao, H.-L. Liu and Y.-W. Guo, J. Asian Nat.
Prod. Res., 2014, 16, 685–689, DOI: 10.1080/
10286020.2014.924511.
464 Y.-J. Jun, M. Lee, T. Shin, N. Yoon, J.-H. Kim and H.-R. Kim,
Molecules, 2014, 19, 15638–15652, DOI: 10.3390/
molecules191015638.
465 S.-H. Eom, D.-S. Lee, Y.-J. Jung, J.-H. Park, J.-I. Choi,
M.-J. Yim, J.-M. Jeon, H.-W. Kim, K.-T. Son, J.-Y. Je,
M.-S. Lee and Y.-M. Kim, Appl. Microbiol. Biotechnol.,
2014, 98, 9795–9804, DOI: 10.1007/s00253-014-6041-8.
466 H. A. Jung, H. J. Jung, H. Y. Jeong, H. J. Kwon, M. Y. Ali and
J. S. Choi, Fitoterapia, 2014, 92, 260–269, DOI: 10.1016/
j.tote.2013.12.003.
467 F. Karadeniz, K.-H. Kang, J. W. Park, S.-J. Park and
S.-K. Kim, Biosci., Biotechnol., Biochem., 2014, 78, 1151–
1158, DOI: 10.1080/09168451.2014.923282.
468 J.-S. Choi, K. Lee, B.-B. Lee, Y.-C. Kim, Y. D. Kim,
Y.-K. Hong, K. K. Cho and I. S. Choi, Bot. Sci., 2014, 92,
425–431.
469 Y.-I. Yang, S.-H. Jung, K.-T. Lee and J.-H. Choi, Int.
Immunopharmacol., 2014, 23, 460–468, DOI: 10.1016/
j.intimp.2014.09.019.
470 H.-J. Choi, J.-H. Park, B. H. Lee, H. Y. Chee, K. B. Lee and
S.-M. Oh, Appl. Biochem. Biotechnol., 2014, 173, 957–967,
DOI: 10.1007/s12010-014-0910-6.
471 J. H. Kwak, Y. He, B. Yoon, S. Koo, Z. Yang, E. J. Kang,
B. H. Lee, S.-Y. Han, Y. C. Yoo, K. B. Lee and J. S. Kim,
Chem. Commun., 2014, 50, 13045–13048, DOI: 10.1039/
c4cc04270k.
472 V.-T. Nguyen, Z.-J. Qian, B. Lee, S.-J. Heo, K.-N. Kim,
Y.-J. Jeon, W. S. Park, I.-W. Choi, C. H. Jang, S.-C. Ko,
S.-J. Park, Y.-T. Kim, G.-H. Kim, D.-S. Lee, M.-J. Yim,This journal is © The Royal Society of Chemistry 2016





























































































View Article OnlineJ.-Y. Je and W.-K. Jung, Algae, 2014, 29, 355–366, DOI:
10.4490/algae.2014.29.4.355.
473 Y. Zhang, H. Fang, Q. Xie, J. Sun, R. Liu, Z. Hong, R. Yi and
H. Wu, Molecules, 2014, 19, 2100–2113, DOI: 10.3390/
molecules19022100.
474 M.-C. Kang, K.-N. Kim, H. H. C. Lakmal, E.-A. Kim,
W. A. J. P. Wijesinghe, X. Yang, S.-J. Heo and Y.-J. Jeon,
Environ. Toxicol. Pharmacol., 2014, 38, 607–615, DOI:
10.1016/j.etap.2014.08.001.
475 S.-H. Lee, S.-M. Kang, S.-C. Ko, S.-H. Moon, B.-T. Jeon,
D. H. Lee and Y.-J. Jeon, Food Funct., 2014, 5, 2602–2608,
DOI: 10.1039/c4fo00420e.
476 K. C. Kim, M. J. Piao, J. Zheng, C. W. Yao, J. W. Cha,
M. H. S. R. Kumara, X. Han, H. K. Kang, N. H. Lee and
J. W. Hyun, Biomol. Ther., 2014, 22, 301–307, DOI:
10.4062/biomolther.2014.044.
477 G. Lopes, G. Daletos, P. Proksch, P. B. Andrade and
P. Valenta˜o, Mar. Drugs, 2014, 12, 1406–1418, DOI:
10.3390/md12031406.
478 A. H. Banskota, R. Stefanova, S. Sperker, S. Lall, J. S. Craigie
and J. T. Haing, J. Appl. Phycol., 2014, 26, 1565–1571, DOI:
10.1007/s10811-013-0174-5.
479 A. H. Banskota, R. Stefanova, S. Sperker, S. P. Lall,
J. S. Craigie, J. T. Haing and A. T. Critchley,
Phytochemistry, 2014, 101, 101–108, DOI: 10.1016/
j.phytochem.2014.02.004.
480 T. Umezawa, Y. Oguri, H. Matsuura, S. Yamazaki,
M. Suzuki, E. Yoshimura, T. Furuta, Y. Nogata,
Y. Serisawa, K. Matsuyama-Serisawa, T. Abe, F. Matsuda,
M. Suzuki and T. Okino, Angew. Chem., Int. Ed., 2014, 53,
3909–3912, DOI: 10.1002/anie.201311175.
481 A. Gutie´rrez-Cepeda, A. H. Daranas, J. J. Ferna´ndez,
M. Norte and M. L. Souto, Mar. Drugs, 2014, 12, 4031–
4044, DOI: 10.3390/md12074031.
482 K. Kokkotou, E. Ioannou, M. Nomikou, F. Pitterl,
A. Vonaparti, E. Siapi, M. Zervou and V. Roussis,
Phytochemistry, 2014, 108, 208–219, DOI: 10.1016/
j.phytochem.2014.10.007.
483 C. A. Motti, P. Thomas-Hall, K. A. Hagiwara, C. J. Simmons,
R. Willis and A. D. Wright, J. Nat. Prod., 2014, 77, 1193–
1200, DOI: 10.1021/np500059h.
484 X.-Q. Yu, W.-F. He, D.-Q. Liu, M.-T. Feng, Y. Fang, B. Wang,
L.-H. Feng, Y.-W. Guo and S.-C. Mao, Phytochemistry, 2014,
103, 162–170, DOI: 10.1016/j.phytochem.2014.03.021.
485 F. L. da Silva Machado, T. L. B. Ventura, L. M. de Souza
Gestinari, V. Cassano, J. Antoˆnio, L. C. Resende,
C. s. R. Kaiser, E. B. Lasunskaia, M. F. Muzitano and
A. R. Soares, Molecules, 2014, 19, 3181–3192, DOI:
10.3390/molecules19033181.
486 R. F. Angawi, W. M. Alarif, R. I. Hamza, F. A. Badria and
S.-E. N. Ayyad, Helv. Chim. Acta, 2014, 97, 1388–1395, DOI:
10.1002/hlca.201300464.
487 M. Kladi, D. Ntountaniotis, M. Zervou, C. Vagias,
E. Ioannou and V. Roussis, Tetrahedron Lett., 2014, 55,
2835–2837, DOI: 10.1016/j.tetlet.2014.03.083.
488 H.-Y. Fang, S.-F. Chiou, C. Uvarani, Z.-H. Wen, C.-H. Hsu,
Y.-C. Wu, W.-L. Wang, C.-C. Liaw and J.-H. Sheu, Bull.This journal is © The Royal Society of Chemistry 2016Chem. Soc. Jpn., 2014, 87, 1278–1280, DOI: 10.1246/
bcsj.20140165.
489 X. Xu, L. Yin, J. Gao, L. Gao and F. Song, Chem. Biodiversity,
2014, 11, 807–811, DOI: 10.1002/cbdv.201300239.
490 S. Greﬀ, M. Zubia, G. Genta-Jouve, L. Massi, T. Perez and
O. P. Thomas, J. Nat. Prod., 2014, 77, 1150–1155, DOI:
10.1021/np401094h.
491 S. Takahashi, M. Yasuda, T. Nakamura, K. Hatano,
K. Matsuoka and H. Koshino, J. Org. Chem., 2014, 79,
9373–9380, DOI: 10.1021/jo501228v.
492 L. R. de Carvalho, M. T. Fujii, N. F. Roque and J. H. G. Lago,
Phytochemistry, 2006, 67, 1331–1335, DOI: 10.1016/
j.phytochem.2006.04.020.
493 A. G. Gonza´lez, J. Derias, J. D. Martin and C. Pe´rez,
Tetrahedron Lett., 1974, 15, 1249–1250, DOI: 10.1016/
s0040-4039(01)82457-6.
494 A. E. Leung, R. Rubbiani, G. Gasser and K. L. Tuck, Org.
Biomol. Chem., 2014, 12, 8239–8246, DOI: 10.1039/
c4ob01662a.
495 N. Mihopoulos, C. Vagias, E. Mikros, M. Scoullos and
V. Roussis, Tetrahedron Lett., 2001, 42, 3749–3752, DOI:
10.1016/s0040-4039(01)00538-x.
496 C. V. Vogel, H. Pietraszkiewicz, O. M. Sabry, W. H. Gerwick,
F. A. Valeriote and C. D. Vanderwal, Angew. Chem., Int. Ed.,
2014, 53, 12205–12209, DOI: 10.1002/anie.201407726.
497 J. H. Cardellina, S. B. Horsley, J. Clardy, S. R. Leow and
J. Meinwald, Can. J. Chem., 1982, 60, 2675–2677, DOI:
10.1139/v82-384.
498 G. Kim, T.-i. Sohn, D. Kim and R. S. Paton, Angew. Chem.,
Int. Ed., 2014, 53, 272–276, DOI: 10.1002/anie.201308077.
499 M. Kuniyoshi, P. G. Wahome, T. Miono, T. Hashimoto,
M. Yokoyama, K. L. Shrestha and T. Higa, J. Nat. Prod.,
2005, 68, 1314–1317, DOI: 10.1021/np058004a.
500 C. Recsei, B. Chan and C. S. P. McErlean, J. Org. Chem.,
2014, 79, 880–887, DOI: 10.1021/jo402790x.
501 R. de Nys, A. D. Wright, G. M. Ko¨nig, O. Sticher and
P. M. Alino, J. Nat. Prod., 1993, 56, 877–883, DOI: 10.1021/
np50096a011.
502 W. A. J. P. Wijesinghe, M.-C. Kang, W.-W. Lee, H.-S. Lee,
T. Kamada, C. S. Vairappan and Y.-J. Jeon, Algae, 2014,
29, 333–341, DOI: 10.4490/algae.2014.29.4.333.
503 W. A. J. P. Wijesinghe, E.-A. Kim, M.-C. Kang, W.-W. Lee,
H.-S. Lee, C. S. Vairappan and Y.-J. Jeon, Environ. Toxicol.
Pharmacol., 2014, 37, 110–117, DOI: 10.1016/
j.etap.2013.11.006.
504 A. Abdel-Lateﬀ, W. M. Alarif, H. Z. Asfour, S.-E. N. Ayyad,
A. Khedr, F. A. Badria and S. S. Al-lihaibi, Environ. Toxicol.
Pharmacol., 2014, 37, 928–935, DOI: 10.1016/
j.etap.2014.03.005.
505 G. A. Mohamed, A. E. E. Abd-Elrazek, H. A. Hassanean,
D. T. A. Youssef and R. van Soest, Phytochem. Lett., 2014,
9, 51–58, DOI: 10.1016/j.phytol.2014.04.008.
506 C.-K. Kim, I.-H. Song, H. Y. Park, Y.-J. Lee, H.-S. Lee,
C. J. Sim, D.-C. Oh, K.-B. Oh and J. Shin, J. Nat. Prod.,
2014, 77, 1396–1403, DOI: 10.1021/np500156n.Nat. Prod. Rep., 2016, 33, 382–431 | 419





























































































View Article Online507 T. Kubota, H. Suzuki, A. Takahashi-Nakaguchi, J. Fromont,
T. Gonoi and J. Kobayashi, RSC Adv., 2014, 4, 11073–11079,
DOI: 10.1039/c3ra47796g.
508 C.-W. Chiu, H.-J. Su, M.-C. Lu, W.-H. Wang, J.-H. Sheu and
J.-H. Su, Bull. Chem. Soc. Jpn., 2014, 87, 1231–1234, DOI:
10.1246/bcsj.20140188.
509 S.-E. N. Ayyad, R. A. Alarif, E. A. Saqer and F. A. Badria, Z.
Naturforsch., C: J. Biosci., 2014, 69, 117–123, DOI: 10.5560/
znc.2013-0088.
510 K. Takada, S. Okada and S. Matsunaga, Fish. Sci., 2014, 80,
1057–1064, DOI: 10.1007/s12562-014-0776-0.
511 Y.-S. Juan, C.-C. Lee, C.-W. Tsao, M.-C. Lu, M. El-Shazly,
H.-C. Shih, Y.-C. Chen, Y.-C. Wu and J.-H. Su, Int. J. Mol.
Sci., 2014, 15, 16511–16521, DOI: 10.3390/ijms150916511.
512 H. Kim, K.-J. Kim, J.-T. Yeon, S. H. Kim, D. H. Won, H. Choi,
S.-J. Nam, Y.-J. Son and H. Kang, Mar. Drugs, 2014, 12,
2054–2065, DOI: 10.3390/md12042054.
513 L.-F. Liang, T. Wang, Y.-S. Cai, W.-F. He, P. Sun, Y.-F. Li,
Q. Huang, O. Taglialatela-Scafati, H.-Y. Wang and
Y.-W. Guo, Eur. J. Med. Chem., 2014, 79, 290–297, DOI:
10.1016/j.ejmech.2014.04.003.
514 Y. Hitora, K. Takada, S. Okada and S. Matsunaga,
Tetrahedron, 2011, 67, 4530–4534, DOI: 10.1016/
j.tet.2011.04.085.
515 K. Mori, K. Akasaka and S. Matsunaga, Tetrahedron, 2014,
70, 392–401, DOI: 10.1016/j.tet.2013.11.045.
516 I. Carletti, G. Massiot and C. Debitus, WO 2011/051380 A1,
2011.
517 E. De Gussem, W. Herrebout, S. Specklin, C. Meyer, J. Cossy
and P. Bultinck, Chem.–Eur. J., 2014, 20, 17385–17394, DOI:
10.1002/chem.201404822.
518 G. Chianese, M. Persico, F. Yang, H.-W. Lin, Y.-W. Guo,
N. Basilico, S. Parapini, D. Taramelli, O. Taglialatela-
Scafati and C. Fattorusso, Bioorg. Med. Chem., 2014, 22,
4572–4580, DOI: 10.1016/j.bmc.2014.07.034.
519 A. Trianto, N. J. de Voodg and J. Tanaka, J. Asian Nat. Prod.
Res., 2014, 16, 163–168, DOI: 10.1080/
10286020.2013.844128.
520 M. Carbone, L. Nu´n˜ez-Pons, M. L. Ciavatta, F. Castelluccio,
C. Avila and M. Gavagnin, Nat. Prod. Commun., 2014, 9,
469–539.
521 D. P. Clark, J. Carroll, S. Naylor and P. Crews, J. Org. Chem.,
1998, 63, 8757–8764, DOI: 10.1021/jo980758p.
522 H. Tajima, T. Wakimoto, K. Takada, Y. Ise and I. Abe, J. Nat.
Prod., 2014, 77, 154–158, DOI: 10.1021/np400668k.
523 L. Coello, F. Reyes, M. J. Mart´ın, C. Cuevas and
R. Ferna´ndez, J. Nat. Prod., 2014, 77, 298–303, DOI:
10.1021/np400888e.
524 M. Pelay-Gimeno, Y. Garcia-Ramos, M. J. Martin,
J. Spengler, J. M. Molina-Guijarro, S. Munt,
A. M. Francesch, C. Cuevas, J. Tulla-Puche and
F. Albericio, Nat. Commun., 2013, 4, 2352, DOI: 10.1038/
ncomms3352.
525 M. J. Mart´ın, R. Rodr´ıguez-Acebes, Y. Garc´ıa-Ramos,
V. Mart´ınez, C. Murcia, I. Digo´n, I. Marco, M. Pelay-
Gimeno, R. Ferna´ndez, F. Reyes, A. M. Francesch,420 | Nat. Prod. Rep., 2016, 33, 382–431S. Munt, J. Tulla-Puche, F. Albericio and C. Cuevas, J. Am.
Chem. Soc., 2014, 136, 6754–6762, DOI: 10.1021/ja502744a.
526 T. D. Tran, N. B. Pham, G. A. Fechner, J. N. A. Hooper and
R. J. Quinn,Mar. Drugs, 2014, 12, 3399–3415, DOI: 10.3390/
md12063399.
527 K. C. Tan, T. Wakimoto and I. Abe, Org. Lett., 2014, 16,
3256–3259, DOI: 10.1021/ol501271v.
528 X. Wang, B. I. Morinaka and T. F. Molinski, J. Nat. Prod.,
2014, 77, 625–630, DOI: 10.1021/np400891s.
529 K.-X. Zhan, W.-H. Jiao, F. Yang, J. Li, S.-P. Wang, Y.-S. Li,
B.-N. Han and H.-W. Lin, J. Nat. Prod., 2014, 77, 2678–
2684, DOI: 10.1021/np5006778.
530 J. Song, J.-e. Jeon, T. H. Won, C. J. Sim, D.-C. Oh, K.-B. Oh
and J. Shin, Mar. Drugs, 2014, 12, 2760–2770, DOI:
10.3390/md12052760.
531 D. T. A. Youssef, L. A. Shaala, G. A. Mohamed, J. M. Badr,
F. H. Bamanie and S. R. M. Ibrahim, Mar. Drugs, 2014,
12, 1911–1923, DOI: 10.3390/md12041911.
532 H. Li, J. J. Bowling, M. Sua, J. Hong, B.-J. Lee, M. T. Hamann
and J. H. Jung, Biochim. Biophys. Acta, Gen. Subj., 2014,
1840, 977–984, DOI: 10.1016/j.bbagen.2013.11.001.
533 C.-D. Pham, R. Hartmann, P. Bo¨hler, B. Stork,
S. Wesselborg, W. Lin, D. Lai and P. Proksch, Org. Lett.,
2014, 16, 266–269, DOI: 10.1021/ol403241v.
534 D. Uemura, K. Takahashi, T. Yamamoto, C. Katayama,
J. Tanaka, Y. Okumura and Y. Hirata, J. Am. Chem. Soc.,
1985, 107, 4796–4798, DOI: 10.1016/S0040-4039(00)98121-
8.
535 Y. Hirata and D. Uemura, Pure Appl. Chem., 1986, 58, 701–
710, DOI: 10.1351/pac198658050701.
536 A. Ueda, A. Yamamoto, D. Kato and Y. Kishi, J. Am. Chem.
Soc., 2014, 136, 5171–5176, DOI: 10.1021/ja5013307.
537 Y. Chen, Y. Peng, C. Gao and R. Huang, Nat. Prod. Res.,
2014, 28, 1010–1014, DOI: 10.1080/14786419.2014.903397.
538 A. S. Dewi, T. A. Hadi, N. D. Fajarningsih, J. T. Blancheld,
P. V. Bernhardt and M. J. Garson, Aust. J. Chem., 2014, 67,
1205–1210, DOI: 10.1071/ch14107.
539 A. Furusato, H. Kato, T. Nehira, K. Eguchi, T. Kawabata,
Y. Fujiwara, F. Losung, R. E. P. Mangindaan, N. J. de
Voogd, M. Takeya, H. Yokosawa and S. Tsukamoto, Org.
Lett., 2014, 16, 3888–3891, DOI: 10.1021/ol5015569.
540 A. H. El-Desoky, H. Kato, K. Eguchi, T. Kawabata,
Y. Fujiwara, F. Losung, R. E. P. Mangindaan, N. J. de
Voogd, M. Takeya, H. Yokosawa and S. Tsukamoto, J. Nat.
Prod., 2014, 77, 1536–1540, DOI: 10.1021/np500290a.
541 J.-Z. Sun, C.-S. Jiang, X.-Q. Chen, K.-S. Chen, X.-C. Zhen,
R. W. M. van Soest and Y.-W. Guo, Tetrahedron, 2014, 70,
3166–3171, DOI: 10.1016/j.tet.2014.03.051.
542 S. Matsunaga, R. Kishi, K. Otsuka, M. J. Fujita, M. Oikawa
and R. Sakai, Org. Lett., 2014, 16, 3090–3093, DOI:
10.1021/ol5011888.
543 W.-F. He, D.-Q. Xue, L.-G. Yao, J.-Y. Li, J. Li and Y.-W. Guo,
Mar. Drugs, 2014, 12, 3982–3993, DOI: 10.3390/
md12073982.
544 N. Tanaka, R. Momose, A. Takahashi-Nakaguchi, T. Gonoi,
J. Fromont and J. Kobayashi, Tetrahedron, 2014, 70, 832–
837, DOI: 10.1016/j.tet.2013.12.032.This journal is © The Royal Society of Chemistry 2016





























































































View Article Online545 E. Sakai, H. Kato, H. Rotinsulu, F. Losung,
R. E. P. Mangindaan, N. J. de Voogd, H. Yokosawa and
S. Tsukamoto, J. Nat. Med., 2014, 68, 215–219, DOI:
10.1007/s11418-013-0778-8.
546 S. Khokhar, Y. Feng, M. R. Campitelli, M. G. Ekins,
J. N. A. Hooper, K. D. Beattie, M. C. Sadowski,
C. C. Nelson and R. A. Davis, Bioorg. Med. Chem. Lett.,
2014, 24, 3329–3332, DOI: 10.1016/j.bmcl.2014.05.104.
547 J. Dai, J. I. Jimenez, M. Kelly and P. G. Williams, J. Org.
Chem., 2010, 75, 2399–2402, DOI: 10.1021/jo902566n.
548 A. Skiredj, M. A. Beniddir, D. Joseph, K. Leblanc,
G. Bernadat, L. Evanno and E. Poupon, Angew. Chem., Int.
Ed., 2014, 53, 6419–6424, DOI: 10.1002/anie.201403454.
549 M. Arai, C. Han, Y. Yamano, A. Setiawan and M. Kobayashi,
J. Nat. Med., 2014, 68, 372–376, DOI: 10.1007/s11418-013-
0811-y.
550 H.-B. Yu, F. Yang, F. Sun, J. Li, W.-H. Jiao, J.-H. Gan,
W.-Z. Hu and H.-W. Lin, Mar. Drugs, 2014, 12, 6003–6013,
DOI: 10.3390/md12126003.
551 H.-B. Yu, F. Yang, F. Sun, G.-Y. Ma, J.-H. Gan, W.-Z. Hu,
B.-N. Han, W.-H. Jiao and H.-W. Lin, J. Nat. Prod., 2014,
77, 2124–2129, DOI: 10.1021/np500583z.
552 T. D. Tran, N. B. Pham and R. J. Quinn, Eur. J. Org. Chem.,
2014, 2014, 4805–4816, DOI: 10.1002/ejoc.201402372.
553 A. Ahond, M. B. Zurita, M. Colin, C. Fizames, P. Laboute,
F. Lavelle, D. Laurent, C. Poupat, J. Pusset and M. Pusset,
C. R. Acad. Sci., Ser. II: Mec., Phys., Chim., Sci. Terre
Univers, 1988, 307, 145–148.
554 S.-Y. Fung, V. Soyev, J. Schneiderman, A. F. Hirschfeld,
R. E. Victor, K. Woods, J. S. Piotrowski, R. Deshpande,
S. C. Li, N. J. de Voogd, C. L. Myers, C. Boone,
R. J. Andersen and S. E. Turvey, ACS Chem. Biol., 2014, 9,
247–257, DOI: 10.1021/cb400740c.
555 T. N. Makarieva, E. K. Ogurtsova, V. A. Denisenko,
P. S. Dmitrenok, K. M. Tabakmakher, A. G. Guzii,
E. A. Pislyagin, A. A. Es'kov, V. B. Kozhemyako,
D. L. Aminin, Y.-M. Wang and V. A. Stonik, Org. Lett.,
2014, 16, 4292–4295, DOI: 10.1021/ol502013f.
556 T. Grkovic, J. Blees, M. Bayer, N. Colburn, C. Thomas,
C. Henrich, M. Peach, J. McMahon, T. Schmid and
K. Gustafson, Mar. Drugs, 2014, 12, 4593–4601, DOI:
10.3390/md12084593.
557 E. Gros, A. Al-Mourabit, M.-T. Martin, J. Sorres, J. Vacelet,
M. Frederich, M. Aknin, Y. Kashman and A. Gauvin-
Bialecki, J. Nat. Prod., 2014, 77, 818–823, DOI: 10.1021/
np4009283.
558 F. Plisson, P. Prasad, X. Xiao, A. M. Piggott, X.-c. Huang,
Z. Khalil and R. J. Capon, Org. Biomol. Chem., 2014, 12,
1579–1584, DOI: 10.1039/c4ob00091a.
559 T. Kusama, N. Tanaka, A. Takahashi-Nakaguchi, T. Gonoi,
J. Fromont and J. Kobayashi, Chem. Pharm. Bull., 2014,
62, 499–503, DOI: 10.1248/cpb.c14-00077.
560 T. Kusama, N. Tanaka, K. Sakai, T. Gonoi, J. Fromont,
Y. Kashiwada and J. Kobayashi, Org. Lett., 2014, 16, 3916–
3918, DOI: 10.1021/ol501664b.This journal is © The Royal Society of Chemistry 2016561 T. Kusama, N. Tanaka, K. Sakai, T. Gonoi, J. Fromont,
Y. Kashiwada and J. Kobayashi, Org. Lett., 2014, 16, 5176–
5179, DOI: 10.1021/ol502528m.
562 S. Urban, P. D. Leone, A. R. Carroll, G. A. Fechner, J. Smith,
J. N. A. Hooper and R. J. Quinn, J. Org. Chem., 1999, 64, 731–
735, DOI: 10.1021/jo981034g.
563 R. A. Rodriguez, D. B. Steed, Y. Kawamata, S. Su,
P. A. Smith, T. C. Steed, F. E. Romesberg and P. S. Baran,
J. Am. Chem. Soc., 2014, 136, 15403–15413, DOI: 10.1021/
ja508632y.
564 R. P. Walker, D. J. Faulkner, D. van Engen and J. Clardy, J.
Am. Chem. Soc., 1981, 103, 6772–6773, DOI: 10.1021/
ja00412a052.
565 M. Assmann andM. Ko¨ck, Z. Naturforsch., C: J. Biosci., 2002,
57, 157–160, URL: http://www.znaturforsch.com/ac/v57c/
s57c0157.pdf.
566 P. A. Keifer, R. E. Schwartz, M. E. S. Koker, R. G. Hughes,
D. Rittschof and K. L. Rinehart, J. Org. Chem., 1991, 56,
2965–2975, DOI: 10.1021/jo00009a008.
567 J. Kobayashi, M. Tsuda, T. Murayama, H. Nakamura,
Y. Ohizumi, M. Ishibashi, M. Iwamura, T. Ohta and
S. Nozoe, Tetrahedron, 1990, 46, 5579–5586, DOI: 10.1016/
s0040-4020(01)87756-5.
568 S. Nishimura, S. Matsunaga, M. Shibazaki, K. Suzuki and
K. Furihata, Org. Lett., 2003, 5, 2255–2257, DOI: 10.1021/
ol034564u.
569 A. Grube, S. Immel, P. S. Baran and M. Ko¨ck, Angew. Chem.,
Int. Ed., 2007, 46, 6721–6724, DOI: 10.1002/anie.200701935.
570 R. B. Kinnel, H. Gehrken, R. Swali, G. Skoropowski and
P. J. Scheuer, J. Org. Chem., 1998, 63, 3281–3286, DOI:
10.1021/jo971987z.
571 Z. Ma, X. Wang, X. Wang, R. A. Rodriguez, C. E. Moore,
S. Gao, X. Tan, Y. Ma, A. L. Rheingold, P. S. Baran and
C. Chen, Science, 2014, 346, 219–224, DOI: 10.1126/
science.1255677.
572 L.-W. Tian, Y. Feng, Y. Shimizu, T. A. Pfeifer, C. Wellington,
J. N. A. Hooper and R. J. Quinn, Bioorg. Med. Chem. Lett.,
2014, 24, 3537–3540, DOI: 10.1016/j.bmcl.2014.05.054.
573 L.-W. Tian, Y. Feng, Y. Shimizu, T. Pfeifer, C. Wellington,
J. N. A. Hooper and R. J. Quinn, J. Nat. Prod., 2014, 77,
1210–1214, DOI: 10.1021/np500119e.
574 M. M. K. Kumar, J. D. Naik, K. Satyavathi, H. Ramana,
P. R. Varma, K. P. Nagasree, D. Smitha and D. V. Rao,
Nat. Prod. Res., 2014, 28, 888–894, DOI: 10.1080/
14786419.2014.891112.
575 B. Wang, Y. Lin, Y. Chen and R. Huang, Nat. Prod.
Commun., 2014, 9, 471–473.
576 M. Farrugia, N. Trotter, S. Vijayasarathy, A. A. Salim,
Z. G. Khalil, E. Lacey and R. J. Capon, Tetrahedron Lett.,
2014, 55, 5902–5904, DOI: 10.1016/j.tetlet.2014.08.116.
577 D. R. Abou-Hussein, J. M. Badr and D. T. A. Youssef, Nat.
Prod. Res., 2014, 28, 1134–1141, DOI: 10.1080/
14786419.2014.915828.
578 Q. Go¨thel and M. Ko¨ck, Beilstein J. Org. Chem., 2014, 10,
613–621, DOI: 10.3762/bjoc.10.52.
579 N. K. Utkin and V. A. Denisenko, Nat. Prod. Commun., 2014,
9, 757–765.Nat. Prod. Rep., 2016, 33, 382–431 | 421





























































































View Article Online580 W.-H. Jiao, J. Li, Q. Liu, T.-T. Xu, G.-H. Shi, H.-B. Yu,
F. Yang, B.-N. Han, M. Li and H.-W. Lin, Molecules, 2014,
19, 18025–18032, DOI: 10.3390/molecules191118025.
581 W.-H. Jiao, T.-T. Xu, H.-B. Yu, F.-R. Mu, J. Li, Y.-S. Li,
F. Yang, B.-N. Hana and H.-W. Lin, RSC Adv., 2014, 4,
9236–9246, DOI: 10.1039/c3ra47265e.
582 W.-H. Jiao, T.-T. Xu, H.-B. Yu, G.-D. Chen, X.-J. Huang,
F. Yang, Y.-S. Li, B.-N. Han, X.-Y. Liu and H.-W. Lin, J.
Nat. Prod., 2014, 77, 346–350, DOI: 10.1021/np4009392.
583 G. Daletos, N. J. de Voogd, W. E. G. Mu¨ller, V. Wray,
W. H. Lin, D. Feger, M. Kubbutat, A. H. Aly and
P. Proksch, J. Nat. Prod., 2014, 77, 218–226, DOI: 10.1021/
np400633m.
584 M. Yamakuma, H. Kato, K. Matsuo, A. H. El-Desoky,
T. Kawabata, F. Losung, R. E. P. Mangindaan, N. J. de
Voogd, H. Yokosawa and S. Tsukamoto, Heterocycles,
2014, 89, 2605–2610, DOI: 10.3987/com-14-13087.
585 R. M. Centko, A. Steinø, F. I. Rosell, B. O. Patrick, N. de
Voogd, A. G. Mauk and R. J. Andersen, Org. Lett., 2014,
16, 6480–6483, DOI: 10.1021/ol503337f.
586 A. Bisio, E. Fedele, A. Pittaluga, G. Olivero, M. Grilli,
J. Chen, G. Mele, N. Malafronte, N. De Tommasi,
F. Leddae, R. Manconi, R. Pronzato and M. Marchi, Nat.
Prod. Commun., 2014, 9, 1581–1585.
587 W. Cheng, D. Liu, F. Zhang, Q. Zhang, P. Pedpradab,
P. Proksch, H. Liang and W. Lin, Tetrahedron, 2014, 70,
3576–3583, DOI: 10.1016/j.tet.2014.04.008.
588 D. Hahn, J. Chin, H. Kim, I. Yang, D. H. Won, M. Ekins,
H. Choi, S.-J. Nam and H. Kang, Tetrahedron Lett., 2014,
55, 4716–4719, DOI: 10.1016/j.tetlet.2014.07.019.
589 W. Liu, K.-J. Liang, C.-Y. Chiang, M.-C. Lu and J.-H. Su,
Chem. Pharm. Bull., 2014, 62, 392–394, DOI: 10.1248/
cpb.c13-00851.
590 P. V. Kiem, C. V. Minh, N. X. Nhiem, N. T. Cuc, N. V. Quang,
H. L. T. Anh, B. H. Tai, P. H. Yen, N. T. Hoai, K. Y. Ho,
N. Kim, S. J. Park and S. H. Kim, Magn. Reson. Chem.,
2014, 52, 51–56, DOI: 10.1002/mrc.4030.
591 J.-R. Rho, J. Korean Magn. Reson. Soc., 2014, 18, 82–88, DOI:
10.6564/JKMRS.2014.18.2.082.
592 F. Yang, Y. Zou, R.-P. Wang, M. Hamann, H.-J. Zhang,
W.-H. Jiao, B.-N. Han, S.-J. Song and H.-W. Lin, Mar.
Drugs, 2014, 12, 4399–4416, DOI: 10.3390/md12084399.
593 S. M. Parrish, W. Y. Yoshida, T. P. Kondratyuk, E.-J. Park,
J. M. Pezzuto, M. Kelly and P. G. Williams, J. Nat. Prod.,
2014, 77, 1644–1649, DOI: 10.1021/np500256w.
594 J. M. Wojnar, K. O. Dowle and P. T. Northcote, J. Nat. Prod.,
2014, 77, 2288–2295, DOI: 10.1021/np500549g.
595 S.-J. Piao, W.-H. Jiao, F. Yang, Y.-H. Yi, Y.-T. Di, B.-N. Han
and H.-W. Lin, Mar. Drugs, 2014, 12, 4096–4109, DOI:
10.3390/md12074096.
596 C. Festa, C. Cassiano, M. V. D'Auria, C. Debitus,
M. C. Monti and S. De Marino, Org. Biomol. Chem., 2014,
12, 8646–8655, DOI: 10.1039/c4ob01510j.
597 Y.-J. Lee, J.-W. Lee, D.-G. Lee, H.-S. Lee, J. Kang and J. Yun,
Int. J. Mol. Sci., 2014, 15, 20045–20053, DOI: 10.3390/
ijms151120045.422 | Nat. Prod. Rep., 2016, 33, 382–431598 L. Yin, H. Li, X. Chen and Y. Qiu, Rec. Nat. Prod., 2014, 8,
417–421, URL: http://www.acgpubs.org/RNP/2014/
Volume8/Issue%201/58-RNP-1309-433.pdf.
599 F. Yang, J.-H. Gan, X.-Y. Liu and H.-W. Lin, Nat. Prod.
Commun., 2014, 9, 763–767.
600 J.-K. Woo, C.-K. Kim, S.-H. Kim, H. Kim, D.-C. Oh, K.-B. Oh
and J. Shin, Org. Lett., 2014, 16, 2826–2829, DOI: 10.1021/
ol500868s.
601 Y. Lee, W. Wang, H. Kim, A. G. Giri, D. H. Won, D. Hahn,
K. R. Baek, J. Lee, I. Yang, H. Choi, S.-J. Nam and
H. Kang, Bioorg. Med. Chem. Lett., 2014, 24, 4095–4098,
DOI: 10.1016/j.bmcl.2014.07.066.
602 C. Viegelmann, J. Parker, T. Ooi, C. Clements, G. Abbott,
L. Young, J. Kennedy, A. D. W. Dobson and R. Edrada-
Ebel, Mar. Drugs, 2014, 12, 2937–2952, DOI: 10.3390/
md12052937.
603 V. Sepe, C. D'Amore, R. Ummarino, B. Renga, M. V. D'Auria,
E. Novellino, A. Sinisi, O. Taglialatela-Scafati, Y. Nakao,
V. Limongelli, A. Zampella and S. Fiorucci, Eur. J. Med.
Chem., 2014, 73, 126–134, DOI: 10.1016/
j.ejmech.2013.12.005.
604 S. N. Sunassee, T. Ransom, C. J. Henrich, J. A. Beutler,
D. G. Covell, J. B. McMahon and K. R. Gustafson, J. Nat.
Prod., 2014, 77, 2475–2480, DOI: 10.1021/np500556t.
605 I. Yang, H. Choi, D. H. Won, S.-J. Nam and H. Kang, Bull.
Korean Chem. Soc., 2014, 35, 3360–3362, DOI: 10.5012/
bkcs.2014.35.11.3360.
606 G. Chianese, V. Sepe, V. Limongelli, B. Renga, C. D'Amore,
A. Zampella, O. Taglialatela-Scafati and S. Fiorucci,
Steroids, 2014, 83, 80–85, DOI: 10.1016/
j.steroids.2014.02.003.
607 J. Gong, P. Sun, N. Jiang, R. Riccio, G. Lauro, G. Bifulco,
T.-J. Li, W. H. Gerwick and W. Zhang, Org. Lett., 2014, 16,
2224–2227, DOI: 10.1021/ol5007345.
608 K. Machida, T. Abe, D. Arai, M. Okamoto, I. Shimizu,
N. J. de Voogd, N. Fusetani and Y. Nakao, Org. Lett., 2014,
16, 1539–1541, DOI: 10.1021/ol5000023.
609 D.-J. Jin, S.-A. Tang, G.-S. Xing, W.-J. Zhao, C. Zhao,
H.-Q. Duan and W.-H. Lin, J. Asian Nat. Prod. Res., 2014,
16, 427–433, DOI: 10.1080/10286020.2014.911288.
610 S.-E. N. Ayyad, R. F. Angawi, E. Saqer, A. Abdel-Lateﬀ and
F. A. Badria, Pharmacogn. Mag., 2014, 10, 334–341, DOI:
10.4103/0973-1296.133292.
611 A. Zampella, C. Giannini, C. Debitus, C. Roussakis and
M. V. D'Auria, J. Nat. Prod., 1999, 62, 332–334, DOI:
10.1021/np9803225.
612 J. J. La Clair, S. T. Loveridge, K. Tenney, M. O'Neil-Johnson,
E. Chapman and P. Crews, PLoS One, 2014, 9, e100474, DOI:
10.1371/journal.pone.0100474.
613 G. D. Sala, T. Hochmuth, R. Teta, V. Costantino and
A. Mangoni, Mar. Drugs, 2014, 12, 5425–5440, DOI:
10.3390/md12115425.
614 S. Sakemi, T. Ichiba, S. Kohmoto, G. Saucy and T. Higa, J.
Am. Chem. Soc., 1988, 110, 4851–4853, DOI: 10.1021/
ja00222a068.
615 T. Hamada, S. Matsunaga, G. Yano and N. Fusetani, J. Am.
Chem. Soc., 2005, 127, 110–118, DOI: 10.1021/ja045749e.This journal is © The Royal Society of Chemistry 2016





























































































View Article Online616 J. Kobayashi, M. Sato, M. Ishibashi, H. Shigemori,
T. Nakamura and Y. Ohizumi, J. Chem. Soc., Perkin Trans.
1, 1991, 10, 2609–2611, DOI: 10.1039/p19910002609.
617 N. Fusetani, S. Matsunaga, H. Matsumoto and
Y. Takebayashi, J. Am. Chem. Soc., 1990, 112, 7053–7054,
DOI: 10.1021/ja00175a045.
618 D. G. Corley, R. Herb, R. E. Moore, P. J. Scheuer and
V. J. Paul, J. Org. Chem., 1988, 53, 3644–3646, DOI:
10.1021/jo00250a053.
619 L. M. West, P. T. Northcote and C. N. Battershill, J. Org.
Chem., 2000, 65, 445–449, DOI: 10.1021/jo991296y.
620 A. E. Prota, K. Bargsten, P. T. Northcote, M. Marsh,
K.-H. Altmann, J. H. Miller, J. F. Diaz and
M. O. Steinmetz, Angew. Chem., Int. Ed., 2014, 53, 1621–
1625, DOI: 10.1002/anie.201307749.
621 H. Nakamura, J. Kobayashi, Y. Ohizumi and Y. Hirata,
Tetrahedron Lett., 1982, 23, 5555–5558, DOI: 10.1016/
s0040-4039(00)85893-1.
622 F. Funk, K. Kru¨ger, C. Henninger, W. Wa¨tjen, P. Proksch,
J. Thomale and G. Fritz, Anti-Cancer Drugs, 2014, 25, 917–
929, DOI: 10.1097/cad.0000000000000119.
623 M.-J. Kim, S. W. Woo, M.-S. Kim, J.-E. Park and J.-K. Hwang,
J. Asian Nat. Prod. Res., 2014, 16, 1139–1147, DOI: 10.1080/
10286020.2014.983092.
624 R. Capon, E. L. Ghisalberti, P. R. Jeﬀeries, B. W. Skelton and
A. H. White, J. Chem. Soc., Perkin Trans. 1, 1981, 2464–2467,
DOI: 10.1039/p19810002464.
625 K. A. Salam, A. Furuta, N. Noda, S. Tsuneda, Y. Sekiguchi,
A. Yamashita, K. Moriishi, M. Nakakoshi, H. Tani,
S. R. Roy, J. Tanaka, M. Tsubuki and N. Akimitsu,
Molecules, 2014, 19, 4006–4020, DOI: 10.3390/
molecules19044006.
626 M. Xu, R. A. Davis, Y. J. Feng, M. L. Sykes, T. Shelper,
V. M. Avery, D. Camp and R. J. Quinn, J. Nat. Prod., 2012,
75, 1001–1005, DOI: 10.1021/np300147d.
627 M. S. Buchanan, A. R. Carroll, G. A. Fechner, A. Boyle,
M. M. Simpson, R. Addepalli, V. M. Avery, J. N. A. Hooper,
N. Su, H. Chen and R. J. Quinn, Bioorg. Med. Chem. Lett.,
2007, 17, 6860–6863, DOI: 10.1016/j.bmcl.2007.10.021.
628 R. A. Davis, D. Vullo, C. T. Supuran and S.-A. Poulsen,
BioMed Res. Int., 2014, 2014, 374079, DOI: 10.1155/2014/
374079.
629 R. Kazlauskas, P. T. Murphy, R. J. Quinn and R. J. Wells,
Tetrahedron Lett., 1976, 2631–2634, DOI: 10.1016/s0040-
4039(00)91753-2.
630 C. Cassiano, R. Esposito, A. Tosco, A. Zampella,
M. V. D'Auria, R. Riccio, A. Casapullo and M. C. Monti,
Chem. Commun., 2014, 50, 406–408, DOI: 10.1039/
C3CC45454A.
631 S. Urban and R. J. Capon, Lipids, 1997, 32, 675–677, DOI:
10.1007/s11745-997-0086-0.
632 A. M. Langseter, Y. Stenstrøm and L. Skattebøl, Molecules,
2014, 19, 3804–3812, DOI: 10.3390/molecules19033804.
633 K. Watanabe, Y. Tsuda, Y. Yamane, K. Takahashi, K. Iguchi,
H. Naoki and T. Fujita, Tennen Yuki Kagobutsu Toronkai
Koen Yoshishu, 2000, 42, 367–372.This journal is © The Royal Society of Chemistry 2016634 N. G. Shallu, G. L. Kad and J. Singh, Nat. Prod. Res., 2014,
28, 424–430, DOI: 10.1080/14786419.2013.867855.
635 S. Sirirath, J. Tanaka, I. I. Ohtani, T. Ichiba, R. Rachmat,
K. Ueda, T. Usui, H. Osada and T. Higa, J. Nat. Prod.,
2002, 65, 1820–1823, DOI: 10.1021/np0200865.
636 K. M. Reddy, J. Shashidhar and S. Ghosh, Org. Biomol.
Chem., 2014, 12, 4002–4012, DOI: 10.1039/c4ob00250d.
637 K. W. L. Yong, J. D. de Voss, J. N. A. Hooper and
M. J. Garson, J. Nat. Prod., 2011, 74, 194–207, DOI:
10.1021/np100620x.
638 H. Sugimura, S. Sato, K. Tokudome and T. Yamada, Org.
Lett., 2014, 16, 3384–3387, DOI: 10.1021/ol501446w.
639 Y. Chen, K. B. Killday, P. J. McCarthy, R. Schmoler,
K. Chilson, C. Selitrennikoﬀ, S. A. Pomponi and
A. E. Wright, J. Nat. Prod., 2001, 64, 262–264, DOI:
10.1021/np000368.
640 C. Jimenez-Romero, I. Ortiz, J. Vicente, B. Vera,
A. D. Rodriguez, S. Nam and R. Jove, J. Nat. Prod., 2010,
73, 1694–1700, DOI: 10.1021/np100461t.
641 X.-Y. Tian, J.-W. Han, Q. Zhao and H. N. C. Wong, Org.
Biomol. Chem., 2014, 12, 3686–3700, DOI: 10.1039/
c4ob00448e.
642 C. Festa, S. De Marino, M. V. D'Auria, E. Deharo,
G. Gonzalez, C. Deyssard, S. Petek, G. Bifulco and
A. Zampella, Tetrahedron, 2012, 68, 10157–10163, DOI:
10.1016/j.tet.2012.09.106.
643 C. M. Rasik and M. K. Brown, Angew. Chem., Int. Ed., 2014,
53, 14522–14526, DOI: 10.1002/anie.201408055.
644 A. Bishara, A. Rudi, M. Aknin, D. Neumann, N. Ben-Califa
and Y. Kashman, Org. Lett., 2008, 10, 4307–4309, DOI:
10.1021/ol801750y.
645 J. N. deGruyter and W. A. Maio, Org. Lett., 2014, 16, 5196–
5199, DOI: 10.1021/ol5025585.
646 Y. J. Feng, A. R. Carroll, D. M. Pass, J. K. Archbold,
V. M. Avery and R. J. Quinn, J. Nat. Prod., 2008, 71, 8–11,
DOI: 10.1021/np070094r.
647 G. Santhakumar and R. J. Payne, Org. Lett., 2014, 16, 4500–
4503, DOI: 10.1021/ol502045u.
648 M. V. D'Auria, V. Sepe, R. D'Orsi, F. Bellotta, C. Debitus and
A. Zampella, Tetrahedron, 2007, 63, 131–140, DOI: 10.1016/
j.tet.2006.10.032.
649 M. Kikuchi and H. Konno, Org. Lett., 2014, 16, 4324–4327,
DOI: 10.1021/ol5020619.
650 X. Luo, F. Li, J. Hong, C.-O. Lee, C. J. Sim, K. S. Im and
J. H. Jung, J. Nat. Prod., 2006, 69, 567–571, DOI: 10.1021/
np0503552.
651 R. Towada and S. Kuwahara, Tetrahedron, 2014, 70, 3774–
3781, DOI: 10.1016/j.tet.2014.04.040.
652 Y. Naka, T. Maki and S. Matsunaga, Tennen Yuki Kagobutsu
Toronkai Koen Yoshishu, 2000, 42, 19–24.
653 Y. Gao, Q. Shan, J. Liu, L. Wang and Y. Du, Org. Biomol.
Chem., 2014, 12, 2071–2079, DOI: 10.1039/c3ob42364f.
654 H. Sorek, A. Rudi, M. Aknin, E. M. Gaydou and Y. Kashman,
J. Nat. Prod., 2010, 73, 456–458, DOI: 10.1021/np900500c.
655 M. Amat, G. Guignard, N. Llor and J. Bosch, J. Org. Chem.,
2014, 79, 2792–2802, DOI: 10.1021/jo5002627.Nat. Prod. Rep., 2016, 33, 382–431 | 423





























































































View Article Online656 T. Kubota, T. Nishi, E. Fukushi, J. Kawabata, J. Fromont and
J. Kobayashi, Tetrahedron Lett., 2007, 48, 4983–4985, DOI:
10.1016/j.tetlet.2007.05.121.
657 S. G. Davies, A. M. Fletcher, P. M. Roberts, R. S. Shah,
A. L. Thompson and J. E. Thomson, Org. Lett., 2014, 16,
1354–1357, DOI: 10.1021/ol500096r.
658 R. A. Davis, S. Duﬀy, S. Fletcher, V. M. Avery and R. J. Quinn,
J. Org. Chem., 2013, 78, 9608–9613, DOI: 10.1021/jo400988y.
659 R. H. Pouwer, S. M. Deydier, P. V. Le, B. D. Schwartz,
N. C. Franken, R. A. Davis, S. A. Charman, M. D. Edstein,
T. S. Skinner-Adams, K. T. Andrews, I. D. Jenkins and
R. J. Quinn, ACS Med. Chem. Lett., 2014, 5, 178–182, DOI:
10.1021/ml400447v.
660 M. Kuramoto, N. Miyake, Y. Ishimaru, N. Ono and H. Uno,
Org. Lett., 2008, 10, 5465–5468, DOI: 10.1021/ol802263j.
661 M. Iwata, K. Kanoh, T. Imaoka and K. Nagasawa, Chem.
Commun., 2014, 50, 6991–6994, DOI: 10.1039/c4cc00137k.
662 F. A. Khan, S. Ahmad, N. Kodipelli, G. Shivange and
R. Anindya, Org. Biomol. Chem., 2014, 12, 3847–3865, DOI:
10.1039/c3ob42537a.
663 C. Pieri, D. Borselli, C. Di Giorgio, M. De Me´o, J.-M. Bolla,
N. Vidal, S. Combes and J. M. Brunel, J. Med. Chem.,
2014, 57, 4263–4272, DOI: 10.1021/jm500194e.
664 N. Fusetani, Y. Masuda, Y. Nakao and S. Matsunaga,
Tetrahedron, 2001, 57, 7507–7511, DOI: 10.1016/S0040-
4020(01)00735-9.
665 I. Mancini, G. Guella, P. Laboute, C. Debitus and F. Pietra, J.
Chem. Soc., Perkin Trans. 1, 1993, 3121–3125, DOI: 10.1039/
p19930003121.
666 H. Kubo, K. Matsui, T. Saitoh and S. Nishiyama,
Tetrahedron, 2014, 70, 6392–6397, DOI: 10.1016/
j.tet.2014.07.049.
667 P. A. Searle and T. F. Molinski, J. Org. Chem., 1995, 60,
4296–4298, DOI: 10.1021/jo00118a059.
668 H. Ding, W. Li, Z. Ruan, R. Yang, Z. Mao, Q. Xiao and J. Wu,
Beilstein J. Org. Chem., 2014, 10, 1681–1685, DOI: 10.1002/
ejoc.201403091.
669 Z. V. Peitsinis, D. A. Melidou, J. G. Stefanakis, H. Evgenidou
and A. E. Koumbis, Eur. J. Org. Chem., 2014, 2014, 8160–
8166, DOI: 10.3762/bjoc.10.176.
670 R. Kazlauskas, P. T. Murphy, R. G. Warren, R. J. Wells and
J. F. Blount, Aust. J. Chem., 1978, 31, 2685–2697, DOI:
10.1071/ch9782685.
671 A. Ferna´ndez, E. Alvarez, R. Alvarez-Manzaneda,
R. Chahboun and E. Alvarez-Manzaneda, Chem. Commun.,
2014, 50, 13100–13102, DOI: 10.1039/c4cc05116e.
672 S. Urban and R. J. Capon, Aust. J. Chem., 1996, 49, 611–615,
DOI: 10.1071/ch9960611.
673 M. Go¨hl and K. Seifert, Eur. J. Org. Chem., 2014, 2014, 6975–
6982, DOI: 10.1002/ejoc.201402873.
674 R. M. Rosser and D. J. Faulkner, J. Org. Chem., 1984, 49,
5157–5160, DOI: 10.1021/jo00200a029.
675 M. Gans and F. Bracher, Tetrahedron, 2014, 70, 1084–1090,
DOI: 10.1016/j.tet.2013.11.065.
676 R. A. Keyzers, J. Daoust, M. T. Davies-Coleman, R. Van
Soest, A. Balgi, E. Donohue, M. Roberge and424 | Nat. Prod. Rep., 2016, 33, 382–431R. J. Andersen, Org. Lett., 2008, 10, 2959–2962, DOI:
10.1021/ol800937u.
677 S.-S. Wang, Y. Shi and W.-S. Tian, Org. Lett., 2014, 16, 2177–
2179, DOI: 10.1021/ol500727c.
678 S. J. Robinson, E. K. Hoobler, M. Riener, S. T. Loveridge,
K. Tenney, F. A. Valeriote, T. R. Holman and P. Crews, J.
Nat. Prod., 2009, 72, 1857–1863, DOI: 10.1021/np900465e.
679 E. Boulifa, A. Ferna´ndez, E. Alvarez, R. Alvarez-Manzaneda,
A. I. Mansour, R. Chahboun and E. Alvarez-Manzaneda, J.
Org. Chem., 2014, 79, 10689–10695, DOI: 10.1021/
jo502048y.
680 M. Tsoukatou, H. Siapi, C. Vagias and V. Roussis, J. Nat.
Prod., 2003, 66, 444–446, DOI: 10.1021/np020471u.
681 T. Tonoi, K. Mameda, M. Fujishiro and Y. Yoshinaga,
Beilstein J. Org. Chem., 2014, 10, 2421–2427, DOI: 10.3762/
bjoc.10.252.
682 D. L. Dixson, D. Abrego and M. E. Hay, Science, 2014, 345,
892–897, DOI: 10.1126/science.1255057.
683 C. Gao, L. Lin, B. Long, Y. Chen, B. He, H. Sun and
R. Huang, Nat. Prod. Res., 2014, 28, 473–476, DOI:
10.1080/14786419.2013.879134.
684 Z.-H. Sun, Y.-H. Cai, C.-Q. Fan, G.-H. Tang, H.-B. Luo and
S. Yin, Mar. Drugs, 2014, 12, 672–681, DOI: 10.3390/
md12020672.
685 C. Audoin, V. Cocandeau, O. Thomas, A. Bruschini,
S. Holderith and G. Genta-Jouve, Metabolites, 2014, 4,
421–432, DOI: 10.3390/metabo4020421.
686 F. Cen-Pacheco, M. Norte, J. J. Ferna´ndez and
A. H. Daranas, Org. Lett., 2014, 16, 2880–2883, DOI:
10.1021/ol500860v.
687 F. Cen-Pacheco, M. Mart´ın, J. Ferna´ndez and A. H. Daranas,
Mar. Drugs, 2014, 12, 5188–5196, DOI: 10.3390/
md12105188.
688 Y.-B. Cheng, C.-C. Lan, W.-C. Liu, W.-C. Lai, Y.-C. Tsai,
M. Y. Chiang, Y.-C. Wu and F.-R. Chang, Tetrahedron
Lett., 2014, 55, 5369–5372, DOI: 10.1016/
j.tetlet.2014.07.101.
689 P. Ciminiello, C. Dell'Aversano, E. D. Iacovo, M. Forino,
L. Tartaglione, M. Pelin, S. Sosa, A. Tubaro, O. Chaloin,
M. Poli and G. Bignami, J. Nat. Prod., 2014, 77, 351–357,
DOI: 10.1021/np4009514.
690 P. Ciminiello, Chem. Res. Toxicol., 2009, 22, 1851–1859,
DOI: 10.1021/tx900259v.
691 P. Ciminiello, C. Dell'Aversano, E. D. Iacovo, M. Forino,
A. Randazzo and L. Tartaglione, J. Org. Chem., 2014, 79,
72–79, DOI: 10.1021/jo4022953.
692 J. Zhang, Y. Liang, X.-J. Liao, Z. Deng and S.-H. Xu, Nat.
Prod. Res., 2014, 28, 150–155, DOI: 10.1080/
14786419.2013.857668.
693 B. Yang, X. Wei, J. Huang, X. Lin, J. Liu, S. Liao, J. Wang,
X. Zhou, L. Wang and Y. Liu, Mar. Drugs, 2014, 12, 5316–
5327, DOI: 10.3390/md12105316.
694 J. Zhang, Y. Liang, L.-C. Li and S.-H. Xu, Helv. Chim. Acta,
2014, 97, 128–136, DOI: 10.1002/hlca.201300296.
695 P. Georgantea, E. Ioannou, C. Vagias and V. Roussis,
Phytochem. Lett., 2014, 8, 86–91, DOI: 10.1016/
j.phytol.2014.02.006.This journal is © The Royal Society of Chemistry 2016





























































































View Article Online696 H.-M. Chung, W.-H. Wang, T.-L. Hwang, J.-J. Chen,
L.-S. Fang, Z.-H. Wen, Y.-B. Wang, Y.-C. Wu and
P.-J. Sung, Int. J. Mol. Sci., 2014, 15, 15679–15688, DOI:
10.3390/ijms150915679.
697 H.-M. Chung, W.-H. Wang, T.-L. Hwang, L.-S. Fang,
Z.-H. Wen, J.-J. Chen, Y.-C. Wu and P.-J. Sung, Mar. Drugs,
2014, 12, 5856–5863, DOI: 10.3390/md12125856.
698 H.-M. Chung, W.-H. Wang, T.-L. Hwang, J.-J. Li, L.-S. Fang,
Y.-C. Wu and P.-J. Sung, Molecules, 2014, 19, 12320–12327,
DOI: 10.3390/molecules190812320.
699 Y.-J. Xio, J.-H. Su, Y.-J. Tseng, B.-W. Chen, W. Liu and
J.-H. Sheu, Mar. Drugs, 2014, 12, 4495–4503, DOI: 10.3390/
md12084495.
700 M. Chen, L. Han, Y. Wang, X.-L. Zhang and C.-Y. Wang, Nat.
Prod. Res., 2014, 28, 1147–1151, DOI: 10.1080/
14786419.2014.918122.
701 S.-Y. Cheng, N.-L. Shih, K.-Y. Hou, M.-J. Ger, C.-N. Yang,
S.-K. Wang and C.-Y. Duh, Bioorg. Med. Chem. Lett., 2014,
24, 473–475, DOI: 10.1016/j.bmcl.2013.12.037.
702 J. L. von Salm, N. G. Wilson, B. A. Vesely, D. E. Kyle, J. Cuce
and B. J. Baker, Org. Lett., 2014, 16, 2630–2633, DOI:
10.1021/ol500792x.
703 E. S. Elkhayat, S. R. M. Ibrahim, M. A. Fouad and
G. A. Mohamed, Tetrahedron, 2014, 70, 3822–3825, DOI:
10.1016/j.tet.2014.03.056.
704 S. Rajaram, D. Ramesh, U. Ramulu, M. Anjum, P. Kumar,
U. S. N. Murthy, M. Altaf Hussain, G. Narahari Sastry and
Y. Venkateswarlu, Indian J. Chem., Sect. B: Org. Chem. Incl.
Med. Chem., 2014, 53, 1086–1090, URL: http://
nopr.niscair.res.in/handle/123456789/29262.
705 L. Xue, P.-L. Li, Z. Liang, X.-L. Tang and G.-Q. Li, Biochem.
Syst. Ecol., 2014, 57, 48–51, DOI: 10.1016/j.bse.2014.06.010.
706 J.-J. Zheng, C.-L. Shao, M. Chen, L.-S. Gan, Y.-C. Fang,
X.-H. Wang and C.-Y. Wang, Mar. Drugs, 2014, 12, 1569–
1579, DOI: 10.3390/md12031569.
707 S. Gaisser, L. Kellenberger, A. L. Kaja, A. J. Weston,
R. E. Lill, G. Wirtz, S. G. Kendrew, L. Low,
R. M. Sheridan, B. Wilkinson, I. S. Galloway, K. Stutzman-
Engwall, H. A. I. McArthur, J. Staunton and P. F. Leadlay,
Org. Biomol. Chem., 2003, 1, 2840–2847, DOI: 10.1039/
b304022d.
708 C. Gao, Y. Wang, Y. Chen, B. He, R. Zhang, M. Xu and
R. Huang, Chem. Biodiversity, 2014, 11, 812–818, DOI:
10.1002/cbdv.201300265.
709 S.-Y. Cheng, S.-K. Wang and C.-Y. Duh, Mar. Drugs, 2014,
12, 6028–6037, DOI: 10.3390/md12126028.
710 S.-Y. Cheng, N.-L. Shih, C.-T. Chuang, S.-F. Chiou,
C.-N. Yang, S.-K. Wang and C.-Y. Duh, Bioorg. Med. Chem.
Lett., 2014, 24, 1562–1564, DOI: 10.1016/
j.bmcl.2014.01.073.
711 N. P. Thao, B. T. T. Luyen, N. T. T. Ngan, S. B. Song,
N. X. Cuong, N. H. Nam, P. V. Kiem, Y. H. Kim and
C. V. Minh, Bioorg. Med. Chem. Lett., 2014, 24, 228–232,
DOI: 10.1016/j.bmcl.2013.11.033.
712 J. Figueroa, B. Vera and A. D. Rodr´ıguez, Helv. Chim. Acta,
2014, 97, 712–721, DOI: 10.1002/hlca.201300282.This journal is © The Royal Society of Chemistry 2016713 W.-Y. Lin, B.-W. Chen, C.-Y. Huang, Z.-H. Wen, P.-J. Sung,
J.-H. Su, C.-F. Dai and J.-H. She, Mar. Drugs, 2014, 12,
840–850, DOI: 10.3390/md12020840.
714 S. S. Al-Lihaibi, W. M. Alarif, A. Abdel-Lateﬀ, S.-E. N. Ayyad,
A. B. Abdel-Naim, F. F. El-Senduny and F. A. Badria, Eur. J.
Med. Chem., 2014, 81, 314–322, DOI: 10.1016/
j.ejmech.2014.05.016.
715 A. Elkhateeb, A. A. El-Beih, A. M. Gamal-Eldeen,
M. A. Alhammady, S. Ohta, P. W. Pare´ and
M.-E. F. Hegazy, Mar. Drugs, 2014, 12, 1977–1986, DOI:
10.3390/md12041977.
716 Z.-B. Cheng, Q. Liao, Y. Chen, C.-Q. Fan, Z.-Y. Huang,
X.-J. Xu and S. Yin, Magn. Reson. Chem., 2014, 52, 515–
520, DOI: 10.1002/mrc.4108.
717 N. A. Eltahawy, A. K. Ibrahim, M. M. Radwan, M. A. El-
Sohly, H. A. Hassanean and S. A. Ahmed, Tetrahedron
Lett., 2014, 55, 3984–3988, DOI: 10.1016/
j.tetlet.2014.05.013.
718 L.-F. Lei, M.-F. Chen, T. Wang, X.-X. He, B.-X. Liu, Y. Deng,
X.-J. Chen, Y.-T. Li, S.-Y. Guan, J.-H. Yao, W. Li, W.-C. Ye,
D.-M. Zhang and C.-X. Zhang, Tetrahedron, 2014, 70,
6851–6858, DOI: 10.1016/j.tet.2014.07.042.
719 Y.-J. Tseng, Y.-C. Yang, S.-K. Wang and C.-Y. Duh, Mar.
Drugs, 2014, 12, 3371–3380, DOI: 10.3390/md12063371.
720 K.-E. Lillsunde, C. Festa, H. Adel, S. de Marino,
V. Lombardi, S. Tilvi, D. Nawrot, A. Zampella, L. D'Souza,
M. D'Auria and P. Tammela, Mar. Drugs, 2014, 12, 4045–
4068, DOI: 10.3390/md12074045.
721 K.-H. Lin, Y.-J. Tseng, B.-W. Chen, T.-L. Hwang, H.-Y. Chen,
C.-F. Dai and J.-H. Sheu, Org. Lett., 2014, 16, 1314–1317,
DOI: 10.1021/ol403723b.
722 K.-H. Chen, C.-F. Dai, T.-L. Hwang, C.-Y. Chen, J.-J. Li,
J.-J. Chen, Y.-C. Wu, J.-H. Sheu, W.-H. Wang and
P.-J. Sung, Mar. Drugs, 2014, 12, 385–393, DOI: 10.3390/
md12010385.
723 A. Bahl, S. M. Jachak, K. Palaniveloo, T. Ramachandram,
C. S. Vairappan and H. K. Chopra, Nat. Prod. Commun.,
2014, 9, 1139–1180.
724 M.-P. La, J. Li, C. Li, H. Tang, B.-S. Liu, P. Sun, C.-L. Zhuang,
T.-J. Li and W. Zhang, Mar. Drugs, 2014, 12, 6178–6189,
DOI: 10.3390/md12126178.
725 Y.-D. Su, C.-H. Cheng, W.-F. Chen, Y.-C. Chang, Y.-H. Chen,
T.-L. Hwang, Z.-H. Wen, W.-H. Wang, L.-S. Fang, J.-J. Chen,
Y.-C. Wu, J.-H. Sheu and P.-J. Sung, Tetrahedron Lett., 2014,
55, 6065–6067, DOI: 10.1016/j.tetlet.2014.09.032.
726 W. Zhou, J. Li, H.-C. E, B.-S. Liu, H. Tang, W. H. Gerwick,
H.-M. Hua and W. Zhang, Mar. Drugs, 2014, 12, 589–600,
DOI: 10.3390/md12020589.
727 H. Lei, J.-F. Sun, Z. Han, X.-F. Zhou, B. Yang and Y. Liu, RSC
Adv., 2014, 4, 5261–5271, DOI: 10.1039/c3ra46163g.
728 Y.-M. Zhou, C.-L. Shao, H. Huang, X.-L. Zhang and
C.-Y. Wang, Nat. Prod. Res., 2014, 28, 7–11, DOI: 10.1080/
14786419.2013.827191.
729 C.-C. Liaw, Y.-B. Cheng, Y.-S. Lin, Y.-H. Kuo, T.-L. Hwang
and Y.-C. Shen, Mar. Drugs, 2014, 12, 4677–4692, DOI:
10.3390/md12084677.Nat. Prod. Rep., 2016, 33, 382–431 | 425





























































































View Article Online730 C.-H. Gao, B.-J. He, Y.-N. Chen, K. Ke, L. Lin, B. Long and
R.-M. Huang, Z. Naturforsch., B: J. Chem. Sci., 2014, 69,
116–120, DOI: 10.5560/znb.2014-3213.
731 Y.-M. Zhou, M. Chen, X.-M. Fu, Y.-C. Fang and C.-Y. Wang,
Nat. Prod. Res., 2014, 28, 1176–1181, DOI: 10.1080/
14786419.2014.923423.
732 T.-H. Chen, C.-H. Cheng, Y.-H. Chen, M.-C. Lu, L.-S. Fang,
W.-F. Chen, Z.-H. Wen, W.-H. Wang, Y.-C. Wu and
P.-J. Sung, Nat. Prod. Commun., 2014, 9, 613–617.
733 F.-Y. Chang, F.-J. Hsu, C.-J. Tai, W.-C. Wei, N.-S. Yang and
J.-H. Sheu, Mar. Drugs, 2014, 12, 3060–3071, DOI: 10.3390/
md12053060.
734 T.-H. Chen, W.-F. Chen, Z.-H. Wen, M.-C. Lu, W.-H. Wang,
J.-J. Li, Y.-C. Wu and P.-J. Sung, Mar. Drugs, 2014, 12, 2144–
2155, DOI: 10.3390/md12042144.
735 Y.-N. Lee, C.-J. Tai, T.-L. Hwang and J.-H. Sheu, Mar. Drugs,
2014, 12, 1148–1156, DOI: 10.3390/md12021148.
736 C.-J. Tai, U. Chokkalingam, Y. Cheng, S.-P. Shih, M.-C. Lu,
J.-H. Su, T.-L. Hwang and J.-H. Sheu, Int. J. Mol. Sci., 2014,
15, 21865–21874, DOI: 10.3390/ijms151221865.
737 T.-Z. Huang, B.-W. Chen, C.-Y. Huang, T.-L. Hwang,
C.-F. Dai and J.-H. Sheu, Mar. Drugs, 2014, 12, 2446–2457,
DOI: 10.3390/md12052446.
738 M. C. Lin, B. W. Chen, C. Y. Huang, C. F. Dai, T. L. Hwang
and J. H. Sheu, J. Nat. Prod., 2013, 76, 1661–1667, DOI:
10.1021/np400372v.
739 P. K. Roy, M. C. Roy, J. Taira and K. Ueda, Tetrahedron Lett.,
2014, 55, 1421–1423, DOI: 10.1016/j.tetlet.2014.01.035.
740 E. H. Andrianasolo, L. Haramaty, E. White, R. Lutz and
P. Falkowski, Mar. Drugs, 2014, 12, 1102–1115, DOI:
10.3390/md12021102.
741 Y.-C. Lin, S.-S. Wang, C.-H. Chen, Y.-H. Kuo and Y.-C. Shen,
Mar. Drugs, 2014, 12, 3477–3486, DOI: 10.3390/
md12063477.
742 L.-F. Liang, T. Kurta´n, A. Ma´ndi, L.-X. Gao, J. Li, W. Zhang
and Y.-W. Guo, Eur. J. Org. Chem., 2014, 2014, 1841–1847,
DOI: 10.1002/ejoc.201301683.
743 M. Zhang, K. Long, K. Ma, X. Huang and H. Wu, J. Nat.
Prod., 1995, 58, 414–418, DOI: 10.1021/np50117a010.
744 Z.-B. Cheng, Y.-L. Deng, C.-Q. Fan, Q.-H. Han, S.-L. Lin,
G.-H. Tang, H.-B. Luo and S. Yin, J. Nat. Prod., 2014, 77,
1928–1936, DOI: 10.1021/np500394d.
745 C.-Y. Kuo, Y.-S. Juan, M.-C. Lu, M. Chiang, C.-F. Dai,
Y.-C. Wu and P.-J. Sung, Int. J. Mol. Sci., 2014, 15, 10136–
10149, DOI: 10.3390/ijms150610136.
746 M. Liu, C.-L. Shao, M. Chen, J. Qi, Y. Wang, Y.-C. Fang and
C.-Y. Wang, Chem. Biodiversity, 2014, 11, 1109–1120, DOI:
10.1002/cbdv.201400021.
747 W.-T. Chen, H.-L. Liu, L.-G. Yao and Y.-W. Guo, Steroids,
2014, 92, 56–61, DOI: 10.1016/j.steroids.2014.08.027.
748 F. Cao, C.-L. Shao, Y. Wang, K.-X. Xu, X. Qi and C.-Y. Wang,
Helv. Chim. Acta, 2014, 97, 900–908, DOI: 10.1002/
hlca.201300397.
749 F. Cao, C.-L. Shao, M. Chen, M.-Q. Zhang, K.-X. Xu, H. Meng
and C.-Y. Wang, J. Nat. Prod., 2014, 77, 1488–1493, DOI:
10.1021/np500252q.426 | Nat. Prod. Rep., 2016, 33, 382–431750 N. P. Thao, B. T. T. Luyen, Y. N. Sun, S. B. Song, N. V. Thanh,
N. X. Cuong, N. H. Nam, P. V. Kiem, Y. H. Kim and
C. V. Minh, Bioorg. Med. Chem. Lett., 2014, 24, 2834–2838,
DOI: 10.1016/j.bmcl.2014.04.103.
751 R. Xu, M.-H. Jin, Y. Jiao, G.-S. Xing, W.-J. Zhao, C. Zhao,
H.-Q. Duan and S.-A. Tang, J. Asian Nat. Prod. Res., 2014,
16, 351–357, DOI: 10.1080/10286020.2013.879469.
752 M. Moritz, L. Marostica, E´. Bianco, M. Almeida, J. Carraro,
G. Cabrera, J. Palermo, C. Simo˜es and E. Schenkel, Mar.
Drugs, 2014, 12, 5864–5880, DOI: 10.3390/md12125864.
753 J. Zhang, Y. Liang, K.-L. Wang, X.-J. Liao, Z. Deng and
S.-H. Xu, Steroids, 2014, 79, 1–6, DOI: 10.1016/
j.steroids.2013.10.007.
754 S. Yu, X. Ye, L. Chen, X.-Y. Lian and Z. Zhang, Steroids,
2014, 88, 19–25, DOI: 10.1016/j.steroids.2014.06.013.
755 V. Junior, F. Zara, S. Marangoni, D. de Toyama, A. J. de
Souza, S. C. de Oliveira and M. Toyama, J. Venomous
Anim. Toxins Incl. Trop. Dis., 2014, 20, 10, DOI: 10.1186/
1678-9199-20-10.
756 A. A. Rodr´ıguez, E. Salceda, A. G. Garateix, A. J. Zaharenko,
S. Peigneur, O. Lo´pez, T. Pons, M. Richardson, M. D´ıaz,
Y. Herna´ndez, L. Sta¨ndker, J. Tytgat and E. Soto, Peptides,
2014, 53, 3–12, DOI: 10.1016/j.peptides.2013.06.003.
757 M. G. Barzilai, R. Kahn, N. Regev, D. Gordon, Y. Moran and
M. Gurevitz, Biochem. J., 2014, 463, 271–277, DOI: 10.1042/
BJ20140576.
758 N. Nesher, E. Zlotkin and B. Hochner, Biochem. J., 2014,
461, 51–59, DOI: 10.1042/BJ20131454.
759 V. Antonini, V. Pe´rez-Barzaga, S. Bampi, D. Pento´n,
D. Mart´ınez, M. D. Serra and M. Tejuca, PLoS One, 2014,
9, e110824, DOI: 10.1371/journal.pone.0110824.
760 L. Leo´n, E. A. Lissi, G. Celedo´n, G. Gonzalez, F. Pazos,
C. Alvarez and M. E. Lanio, Protein J., 2014, 33, 493–501,
DOI: 10.1007/s10930-014-9582-x.
761 L. L. Pedrera, M. L. Fanani, U. Ros, M. E. Lanio, B. Maggio
and C. A´lvarez, Biochim. Biophys. Acta, Biomembr., 2014,
1838, 1752–1759, DOI: 10.1016/j.bbamem.2014.03.011.
762 W. E. Houssen and M. Jaspars, J. Nat. Prod., 2005, 68, 453–
455, DOI: 10.1021/np049666n.
763 S. S. More, A. Raghunadh, R. Shankar, N. B. Patel,
D. S. Bhalerao and U. K. S. Kumar, Helv. Chim. Acta, 2014,
97, 403–413, DOI: 10.1002/hlca.201300318.
764 T. Iwagawa, M. Miyazaki, H. Okamura, M. Nakatani, M. Doe
and K. Takemura, Tetrahedron Lett., 2003, 44, 2533–2535,
DOI: 10.1016/S0040-4039(03)00331-9.
765 A. Skiredj, M. A. Beniddir, D. Joseph, K. Leblanc,
G. Bernadat, L. Evanno and E. Poupon, Org. Lett., 2014,
16, 4980–4983, DOI: 10.1021/ol502177m.
766 F. J. Schmitz, E. D. Lorance and L. S. Ciereszko, J. Org.
Chem., 1969, 34, 1989–1990, DOI: 10.1021/jo01258a110.
767 S. J. Gharpure, L. N. Nanda and M. K. Shukla, Org. Lett.,
2014, 16, 6424–6427, DOI: 10.1021/ol503246k.
768 A. D. Rodr´ıguez, C. Ramı´rez and I. I. Rodr´ıguez, Tetrahedron
Lett., 1999, 43, 7627–7631, DOI: 10.1016/S0040-4039(99)
01559-2.This journal is © The Royal Society of Chemistry 2016





























































































View Article Online769 A. D. Rodriguez, C. Ramirez, V. Medina and Y. P. Shi,
Tetrahedron Lett., 2000, 41, 5177–5180, DOI: 10.1016/
S0040-4039(00)00767-X.
770 I. I. Rodr´ıguez, A. D. Rodr´ıguez, Y. Wang and
S. G. Franzblau, Tetrahedron Lett., 2006, 47, 3229–3232,
DOI: 10.1016/j.tetlet.2006.03.048.
771 I. T. Chen, I. Baitinger, L. Schreyer and D. Trauner, Org.
Lett., 2014, 16, 166–169, DOI: 10.1021/ol403156r.
772 D. R. Williams and A. A. Shah, J. Am. Chem. Soc., 2014,
8829–8836, DOI: 10.1021/ja5043462.
773 A. D. Rodriguez and J. G. Shi, J. Org. Chem., 1998, 63, 420–
421, DOI: 10.1021/jo971884g.
774 J. Marrero, A. D. Rodriguez and C. L. Barnes, Org. Lett.,
2005, 7, 1877–1880, DOI: 10.1021/ol0505961.
775 D. Stichnoth, P. Ko¨lle, T. J. Kimbrough, E. Riedle, R. de
Vivie-Riedle and D. Trauner, Nat. Commun., 2014, 5, 5597,
DOI: 10.1038/ncomms6597.
776 N. Toelle, H. Weinstabl, T. Gaich and J. Mulzer, Angew.
Chem., Int. Ed., 2014, 53, 3859–3862, DOI: 10.1002/
anie.201400617.
777 M. Alam and P. Sharama, J. Org. Chem., 1989, 54, 1896–
1900, DOI: 10.1021/jo00269a027.
778 D. Friedrich and L. A. Paquette, J. Nat. Prod., 2002, 65, 126–
130, DOI: 10.1021/np0103822.
779 J. S. Clark, L. Delion and L. J. Farrugia, Org. Lett., 2014, 16,
4300–4303, DOI: 10.1021/ol5020152.
780 G. Yue, Y. Zhang, L. Fang, C.-c. Li, T. Luo and Z. Yang,
Angew. Chem., Int. Ed., 2014, 53, 1837–1840, DOI: 10.1002/
anie.201309449.
781 T. Higa, J. Tanaka, Y. Tsukitani and H. Kikuchi, Chem. Lett.,
1981, 1647–1650, DOI: 10.1246/cl.1981.1647.
782 R. Somaiah, K. Ravindar, R. Cencic, J. Pelletier and
P. Deslongchamps, J. Med. Chem., 2014, 57, 2511–2523,
DOI: 10.1021/jm401799j.
783 N. Thao, J. No, B. Luyen, G. Yang, S. Byun, J. Goo, K. Kim,
N. Cuong, N. Nam, C. V. Minh, T. Schmidt, J. Kang and
Y. Kim, Molecules, 2014, 19, 7869–7880, DOI: 10.3390/
molecules1906786.
784 N. P. Thao, N. H. Nam, N. X. Cuong, B. T. T. Luyen,
B. H. Tai, J. E. Kim, S. B. Song, P. V. Kiem, C. V. Minh
and Y. H. Kim, Arch. Pharmacal Res., 2014, 37, 706–712,
DOI: 10.1007/s12272-013-0230-3.
785 R. G. Kerr, S. Brophy and D. J. Derksen, Bioorg. Med. Chem.
Lett., 2014, 24, 4804–4806, DOI: 10.1016/
j.bmcl.2014.09.008.
786 A. Pardo-Vargas, F. A. Ramos, C. C. Cirne-Santos,
P. R. Stephens, I. C. P. Paixa˜o, V. L. Teixeira and
L. Castellanos, Bioorg. Med. Chem. Lett., 2014, 24, 4381–
4383, DOI: 10.1016/j.bmcl.2014.08.019.
787 V. Sepe, F. D. Leva, C. D'Amore, C. Festa, S. De Marino,
B. Renga, M. D'Auria, E. Novellino, V. Limongelli,
L. D'Souza, M. Majik, A. Zampella and S. Fiorucci, Mar.
Drugs, 2014, 12, 3091–3115, DOI: 10.3390/md12063091.
788 R. Kazlauskas, P. T. Murphy and R. J. Wells, Aust. J. Chem.,
1978, 31, 1817–1824, DOI: 10.1071/ch9781817.
789 N.-F. Chen, S.-Y. Huang, C.-H. Lu, C.-L. Chen, C.-W. Feng,
C.-H. Chen, H.-C. Hung, Y.-Y. Lin, P.-J. Sung, C.-S. Sung,This journal is © The Royal Society of Chemistry 2016S.-N. Yang, H.-M. Wang, Y.-C. Chang, J.-H. Sheu,
W.-F. Chen and Z.-H. Wen, Mar. Drugs, 2014, 12, 3792–
3817, DOI: 10.3390/md12073792.
790 J.-J. Lin, J.-H. Su, C.-C. Tsai, Y.-J. Chen, M.-H. Liao and
Y.-J. Wu, Mar. Drugs, 2014, 12, 4783–4798, DOI: 10.3390/
md12094783.
791 C.-C. Su, J. Chen, Z.-H. Din, J.-H. Su, Z.-Y. Yang, Y.-J. Chen,
R. Wang and Y.-J. Wu, Mar. Drugs, 2014, 12, 5295–5315,
DOI: 10.3390/md12105295.
792 P. T. Szymanski, S. A. Ahmed, M. M. Radwan, S. I. Khalifa
and H. Fahmy, Nat. Prod. Commun., 2014, 9, 151–154.
793 P. T. Szymanski, S. A. Ahmed, M. M. Radwan, S. I. Khalifa
and H. Fahmy, Nat. Prod. Commun., 2014, 9, 1143–1146.
794 L. P. Patin˜o, C. Muniain, M. E. Knott, L. Puricelli and
J. A. Palermo, J. Nat. Prod., 2014, 77, 1170–1178, DOI:
10.1021/np500012y.
795 X.-R. Tian, H.-F. Tang, J.-T. Feng, Y.-S. Li, H.-W. Lin,
X.-P. Fan and X. Zhang, Mar. Drugs, 2014, 12, 1987–2003,
DOI: 10.3390/md12041987.
796 X.-R. Tian, H.-F. Tang, Y.-S. Li, H.-W. Lin, X.-P. Fan,
J.-T. Feng and X. Zhang, Phytochem. Lett., 2014, 9, 1–6,
DOI: 10.1016/j.phytol.2014.03.010.
797 Y. Kamano, H. P. Zhang, Y. Ichihara, H. Kizu, K. Komiyama
and G. R. Pettit, Tetrahedron Lett., 1995, 36, 2783–2784,
DOI: 10.1016/0040-4039(95)00395-S.
798 P. D. Fernandes, R. S. Zardo, G. S. M. Figueiredo, B. V. Silva
and A. C. Pinto, Life Sci., 2014, 116, 16–24, DOI: 10.1016/
j.lfs.2014.08.019.
799 J. Kilcoyne, P. McCarron, M. J. Twiner, C. Nulty, S. Crain,
M. A. Quilliam, F. Rise, A. L. Wilkins and C. O. Miles,
Chem. Res. Toxicol., 2014, 27, 587–600, DOI: 10.1021/
tx400434b.
800 M. Carbone, M. L. Ciavatta, G. De Rinaldis, F. Castelluccio,
E. Mollo and M. Gavagnin, Tetrahedron, 2014, 70, 3770–
3773, DOI: 10.1016/j.tet.2014.04.046.
801 M. Gavagnin, A. Spinella, A. Crispino, R. D. A. Epifanio,
A. Marin and G. Cimino, Gazz. Chim. Ital., 1993, 123, 205–
208.
802 V. J. Paul, P. Ciminiello and W. Fenical, Phytochemistry,
1988, 27, 1011–1014, DOI: 10.1016/0031-9422(88)80262-0.
803 M. L. Ciavatta, G. Nuzzo, K. Takada, V. Mathieu, R. Kiss,
G. Villani and M. Gavagnin, J. Nat. Prod., 2014, 77, 1678–
1684, DOI: 10.1021/np500298h.
804 W.-F. He, Y. Li, M.-T. Feng, M. Gavagnin, E. Mollo,
S.-C. Mao and Y.-W. Guo, Fitoterapia, 2014, 96, 109–114,
DOI: 10.1016/j.tote.2014.04.011.
805 F. R. Pereira, M. F. C. Santos, D. E. Williams, R. J. Andersen,
V. Padula, A. G. Ferreira and R. G. S. Berlinck, J. Braz. Chem.
Soc., 2014, 25, 788–794, DOI: 10.5935/0103-5053.20140037.
806 S. Khor, S. A. Wood, L. Salvitti, D. I. Taylor, J. Adamson,
P. McNabb and S. C. Cary, Mar. Drugs, 2014, 12, 1–16,
DOI: 10.3390/md12010001.
807 M.-E. F. Hegazy, A. Y. Moustfa, A. El-H, H. Mohamed,
M. A. Alhammady, S. E. I. Elbehairi, S. Ohta and
P. W. Pare´, Tetrahedron Lett., 2014, 55, 1711–1714, DOI:
10.1016/j.tetlet.2014.01.096.Nat. Prod. Rep., 2016, 33, 382–431 | 427





























































































View Article Online808 C. Jime´nez-Romero, A. M. S. Mayer and A. D. Rodr´ıguez,
Bioorg. Med. Chem. Lett., 2014, 24, 344–348, DOI: 10.1016/
j.bmcl.2013.11.008.
809 B. Esmaeelian, C. A. Abbott, R. K. Le Leu and
K. Benkendorﬀ, Mar. Drugs, 2014, 12, 17–35, DOI:
10.3390/md12010017.
810 D. S. Dalisay, E. W. Rogers, A. S. Edison and T. F. Molinski,
J. Nat. Prod., 2009, 72, 732–738, DOI: 10.1021/np8007649.
811 H. Wahyudi, W. Tantisantisom and S. R. McAlpine,
Tetrahedron Lett., 2014, 55, 2389–2393, DOI: 10.1016/
j.tetlet.2014.02.106.
812 A. L. Pietkiewicz, H. Wahyudi, J. R. McConnell and
S. R. McAlpine, Tetrahedron Lett., 2014, 55, 6979–6982,
DOI: 10.1016/j.tetlet.2014.10.089.
813 G. R. Pettit, S. B. Singh, F. Hogan, P. Lloyd-Williams,
D. L. Herald, D. D. Burkett and P. J. Clewlow, J. Am.
Chem. Soc., 1989, 111, 5463–5465, DOI: 10.1021/
ja00196a061.
814 A. Maderna, M. Doroski, C. Subramanyam, A. Porte,
C. A. Leverett, B. C. Vetelino, Z. Chen, H. Risley, K. Parris,
J. Pandit, A. H. Varghese, S. Shanker, C. Song,
S. C. K. Sukuru, K. A. Farley, M. M. Wagenaar,
M. J. Shapiro, S. Musto, M.-H. Lam, F. Loganzo and
C. J. O'Donnell, J. Med. Chem., 2014, 57, 10527–10543,
DOI: 10.1021/jm501649k.
815 Y. Sun, Y. Lin, X. Cao, L. Xiang and J. Qi, Int. J. Mol. Sci.,
2014, 15, 21660–21673, DOI: 10.3390/ijms151221660.
816 E. Hernando, V. Soto-Cerrato, S. Corte´s-Arroyo, R. Pe´rez-
Toma´s and R. Quesada, Org. Biomol. Chem., 2014, 12,
1771–1778, DOI: 10.1039/C3OB42341G.
817 R. J. Andersen, D. J. Faulkner and H. Cun-heng, J. Am.
Chem. Soc., 1985, 107, 5492–5495, DOI: 10.1021/
ja00305a027.
818 C. Ballot, A. Martoriati, M. Jendoubi, S. Buche,
P. Formstecher, L. Mortier, J. Kluza and P. Marchetti,
Mar. Drugs, 2014, 12, 779–798, DOI: 10.3390/md12020779.
819 H. Liu, H. Zhang, H. Zheng, S. Wang, Z. Guo and G. Zhang,
J. Agric. Food Chem., 2014, 62, 12384–12391, DOI: 10.1021/
jf504648f.
820 B. Nguyen, J.-P. Le Caer, R. Ara´oz, R. Thai, H. Lamthanh,
E. Benoit and J. Molgo´, Toxicon, 2014, 91, 155–163, DOI:
10.1016/j.toxicon.2014.10.006.
821 D.-D. Yuana, Y.-H. Hana, C.-G. Wanga and C.-W. Chi,
Toxicon, 2007, 49, 1135–1149, DOI: 10.1016/
j.toxicon.2007.02.011.
822 A. D. Santos, J. M. McIntosh, D. R. Hillyard, L. J. Cruz and
B. M. Olivera, J. Biol. Chem., 2004, 279, 17596–17606, DOI:
10.1074/jbc.M309654200.
823 B. Nguyen, J.-P. Caer, G. Mourier, R. Thai, H. Lamthanh,
D. Servent, E. Benoit and J. Molgo´, Mar. Drugs, 2014, 12,
3449–3465, DOI: 10.3390/md12063449.
824 E. K. M. Lebbe, S. Peigneur, M. Maiti, B. G. Mille, P. Devi,
S. Ravichandran, E. Lescrinier, E. Waelkens, L. D'Souza,
P. Herdewijn and J. Tytgat, Toxicon, 2014, 91, 145–154,
DOI: 10.1016/j.toxicon.2014.08.074.428 | Nat. Prod. Rep., 2016, 33, 382–431825 R. Sonti, K. N. S. Rao, S. Chidanand, K. H. Gowd,
S. Raghothama and P. Balaram, Chem.–Eur. J., 2014, 20,
5075–5086, DOI: 10.1002/chem.201303687.
826 S. Peigneur, M. Paolini-Bertrand, H. Gaertner, D. Biass,
A. Violette, R. Stocklin, P. Favreau, J. Tytgat and
O. Hartley, J. Biol. Chem., 2014, 289, 35341–35350, DOI:
10.1074/jbc.M114.610436.
827 S. Chhabra, A. Belgi, P. Bartels, B. J. van Lierop,
S. D. Robinson, S. N. Kompella, A. Hung, B. P. Callaghan,
D. J. Adams, A. J. Robinson and R. S. Norton, J. Med.
Chem., 2014, 57, 9933–9944, DOI: 10.1021/jm501126u.
828 Y. Wu, X. Wu, J. Yu, X. Zhu, D. Zhangsun and S. Luo,
Molecules, 2014, 19, 966–979, DOI: 10.3390/
molecules19010966.
829 S. V. Sambasivarao, J. Roberts, V. S. Bharadwaj,
J. G. Slingsby, C. Rohleder, C. Mallory, J. R. Groome,
O. M. McDougal and C. M. Maupin, ChemBioChem, 2014,
15, 413–424, DOI: 10.1002/cbic.201300577.
830 S. Wang, T. Du, Z. Liu, S. Wang, Y. Wu, J. Ding, L. Jiang and
Q. Dai, Biochem. Biophys. Res. Commun., 2014, 454, 151–156,
DOI: 10.1016/j.bbrc.2014.10.055.
831 M. Li, S. Chang, L. Yang, J. Shi, K. McFarland, X. Yang,
A. Moller, C. Wang, X. Zou, C. Chi and J. Cui, J. Biol.
Chem., 2014, 289, 4735–4742, DOI: 10.1074/
jbc.M113.535898.
832 S. R. M. Ibrahim, G. A. Mohamed, L. A. Shaala,
D. T. A. Youssef and A. A. Gab-Alla, Nat. Prod. Res., 2014,
28, 1591–1597, DOI: 10.1080/14786419.2014.927874.
833 T. H. Won, M. You, S.-H. Lee, B. J. Rho, D.-C. Oh, K.-B. Oh
and J. Shin,Mar. Drugs, 2014, 12, 3754–3769, DOI: 10.3390/
md12063754.
834 G. A. Mohamed, S. R. M. Ibrahim, J. M. Badr and
D. T. A. Youssef, Tetrahedron, 2014, 70, 35–40, DOI:
10.3390/toxins6020693.
835 L. A. Shaala, D. T. A. Youssef, S. R. M. Ibrahim,
G. A. Mohamed, J. B. Badr, A. L. Risinger and
S. L. Mooberry, Mar. Drugs, 2014, 12, 5021–5034, DOI:
10.3390/md12095021.
836 M. Tadesse, J. Svenson, K. Sepcˇi´c, L. Trembleau,
M. Engqvist, J. H. Andersen, M. Jaspars, K. Stensva˚g and
T. Haug, J. Nat. Prod., 2014, 77, 364–369, DOI: 10.1021/
np401002s.
837 D. Smitha, M. M. K. Kumar, H. Ramana and D. V. Rao, Nat.
Prod. Res., 2014, 28, 12–17, DOI: 10.1080/
14786419.2013.827194.
838 C. Imperatore, F. D'Aniello, A. Aiello, S. Fiorucci,
C. D'Amore, V. Sepe and M. Menna, Mar. Drugs, 2014, 12,
2066–2078, DOI: 10.3390/md12042066.
839 M. T. Jamison, C. N. Boddy and T. F. Molinski, J. Org.
Chem., 2014, 79, 9992–9997, DOI: 10.1021/jo501486p.
840 W. Hassan, R. Edrada, R. Ebel, V. Wray and P. Proksch,
Mar. Drugs, 2004, 2, 88–100, DOI: 10.3390/md203088.
841 C. Murcia, L. Coello, R. Ferna´ndez, M. J. Mart´ın, F. Reyes,
A. Francesch, S. Munt and C. Cuevas, Mar. Drugs, 2014,
12, 1116–1130, DOI: 10.3390/md12021116.This journal is © The Royal Society of Chemistry 2016





























































































View Article Online842 J. C. Kwan, M. D. B. Tianero, M. S. Donia, T. P. Wyche,
T. S. Bugni and E. W. Schmidt, PLoS One, 2014, 9, e95850,
DOI: 10.1371/journal.pone.0095850.
843 W. E. Houssen, A. F. Bent, A. R. McEwan, N. Pieiller,
J. Tabudravu, J. Koehnke, G. Mann, R. I. Adaba,
L. Thomas, U. W. Hawas, H. Liu, U. Schwarz-Linek,
M. C. M. Smith, J. H. Naismith and M. Jaspars, Angew.
Chem., Int. Ed., 2014, 53, 14171–14174, DOI: 10.1002/
anie.201408082.
844 B. C. M. Potts, D. J. Faulkner, J. A. Chan, G. C. Simolike,
P. Oﬀen, M. E. Hemling and T. A. Francis, J. Am. Chem.
Soc., 1991, 113, 6321–6322, DOI: 10.1021/ja00016a087.
845 H. Fuwa, T. Muto, K. Sekine and M. Sasaki, Chem.–Eur. J.,
2014, 20, 1848–1860, DOI: 10.1002/chem.201303713.
846 F.-M. Zhang and Y.-Q. Tu, Tetrahedron Lett., 2014, 55, 3784–
3787, DOI: 10.1016/j.tetlet.2014.05.065.
847 H. H. Issa, J. Tanaka, R. Rachmat, A. Setiawan, A. Trianto
and T. Higa, Mar. Drugs, 2005, 3, 78–83, DOI: 10.3390/
md303078.
848 J. In, S. Lee, Y. Kwon and S. Kim, Chem.–Eur. J., 2014, 20,
17433–17442, DOI: 10.1002/chem.201404316.
849 N. Gonzalez, J. Rodriguez and C. Jimenez, J. Org. Chem.,
1999, 64, 5705–5707, DOI: 10.1021/jo9903914.
850 J. Ren and R. Tong, J. Org. Chem., 2014, 79, 6987–6995, DOI:
10.1021/jo501142q.
851 J. Sikorska, A. M. Hau, C. Anklin, S. Parker-Nance,
M. T. Davies-Coleman, J. E. Ishmael and K. L. McPhail, J.
Org. Chem., 2012, 77, 6066–6075, DOI: 10.1021/jo3008622.
852 H. Lei, J. Yan, J. Yu, Y. Liu, Z. Wang, Z. Xu and T. Ye, Angew.
Chem., Int. Ed., 2014, 53, 6533–6537, DOI: 10.1002/
anie.201403542.
853 L. Garrido, J. Org. Chem., 2003, 68, 293–299, DOI: 10.1021/
jo020487p.
854 M. Matveenko, G. Liang and E. M. W. Lauterwasser, J. Am.
Chem. Soc., 2012, 134, 9291–9295, DOI: 10.1021/ja301326k.
855 Y. Momoi, K.-i. Okuyama, H. Toya, K. Sugimoto, K. Okano
and H. Tokuyama, Angew. Chem., Int. Ed., 2014, 53, 13215–
13219, DOI: 10.1002/anie.201407686.
856 A. N. Pearce, D. R. Appleton, R. C. Babcock and B. R. Copp,
Tetrahedron Lett., 2003, 44, 3897–3899, DOI: 10.1016/S0040-
4039(03)00831-1.
857 A. E. R. Jolibois, W. Lewis and C. J. Moody, Org. Lett., 2014,
16, 1064–1067, DOI: 10.1021/ol403598k.
858 M. Tadesse, M. B. Strom, J. Svenson, M. Jaspars, B. F. Milne,
V. Torfoss, J. H. Andersen, E. Hansen, K. Stensvag and
T. Haug, Org. Lett., 2010, 12, 4752–4755, DOI: 10.1021/
ol101707u.
859 N. V. Shymanska, I. H. An and J. G. Pierce, Angew. Chem.,
Int. Ed., 2014, 53, 5401–5404, DOI: 10.1002/anie.201402310.
860 R. Trepos, G. Cervin, C. Hellio, H. Pavia, W. Stensen,
K. Stensva˚g, J.-S. Svendsen, T. Haug and J. Svenson, J.
Nat. Prod., 2014, 77, 2105–2113, DOI: 10.1021/np5005032.
861 D. M. Tapiolas, B. F. Bowden, E. Abou-Mansour,
R. H. Willis, J. R. Doyle, A. N. Muirhead, C. Liptrot,
L. E. Llewellyn and C. W. Wolﬀ, J. Nat. Prod., 2009, 72,
1115–1120, DOI: 10.1021/np900099j.This journal is © The Royal Society of Chemistry 2016862 M. Liberio, M. Sadowski, C. Nelson and R. Davis, Mar.
Drugs, 2014, 12, 5222–5239, DOI: 10.3390/md12105222.
863 K. Nozawa, M. Tsuda, H. Ishiyama, T. Sasaki, T. Tsuruo and
R. Kobayashi, Bioorg. Med. Chem., 2006, 14, 1063–1067,
DOI: 10.1016/j.bmc.2005.09.033.
864 S. Kazami, M. Takaine, H. Itoh, T. Kubota, J. Kobayashi and
T. Usui, Biol. Pharm. Bull., 2014, 37, 1944–1947, DOI:
10.1248/bpb.b14-00548.
865 H. Atmaca and S. Uzunoglu, Eur. Cytokine Network, 2014,
25, 1–7, DOI: 10.1684/ecn.2014.0347.
866 D.-S. Lee, X. Cui, W. Ko, K.-S. Kim, I. C. Kim, J. H. Yim,
R.-B. An, Y.-C. Kim and H. Oh, Arch. Pharmacal Res., 2014,
37, 983–991, DOI: 10.1007/s12272-013-0269-18.
867 N. P. Mishchenko, E. A. Vasileva and S. A. Fedoreyev,
Tetrahedron Lett., 2014, 55, 5967–5969, DOI: 10.1016/
j.tetlet.2014.09.018.
868 A. A. Kicha, A. I. Kalinovskii, N. V. Ivanchina,
T. V. Malyarenko, R. S. Popov, F. K. Long and N. A. Hung,
Chem. Nat. Compd., 2014, 50, 1032–1036, DOI: 10.1007/
s10600-014-1153-z6.
869 N. P. Thao, B. T. T. Luyen, T. L. Vien, B. H. Tai, D. L. Dat,
N. X. Cuong, N. H. Nam, P. V. Kiem, C. V. Minh and
Y. H. Kim, Nat. Prod. Commun., 2014, 9, 615–623.
870 A. S. Silchenko, A. I. Kalinovsky, S. A. Avilov,
P. V. Andryjaschenko, P. S. Dmitrenok, E. A. Yurchenko,
I. Y. Dolmatov, A. M. Savchenko and V. I. Kalinin, Nat.
Prod. Commun., 2014, 9, 1421–1429.
871 R. S. Popov, S. A. Avilov, A. S. Silchenko, A. I. Kalinovsky,
P. S. Dmitrenok, B. B. Grebnev, N. V. Ivanchina and
V. I. Kalinin, Biochem. Syst. Ecol., 2014, 57, 191–197, DOI:
10.1016/j.bse.2014.08.009.
872 V. P. Careaga, C. Bueno, C. Muniain, L. Alche´ and
M. S. Maier, Nat. Prod. Res., 2014, 28, 213–220, DOI:
10.1080/14786419.2012.751596.
873 X.-H. Wang, Z.-R. Zou, Y.-H. Yi, H. Han, L. Li andM.-X. Pan,
Mar. Drugs, 2014, 12, 2004–2018, DOI: 10.3390/
md12042004.
874 T. V. Malyarenko, A. A. Kicha, N. V. Ivanchina,
A. I. Kalinovsky, R. S. Popov, O. S. Vishchuk and
V. A. Stonik, Steroids, 2014, 87, 119–127, DOI: 10.1016/
j.steroids.2014.05.027.
875 M. Elbandy, J. R. Rho and R. A, Eur. Food Res. Technol.,
2014, 238, 937–955, DOI: 10.1007/s00217-014-2171-6.
876 Y. Bahrami, W. Zhang, T. Chataway and C. Franco, Mar.
Drugs, 2014, 12, 4439–4473, DOI: 10.3390/md12084439.
877 M. Demeyer, J. De Winter, G. Caulier, I. Eeckhaut,
P. Flammang and P. Gerbaux, Comp. Biochem. Physiol.,
Part B: Biochem. Mol. Biol., 2014, 168, 1–11, DOI: 10.1016/
j.cbpb.2013.10.004.
878 J. M. Sciani, M. C. Sampaio, B. C. Zychar, L. R. deC.
Gonçalves, R. Giorgi, T. de O. Nogueira, R. L. de Melo,
C. de F. P. Teixeira and D. C. Pimenta, Peptides, 2014, 53,
13–21, DOI: 10.1016/j.peptides.2013.07.031.
879 N. Ueki, K. Someya, Y. Matsuo, K. Wakamatsu and
H. Mukai, Pept. Sci., 2007, 88, 190–198, DOI: 10.1002/
bip.20687.Nat. Prod. Rep., 2016, 33, 382–431 | 429





























































































View Article Online880 R. E. Moore, H. Singh and P. J. Scheuer, Tetrahedron Lett.,
1968, 4581–4583, DOI: 10.1016/S0040-4039(01)99190-7.
881 N. D. Pokhilo, G. I. Mel'man, V. P. Glazunov and
V. F. Anufriev, Chem. Nat. Compd., 2014, 50, 417–419,
DOI: 10.1007/s10600-014-0974-0.
882 R. E. Moore, H. Singh and P. J. Scheuer, J. Org. Chem., 1966,
31, 3645–3650, DOI: 10.1021/jo01349a040.
883 E. Pen˜a-Cabrera and L. S. Liebeskind, J. Org. Chem., 2002,
67, 1689–1691, DOI: 10.1021/jo016034m.
884 S. Jeong, H. Kim, I.-S. Song, S. Noh, J. Marquez, K. Ko,
B. Rhee, N. Kim, N. Mishchenko, S. Fedoreyev, V. Stonik
and J. Han, Mar. Drugs, 2014, 12, 4602–4615, DOI:
10.3390/md12084602.
885 S. H. Jeong, H. K. Kim, I.-S. Song, S. J. Lee, K. S. Ko,
B. D. Rhee, N. Kim, N. P. Mishchenko, S. A. Fedoryev,
V. A. Stonik and J. Han, Mar. Drugs, 2014, 12, 2922–2936,
DOI: 10.3390/md12052922.
886 S. Lee, J. Pronto, B.-E. Sarankhuu, K. Ko, B. Rhee, N. Kim,
N. Mishchenko, S. Fedoreyev, V. Stonik and J. Han, Mar.
Drugs, 2014, 12, 3560–3573, DOI: 10.3390/md12063560.
887 N. P. Mischenko, S. A. Fedoreyev, N. D. Pokhilo,
V. P. Anufriev, V. A. Denisenko and V. P. Glazunov, J. Nat.
Prod., 2005, 68, 1390–1393, DOI: 10.1021/np049585r.
888 V. P. Glazunov, D. V. Berdyshev and V. L. Novikov, Russ.
Chem. Bull., 2014, 63, 1993–1999, DOI: 10.1007/s11172-
014-0690-8.
889 I. R. Smith and M. D. Sutherland, Aust. J. Chem., 1971, 24,
1487–1499, DOI: 10.1071/CH9711487.
890 L.-C. Chen, Y.-Y. Lin, Y.-H. Jean, Y. Lu, W.-F. Chen,
S.-N. Yang, H.-M. Wang, I.-Y. Jang, I.-M. Chen, J.-H. Su,
P.-J. Sung, J.-H. Sheu and Z.-H. Wen, Molecules, 2014, 19,
14667–14686, DOI: 10.3390/molecules190914667.
891 E. Turner, R. Klevit, L. J. Hager and B. M. Shapiro,
Biochemistry, 1987, 26, 4028–4036, DOI: 10.1021/
bi00387a043.
892 A. Mirzahosseini, S. Hoszta, G. To´th and B. Nosza´l,
ARKIVOC, 2014, 2014, 1–9, DOI: 10.3998/
ark.5550190.p008.872.
893 H. Song, A. S. Her, F. Raso, Z. Zhen, Y. Huo and P. Liu, Org.
Lett., 2014, 16, 2122–2125, DOI: 10.1021/ol5005438.
894 A. Mirzahosseini, G. Orgova´n, S. Hoszta and B. Nosza´l,
Anal. Bioanal. Chem., 2014, 406, 2377–2387, DOI: 10.1007/
s00216-014-7631-0.
895 G. Russo, M. Russo, I. Castellano, A. Napolitano and
A. Palumbo, Mar. Drugs, 2014, 12, 4069–4085, DOI:
10.3390/md12074069.
896 D. M. Pereira, G. Correia-da-Silva, P. Valenta˜o, N. Teixeira
and P. B. Andrade, PLoS One, 2014, 9, e88341, DOI:
10.1371/journal.pone.0088341.
897 D. M. Pereira, G. Correia-da-Silva, P. Valenta˜o, N. Teixeira
and P. B. Andrade, Mar. Drugs, 2014, 12, 54–68, DOI:
10.3390/md12010054.
898 C. E. Jones, C. B. Otara, N. D. Younan, J. H. Viles and
M. R. Elphick, Biochim. Biophys. Acta, Biomembr., 2014,
1844, 1842–1850, DOI: 10.1016/j.bbapap.2014.08.001.430 | Nat. Prod. Rep., 2016, 33, 382–431899 M. Girard, J. Belanger, J. W. ApSimon, F. X. Garneau,
C. Harvey and J. R. Brisson, Can. J. Chem., 1990, 68, 11–
18, DOI: 10.1139/v90-003.
900 J. Al Shemaili, E. Mensah-Brown, K. Parekh, S. A. Thomas,
S. Attoub, B. Hellman, F. Nyberg, A. Adem, P. Collin and
T. E. Adrian, Eur. J. Cancer, 2014, 50, 1391–1398, DOI:
10.1016/j.ejca.2014.01.002.
901 T. H. Quang, D.-S. Lee, S. J. Han, I. C. Kim, J. H. Yim,
Y.-C. Kim and H. Oh, Bull. Korean Chem. Soc., 2014, 35,
2335–2341, DOI: 10.5012/bkcs.2014.35.8.2335.
902 J. Wang, H. Han, X. Chen, Y. Yi and H. Sun, Mar. Drugs,
2014, 12, 4274–4290, DOI: 10.3390/md12084274.
903 Y. Wang, J. Wang, R. C. Yanagita, C. Liu, X. Hu, P. Dong,
C. Xue and Y. Xue, Biosci., Biotechnol., Biochem., 2014, 78,
139–146, DOI: 10.1080/09168451.2014.877830.
904 A. S. Silchenko, A. I. Kalinovsky, S. A. Avilov,
P. V. Andryjaschenko, P. S. Dmitrenok, E. A. Martyyas,
V. I. Kalinin, P. Jayasandhya, G. C. Rajan and
K. P. Padmakumar, Nat. Prod. Commun., 2013, 8, 301–310.
905 E. A. Pislyagin, D. L. Aminin, A. S. Silchenko, S. A. Avilov,
P. V. Andryjashchenko, V. I. Kalinin and K. Padmakumar,
Nat. Prod. Commun., 2014, 9, 771–772.
906 I. H. Hwang, R. Kulkarni, M. H. Yang, S. J. Choo, W. Zhou,
S. M. Lee, T. S. Jang, G.-S. Jeong, H. W. Chang and M. Na,
Arch. Pharmacal Res., 2014, 37, 1252–1263, DOI: 10.1007/
s12272-014-0374-9.
907 X.-X. Yi, Y. Chen, W.-P. Xie, M.-B. Xu, Y.-N. Chen, C.-H. Gao
and R.-M. Huang, Mar. Drugs, 2014, 12, 2515–2525, DOI:
10.3390/md12052515.
908 C.-H. Gao, X.-X. Yi, W.-P. Xie, Y.-N. Chen, M.-B. Xu,
Z.-W. Su, L. Yu and R.-M. Huang, Mar. Drugs, 2014, 12,
4353–4360, DOI: 10.3390/md12084353.
909 H. Wang, M.-Y. Li, F. Z. Katele, T. Satyanandamurty, J. Wu
and G. Bringmann, Beilstein J. Org. Chem., 2014, 10, 276–
281, DOI: 10.3762/bjoc.10.23.
910 X. Luo, Y. Huang, S. Zhang, H. Yin, C. Li and Q. Li, Biochem.
Syst. Ecol., 2014, 56, 191–195, DOI: 10.1016/
j.bse.2014.05.018.
911 Z.-F. Zhou, O. Taglialatela-Scafati, H.-L. Liu, Y.-C. Gu,
L.-Y. Kong and Y.-W. Guo, Fitoterapia, 2014, 97, 192–197,
DOI: 10.1016/j.tote.2014.06.009.
912 C. Sarigaputi, D. Sommit, T. Teerawatananond and
K. Pudhom, J. Nat. Prod., 2014, 77, 2037–2043, DOI:
10.1021/np5003687.
913 Z.-F. Zhou, H.-L. Liu, W. Zhang, T. Kurta´n, A. Ma´ndi,
A. Be´nyei, J. Li, O. Taglialatela-Scafati and Y.-W. Guo,
Tetrahedron, 2014, 70, 6444–6449, DOI: 10.1016/
j.tet.2014.07.027.
914 Y.-B. Wu, X. Qing, C.-H. Huo, H.-M. Yan, Q.-W. Shi,
F. Sauriol, Y.-C. Gu and H. Kiyota, Tetrahedron, 2014, 70,
4557–4562, DOI: 10.1016/j.tet.2014.04.062.
915 M.-Y. Li, Q. Xiao, T. Satyanandamurty and J. Wu, Chem.
Biodiversity, 2014, 11, 262–275, DOI: 10.1002/
cbdv.201300057.
916 W. Chen, L. Shen, M. Li, Q. Xiao, T. Satyanandamurty and
J. Wu, Fitoterapia, 2014, 94, 108–113, DOI: 10.1016/
j.tote.2014.02.001.This journal is © The Royal Society of Chemistry 2016





























































































View Article Online917 Y. Wu, Y. Bai, X. Guo, J. Qi, M. Dong, F. Sauriol, Q. Shi,
Y. Gu and C. Huo, Chem. Nat. Compd., 2014, 50, 314–316,
DOI: 10.1007/s10600-014-0940-x.
918 C. Ito, S. Katsuno, Y. Kondo, H. T.-W. Tan and H. Furukawa,
Chem. Pharm. Bull., 2000, 48, 339–343, DOI: 10.1248/
cpb.48.339.
919 R. Jain, O. Monthakantirat, P. Tengamnuay and W. De-
Eknamkul, Molecules, 2014, 19, 6809–6821, DOI: 10.3390/
molecules19056809.
920 G.-C. Gao, X.-M. Luo, X.-Y. Wei, S.-H. Qi, H. Yin, Z.-H. Xiao
and S. Zhang, Helv. Chim. Acta, 2010, 93, 339–344, DOI:
10.1002/hlca.200900193.
921 J.-X. Liu, M.-Q. Luo, M. Xia, Q. Wu, S.-M. Long, Y. Hu,
G.-C. Gao, X.-L. Yao, M. He, H. Su, X.-M. Luo and
S.-Z. Yao, Mar. Drugs, 2014, 12, 2790–2801, DOI: 10.3390/
md12052790.
922 M. S. J. Carliera, J. Guitton, F. Be´valot, L. Fanton and
Y. Gaillard, J. Chromatogr. B: Anal. Technol. Biomed. Life
Sci., 2014, 962, 1–8, DOI: 10.1016/j.jchromb.2014.05.014.
923 Y. Deng, Y. Liao, J. Li, L. Yang, H. Zhong, Q. Zhou and
Z. Qing, Nat. Prod. Commun., 2014, 9, 1265–1268.
924 A. S. Devi, J. Rajkunar and T. K. Beenish, Asian J. Chem.,
2014, 26, 458–460, DOI: 10.14233/ajchem.2014.15442.
925 J. Boukouvalas and M.-A. Jean, Tetrahedron Lett., 2014, 55,
4248–4250, DOI: 10.1016/j.tetlet.2014.05.054.
926 J.-P. Yin, C.-L. Tang, L.-X. Gao, W.-P. Ma, J.-Y. Li, Y. Li, J. Li
and F.-J. Nan, Org. Biomol. Chem., 2014, 12, 3441–3445,
DOI: 10.1039/c4ob00214h.
927 X. L. Chen, H. L. Liu, J. Li, G. R. Xin and Y. W. Guo, Org.
Lett., 2011, 13, 5032–5035, DOI: 10.1021/ol201809q.
928 U. W. Hawas, Chem. Nat. Compd., 2014, 50, 629–632, DOI:
10.1007/s10600-014-1040-74.
929 M. M. D. Mohammed, A.-H. A. Hamdy, N. M. El-Fiky,
W. S. A. Mettwally, A. A. El-Beih and N. Kobayashi, Nat.This journal is © The Royal Society of Chemistry 2016Prod. Res., 2014, 28, 377–382, DOI: 10.1080/
14786419.2013.869694.
930 J. Rodr´ıguez, R. M. Nieto, M. Blanco, F. A. Valeriote,
C. Jime´nez and P. Crews, Org. Lett., 2014, 16, 464–467,
DOI: 10.1021/ol403350e.
931 T. V. Ovchinnikova, G. M. Aleshina, S. V. Balandin,
A. D. Krasnosdembskaya, M. L. Markelov, E. I. Frolova,
Y. F. Leonova, A. A. Tagaev, E. G. Krasnodembsky and
V. N. Kokryakov, FEBS Lett., 2004, 577, 209–214, DOI:
10.1016/j.febslet.2004.10.012.
932 A. L. Maltseva, O. N. Kotenko, V. N. Kokryakov,
V. V. Starunov and A. D. Krasnodembskaya, Frontiers in
Physiology, 2014, 5, 497, DOI: 10.3389/fphys.2014.00497.
933 M. Nakamura, T. Suzuki, N. Ishizaka, J. Sato and S. Inouye,
Tetrahedron, 2014, 70, 2161–2168, DOI: 10.1016/
j.tet.2014.01.075.
934 Y. Kudo, J. Finn, K. Fukushima, S. Sakugawa, Y. Cho,
K. Konoki and M. Yotsu-Yamashita, J. Nat. Prod., 2014,
77, 1000–1004, DOI: 10.1021/np401097n.
935 S. Subramanian, N. W. Ross and S. L. MacKinnon, Mar.
Biotechnol., 2009, 11, 748–757, DOI: 10.1007/s10126-009-
9189-y.
936 M. Cantisani, E. Finamore, E. Mignogna, A. Falanga,
G. F. Nicoletti, C. Pedone, G. Morelli, M. Leone,
M. Galdiero and S. Galdiero, Antimicrob. Agents
Chemother., 2014, 58, 5280–5290, DOI: 10.1128/
AAC.02395-149.
937 H.-N. Huang, C.-Y. Pan, Y.-L. Chan, J.-Y. Chen and C.-J. Wu,
Antimicrob. Agents Chemother., 2014, 58, 1538–1545, DOI:
10.1128/aac.02427-133.
938 M. S. Taleshi, R. K. Seidler-Egdal, K. B. Jensen,
T. Schwerdtle and K. A. Francesconi, Organometallics,
2014, 33, 1397–1403, DOI: 10.1021/om40110926.Nat. Prod. Rep., 2016, 33, 382–431 | 431
